<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">52779</article-id><article-id pub-id-type="doi">10.7554/eLife.52779</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-ß-catenin</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-161822"><name><surname>Zhou</surname><given-names>Taifeng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-161823"><name><surname>Gao</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178050"><name><surname>Fan</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161824"><name><surname>Liu</surname><given-names>Yuchen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><contrib contrib-type="author" id="author-161826"><name><surname>Feng</surname><given-names>Shuhao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161825"><name><surname>Cong</surname><given-names>Qian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161836"><name><surname>Zhang</surname><given-names>Xiaolei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161828"><name><surname>Zhou</surname><given-names>Yaxing</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161829"><name><surname>Yadav</surname><given-names>Prem S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161830"><name><surname>Lin</surname><given-names>Jiachen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161831"><name><surname>Wu</surname><given-names>Nan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9429-2889</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161832"><name><surname>Zhao</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161833"><name><surname>Huang</surname><given-names>Dongsheng</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161834"><name><surname>Zhou</surname><given-names>Shuanhu</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-161835"><name><surname>Su</surname><given-names>Peiqiang</given-names></name><email>supq@mail.sysu.edu.cn</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-30284"><name><surname>Yang</surname><given-names>Yingzi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3933-887X</contrib-id><email>yingzi_yang@hsdm.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="dataset1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Developmental Biology, Harvard School of Dental Medicine, Harvard Stem Cell Institute</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Orthopaedic Surgery, Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University</institution><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution>Department of Spine Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University</institution><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff4"><label>4</label><institution>Department of Orthopedic Surgery, Nanfang Hospital, Southern Medical University</institution><addr-line><named-content content-type="city">Guangdong</named-content></addr-line><country>China</country></aff><aff id="aff5"><label>5</label><institution>Department of Operative Dentistry and Endodontics, Guanghua School of Stomatology, Sun Yat-sen University</institution><addr-line><named-content content-type="city">Guangzhou</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution>Department of Orthopedic Surgery and Beijing Key Laboratory for Genetic Research of Skeletal Deformity, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences</institution><addr-line><named-content content-type="city">Beijing</named-content></addr-line><country>China</country></aff><aff id="aff7"><label>7</label><institution>Department of Orthopedic Surgery, Brigham and Women's Hospital</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Reviewing Editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Rosen</surname><given-names>Clifford J</given-names></name><role>Senior Editor</role><aff><institution>Maine Medical Center Research Institute</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>03</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e52779</elocation-id><history><date date-type="received" iso-8601-date="2019-10-16"><day>16</day><month>10</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-03-17"><day>17</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Zhou et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Zhou et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-52779-v2.pdf"/><abstract><p>Mechanical forces are fundamental regulators of cell behaviors. However, molecular regulation of mechanotransduction remain poorly understood. Here, we identified the mechanosensitive channels Piezo1 and Piezo2 as key force sensors required for bone development and osteoblast differentiation. Loss of Piezo1, or more severely Piezo1/2, in mesenchymal or osteoblast progenitor cells, led to multiple spontaneous bone fractures in newborn mice due to inhibition of osteoblast differentiation and increased bone resorption. In addition, loss of Piezo1/2 rendered resistant to further bone loss caused by unloading in both bone development and homeostasis. Mechanistically, Piezo1/2 relayed fluid shear stress and extracellular matrix stiffness signals to activate Ca<sup>2+</sup> influx to stimulate Calcineurin, which promotes concerted activation of NFATc1, YAP1 and ß-catenin transcription factors by inducing their dephosphorylation as well as NFAT/YAP1/ß-catenin complex formation. Yap1 and ß-catenin activities were reduced in the Piezo1 and Piezo1/2 mutant bones and such defects were partially rescued by enhanced ß-catenin activities.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>piezo1/2</kwd><kwd>bone</kwd><kwd>osteoblast</kwd><kwd>hippo signaling</kwd><kwd>wnt signaling</kwd><kwd>mechanotransduction</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>R01DE025866</award-id><principal-award-recipient><name><surname>Cong</surname><given-names>Qian</given-names></name><name><surname>Yang</surname><given-names>Yingzi</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><award-id>R01AR070877</award-id><principal-award-recipient><name><surname>Yadav</surname><given-names>Prem S</given-names></name><name><surname>Yang</surname><given-names>Yingzi</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA222571</award-id><principal-award-recipient><name><surname>Liu</surname><given-names>Yuchen</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004543</institution-id><institution>China Scholarship Council</institution></institution-wrap></funding-source><award-id>201806380049</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Taifeng</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004543</institution-id><institution>China Scholarship Council</institution></institution-wrap></funding-source><award-id>201806210436</award-id><principal-award-recipient><name><surname>Lin</surname><given-names>Jiachen</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000069</institution-id><institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Fan</surname><given-names>Yi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Mechanosensitive channels Piezo1/2 are required for osteoblast differentiation from progenitors by sensing fluid sheer stress and matrix rigidity and regulating NFATc1, YAP1 and ß-catenin activities through Ca<sup>2+</sup> stimulated phosphatase calcineurin.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Mechanical forces are part of environmental cues that are sensed and responded to during embryonic development and adult life for proper morphogenesis and tissue/organ functions. Apart from the well-known complex networks of biochemical signaling that direct the development of higher vertebrate embryos, cells also constantly receive mechanical information from their environment in the form of biophysical stimuli such as stress, strain and fluid flow, which are generated by gravity, cell movement and cell-cell or cell-extracellular matrix (ECM) interactions. The process of mechanotransduction, conversion of mechanical forces into biological signals, is a fundamental physiologic process critical for revealing environmental features to almost all cells in an organism. However, despite the long-recognized key regulatory roles of mechanotransduction for embryonic development and sensory perception (<xref ref-type="bibr" rid="bib105">Wozniak and Chen, 2009</xref>), little concrete information on the molecular mechanisms that integrate biophysical stimuli with gene regulation to guide fundamental events such as cell fate determination, proliferation and apoptosis is known. Among all organs, mechanotransduction is especially important in the skeleton system as its development and physiological functions require consistently sensing and responding to mechanical forces. A range of human conditions in which fetal movement is diminished were found to impact severely on skeletal development (<xref ref-type="bibr" rid="bib73">Nowlan et al., 2010a</xref>). For instance, diseases of the neuromuscular system, such as congenital myotonic dystrophy (<xref ref-type="bibr" rid="bib100">Wesström et al., 1986</xref>) or spinal muscle atrophy (<xref ref-type="bibr" rid="bib72">Nicole et al., 2002</xref>) have a dramatic effect on skeletal development leading to smaller, thinner and weaker long bones, prone to postnatal fracture (<xref ref-type="bibr" rid="bib82">Rodríguez et al., 1988a</xref>; <xref ref-type="bibr" rid="bib83">Rodríguez et al., 1988b</xref>). Indeed, embryonic bone formation was reduced in experimentally induced muscle paralysis in chick (<xref ref-type="bibr" rid="bib34">Hall and Herring, 1990</xref>) or genetically engineered ‘muscleless/reduced muscle’ mouse mutant embryos (<xref ref-type="bibr" rid="bib74">Nowlan et al., 2010b</xref>). In postnatal life, rapid loss of bone mass and even osteoporosis in some cases due to a lack of load caused by prolonged bed rest, spinal cord injury or space flight and the bone anabolic effects of exercise are well documented. The major skeletal cells such as mesenchymal stem cells and the derived osteoblasts, chondrocytes and osteocytes are mechanical receptor cells that perceive and respond to forces, such as those generated by cell-ECM interactions or fluid shear stress (FSS). Ion channels including the transient receptor potential (TRP) polycystin family members have been found to regulate bone development (<xref ref-type="bibr" rid="bib45">Katsianou et al., 2018</xref>). However, the molecular mechanisms whereby mechanical signals are sensed and converted by skeletal cells to biochemical signals leading to transcription factor activation (<xref ref-type="bibr" rid="bib40">Huang and Ogawa, 2010</xref>) and eventually specific cellular responses such as cell fate determination (<xref ref-type="bibr" rid="bib23">Duncan and Turner, 1995</xref>) remain largely unknown.</p><p>Recent advancement in mechanotransduction research (<xref ref-type="bibr" rid="bib42">Ingber, 2006</xref>; <xref ref-type="bibr" rid="bib48">Kelly and Jacobs, 2010</xref>; <xref ref-type="bibr" rid="bib66">McMahon et al., 2008</xref>; <xref ref-type="bibr" rid="bib33">Halder et al., 2012</xref>; <xref ref-type="bibr" rid="bib41">Humphrey et al., 2014</xref>) has opened the door to providing molecular understanding of mechanical force sensing and downstream regulatory events in multiple biological systems. The mechanosensitive (MS) Piezo1 and Piezo2 channels are to date the best characterized biological force-sensing systems (<xref ref-type="bibr" rid="bib78">Parpaite and Coste, 2017</xref>) that are involved in processes as diverse as perceiving touch or regulating the volume of red blood cells in mammals (<xref ref-type="bibr" rid="bib62">Martinac, 2012</xref>; <xref ref-type="bibr" rid="bib16">Coste et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Murthy et al., 2017</xref>). The transcription factors Yap1 and Wwtr1 (also known as TAZ) in the Hippo signaling pathway have been identified as essential effectors of mechanotransduction (<xref ref-type="bibr" rid="bib33">Halder et al., 2012</xref>; <xref ref-type="bibr" rid="bib2">Aragona et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">Codelia et al., 2014</xref>; <xref ref-type="bibr" rid="bib96">Wada et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">Dupont et al., 2011</xref>). The Piezo channels are the first type of MS channels documented to underlie a human disease linked to mechanical pathologies including a number of blood disorders and problems with proprioception (<xref ref-type="bibr" rid="bib11">Chesler et al., 2016</xref>). While recent studies showed that Piezo1 in osteoblast cells and osteocytes are required for bone formation and regulating bone resorption in postnatal mice (<xref ref-type="bibr" rid="bib90">Sun et al., 2019</xref>; <xref ref-type="bibr" rid="bib54">Li et al., 2019</xref>; <xref ref-type="bibr" rid="bib98">Wang et al., 2020</xref>), we additionally investigated in this study the functions and molecular mechanisms of both Piezo 1 and 2 channels in embryonic skeletal development and bone marrow stromal cells (BMSCs). Our work identifies Piezo1/2 and the downstream mechanotransduction pathways as key regulators that link mechanical microenvironment to a signal transduction cascade leading to nuclear transcriptional changes to promote bone formation in development and osteoblast differentiation from stem cells. Our studies provide mechanistic insights to decipher the functions of PIEZO1 in human skeleton. Human PIEZO1 SNPs are associated with body height reduction (<xref ref-type="bibr" rid="bib61">Marouli et al., 2017</xref>). In a recent estimated bone mineral density (eBMD) GWAS of 426,824 individuals in the UK Biobank (<xref ref-type="bibr" rid="bib68">Morris et al., 2019</xref>), novel genetic influences on osteoporosis in humans were identified with two SNPs (rs4238686, rs11643303) in PIEZO1 among the 1103 conditionally independent signals (423 novel) at genome-wide significance (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> Table 2 <xref ref-type="bibr" rid="bib68">Morris et al., 2019</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Piezo 1 and 2 are expressed in the developing long bones</title><p>To test our hypothesis that the MS Piezo channels are key mechanosensors required for skeletal development and homeostasis, we first examined their expression in the developing limb buds, in which long bones form through endochondral ossification. At E12.5 to E14.5, when endochondral bone initiates, we found by whole mount in situ hybridization (WISH) that <italic>Piezo1</italic> is mostly expressed in the interdigit region while <italic>Piezo2</italic> is expressed in the forming digit and wrist (<xref ref-type="fig" rid="fig1">Figure 1a</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a,b</xref>). To further determine the expression of <italic>Piezo1</italic> in the developing long bones, we performed in situ hybridization with <italic>Piezo1</italic> probes using the RNAscope technology on sections (<xref ref-type="bibr" rid="bib97">Wang et al., 2012</xref>). <italic>Piezo1</italic> was most strongly expressed in the connective tissues associated with the muscle and weaker expression of <italic>Piezo1</italic> expression was detected in the muscle and differentiating osteoblast cells in the perichondrium and periosteum (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c</xref>). The weak <italic>Piezo1</italic> expression in the skeletal tissue prompted us to determine Piezo1 protein expression utilizing the <italic>Piezo1<sup>P1-tdT</sup></italic> mice that allow sensitive detection of Piezo1 protein in vivo by expressing a C-terminus fusion protein of Piezo1 with the fluorescent tdTomato reporter from the <italic>Piezo1</italic> locus (<xref ref-type="bibr" rid="bib79">Ranade et al., 2014</xref>). As the direct red fluorescent signal was weak, we used anti-RFP antibodies to detect tdTomato (<xref ref-type="fig" rid="fig1">Figure 1b,c</xref>). Consistent with the in situ hybridization data (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c</xref>), Piezo1 protein was detected in the connective tissue, the associated muscle and differentiating osteoblast cells that express Osterix (Sp7) in the perichondrium and periosteum at E13.5, E15.5 and postnatal day 0 (P0) neonatal pups (<xref ref-type="fig" rid="fig1">Figure 1b,c</xref>). Piezo1 expression was also detected in the hypertrophic chondrocytes, tendons and ligaments (<xref ref-type="fig" rid="fig1">Figure 1b,c</xref>). To detect Piezo2 protein expression, we took an indirect approach using the <italic>Piezo2-EGFP-IRES-Cre</italic> (<italic>Piezo2<sup>EGFP-Cre</sup></italic>) mice that express Piezo2-EGFP-Cre fusion protein from the endogenous <italic>Piezo2</italic> locus (<xref ref-type="bibr" rid="bib104">Woo et al., 2014</xref>). The EGFP signal was too weak to be reliably detected, so we crossed the <italic>Piezo2<sup>EGFP-Cre</sup></italic> mouse with a Rosa-tdTomato reporter mouse (JAX stock # 007914). The tdTomato<sup>+</sup> Piezo2 lineage cells (Piezo2<sup>+</sup> cells and their descendants) included Sp7<sup>+</sup> osteoblast cells, joint cells, sporadic growth plate chondrocytes, tendons and connective tissue cells in the muscle (<xref ref-type="fig" rid="fig1">Figure 1d</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1d,e</xref>). Consistent with previous studies, Piezo2-derived tdTomato<sup>+</sup> cells were found in the skin (<xref ref-type="fig" rid="fig1">Figure 1d</xref>). Taken together, these results show that both Piezo1 and 2 were expressed mostly in the differentiating osteoblasts in the developing skeleton and Piezo1 was also expressed in hypertrophic chondrocytes, suggesting that they may regulate mechanotransduction during bone development.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Characterization of Piezo1 and Piezo2 expression in the developing long bones.</title><p>(<bold>a</bold>) Expression of <italic>Piezo1</italic> and <italic>Piezo2</italic> examined by whole-mount in situ hybridization of embryonic limb buds at the indicated stages. (<bold>b</bold>) Immunostaining for tdTomato, Sp7 and Sox9 in consecutive humerus sections of the Piezo1-tdTomato forelimb buds. Arrows: Membranous tdTomato and nuclear Sp7 were found in the differentiating osteoblasts and hypertrophic chondrocytes in the same regions. Arrowheads: Extra-skeletal Piezo1-tdTomato expression. (<bold>c</bold>) Representative image of GFP and tdTomato fluorescent staining of humerus sections from the Piezo1-tdTomato; Sp7-Cre::GFP mouse at P0. The boxed region was shown in higher magnification in the right panel. Arrows: colocalization of tdTomato and GFP in the differentiating osteoblasts. Arrowheads: Hypertrophic chondrocyte or extra-skeletal expression of Piezo1-tdTomato. (<bold>d</bold>) Representative images of tdTomato costained with Sp7 or Sox9 on consecutive humerus sections from the E13.5 <italic>Piezo2Cre; Rosa26-tdTomato</italic> limb bud. Arrows: TdTomato costained with Sp7 in the differentiating osteoblasts. Arrowheads: Joint or extra-skeletal Piezo1-tdTomato expression. All scale bars, 100 μm. DAPI (blue) stain the nucleus.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Mouse <italic>Piezo1</italic> and <italic>Piezo2</italic> expression.</title><p>(<bold>a, b</bold>) Expression of <italic>Piezo1</italic> and <italic>Piezo2</italic> examined by whole mount in situ hybridization of mouse embryos at E10.5 and E12.5 with <italic>Piezo1</italic> and <italic>Piezo2</italic> sense or antisense probes. (<bold>b</bold>) Ventral view of <italic>Piezo2</italic> expression in the limb bud at the indicated stages. (<bold>c</bold>) Section in situ hybridization by RNAscope to detect <italic>Piezo1</italic> mRNA expression in E16.5 humerus. Arrows: <italic>Piezo1</italic> expression in the differentiating osteoblasts and muscle. Arrowheads: stronger expression of <italic>Piezo1</italic> in the non-muscle connective tissues. Boxed regions are shown in higher magnification on the right panel. Scale bar, 100 μm. (<bold>d and e</bold>) Fluorescent images of tdTomato with costained Sp7 in humerus of the <italic>Piezo2Cre; Rosa26-tdTomato</italic> mouse at P14 (<bold>d</bold>) and E17.5 (<bold>e</bold>). Boxed region in (<bold>e</bold>) is shown on the right side. Some of the Piezo 2 lineage cells expressed Sp7. Scale bars, 100 μm. DAPI stains the nucleus.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Piezo 1 and 2 are required for bone formation and long bone growth</title><p>To investigate whether <italic>Piezo1</italic>/<italic>2</italic> regulate skeletal development in vivo, we removed <italic>Piezo1</italic> and/or <italic>Piezo2</italic> in early limb bud mesenchyme before skeletogenesis starts using the floxed <italic>Piezo1</italic> and <italic>Piezo2 lines</italic> (<xref ref-type="bibr" rid="bib104">Woo et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Cahalan et al., 2015</xref>) and the <italic>Prrx1-Cre</italic> line (<xref ref-type="bibr" rid="bib58">Logan et al., 2002</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). While both <italic>Piezo1<sup>-/-</sup></italic> and <italic>Piezo2<sup>-/-</sup></italic> mutants exhibit embryonic lethality, the <italic>Prrx1-Cre; Piezo1<sup>f/f</sup></italic> (<italic>Piezo1</italic> CKO) and <italic>Prrx1-Cre; Piezo2<sup>f/f</sup></italic> (<italic>Piezo2</italic> CKO) mice were viable at birth. However, the <italic>Piezo1</italic> CKO mice exhibited multiple bone fractures in radius and ulna suggesting severely reduced bone formation (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). The <italic>Piezo2</italic> CKO mice exhibited grossly normal skeletal development with no bone fracture, but the <italic>Piezo1/2</italic> double conditional (<italic>Piezo1/2</italic> DKO) mutant mice demonstrated more severe skeletal defects including additional fractures in the femur (<xref ref-type="fig" rid="fig2">Figure 2a,b</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>, <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>). We also found that long bones were shortened in the absence of <italic>Piezo1,</italic> but not <italic>Piezo 2,</italic> and further shortening was observed in the <italic>Piezo1/2</italic> DKO mutants (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). These results indicate that while <italic>Piezo1</italic> plays a major role, <italic>Piezo2</italic> shares some of the <italic>Piezo1</italic> functions in mesenchymal progenitor cells during skeletal development.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Loss of <italic>Piezo1</italic> or both <italic>Piezo1/2</italic> in embryonic limb mesenchyme led to reduced bone formation and spontaneous bone fractures in neonatal mice.</title><p>(<bold>a</bold>) Whole mount alizarin red and alcian blue staining of P0 mouse pups from the same litter. Bone fractures were indicated by arrows. The forelimb (FL) and hindlimb (HL) were taken out and shown in the lower panel. (<bold>b</bold>) Representative three dimensional μCT images of humerus from 3 weeks old littermate mice with the indicated genotypes. The humerus length was quantified (n = 6, mean ± SD). Bone fracture is indicated by an arrow. (<bold>c</bold>) Representative cross section μCT images of the cortical and trabecular femur bones from 3 weeks old littermate mice. (<bold>d</bold>) Quantified analysis of μCT data. Data are shown as means ± SD. (<bold>e, f</bold>) Histomorphometric analysis of distal femurs from wild type and <italic>Prrx-Cre</italic> driven <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutant mice. Representative images of double Calcein labeling in the cortical (<bold>e</bold>) and trabecular (<bold>f</bold>) bones were showed, and the dynamic bone formation parameters were only quantifiable in the wild type and <italic>Piezo1</italic> CKO group, due to the severely reduced cortical bone formation in the <italic>Piezo1/2</italic> DKO and little bone formation in the secondary spongiosa of the distal metaphysis in both <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutant mice. PO: periosteum; EO; endosteum. Scale bars: 50 μm (<bold>e</bold>); 100 μm (<bold>f</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, one-way ANOVA followed by Tukey’s multiple comparisons tests. In (<bold>e</bold>), p value is calculated by two-tailed unpaired Student’s <italic>t</italic>-test (<xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Loss of <italic>Piezo1</italic> or both <italic>Piezo1/2</italic> in embryonic limb mesenchyme led to reduced cartilage growth and osteoblast differentiation.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig2-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Gross characterization of <italic>Prrx1-Cre</italic> driven <italic>Piezo1 and Piezo2</italic> mutant phenotypes at postnatal stages.</title><p>(<bold>a</bold>) Representative images of alizarin red and alcian blue stained limbs from 3 weeks old mice with the indicated genotypes. Bone fractures are indicated with arrows and quantification (n = 4) is shown on the right side. (<bold>b</bold>) Expression of Pieozo 1 and 2. Western blotting analysis of the humerus bone devoid marrow from the <italic>Piezo1-Tdtomato</italic> mice of the indicated ages. Piezo1 protein levels were shown by RFP immunoblotting. Piezo2 protein was too low to be detected. RT-qPCR analysis of <italic>Piezo2</italic> expression of cortical bones from E18.5 and 3 weeks old mice was performed. n = 5–6. (<bold>c</bold>) Masson’s Trichrome staining of humerus sections from P5 mouse pups. Reduction in collagen content (blue staining) was observed in the <italic>Piezo1</italic> CKO or <italic>Piezo1/2</italic> DKO mutants. Boxed regions are shown in higher magnification in the right panel. (<bold>d</bold>) Detection of serum PINP levels in the 4 weeks old mice with the indicated genotypes by ELISA. Bone formation was most significantly reduced in the <italic>Piezo1/2</italic> DKO mutant. (n = 4–7, means ± SD). (<bold>e, f</bold>) Immunostaining of Ctsk (<bold>e</bold>) and Trap1 (<bold>f</bold>) in humerus sections from P0 mouse pups. Boxed regions were shown in higher magnification in the right panel. Osteoclast differentiation was increased in both <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutants. (<bold>g</bold>) qPCR analysis of osteoblast and osteoclast gene expression from bone tissues of P0 pups with indicated genotypes (n = 3, means ± SD). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, two-tailed unpaired Student’s <italic>t</italic>-test or one-way ANOVA followed by Tukey’s multiple comparisons tests when ANOVA was significant (<bold>a, d and g</bold>) (<xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>).</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Original numbers used for quantification and Western blots.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig2-figsupp1-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig2-figsupp1-v2.tif"/></fig></fig-group><p>Mechanical stress increases postnatally and we found that Piezo1 expression was progressively increased in young mice (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b</xref>), suggesting that Piezo1 also regulates bone formation after birth in adult lives. However, <italic>Piezo2</italic> mRNA expression was reduced in postnatal mice in the cortical bone (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1b</xref>). The μCT analyses showed that both cortical and trabecular bone masses were reduced in the <italic>Piezo1</italic> CKO mice and further reduced in the <italic>Piezo1/2</italic> DKO mice at the age of P21. The <italic>Piezo2</italic> CKO mice exhibited normal bone mass (<xref ref-type="fig" rid="fig2">Figure 2c,d</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). The <italic>Prrx1-Cre; Piezo1<sup>f/+</sup>; Piezo2<sup>f/+</sup></italic> embryos or mice also did not show phenotypic difference compared with wild-type controls. We therefore focused our analyses on the <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO embryos and newborn mice. Analyses of postnatal bone development of <italic>Piezo1/2</italic> mutant pups were performed by Masson’s Trichrome staining, which showed reduction of collagens in the trabecular and cortical bones of the P5 <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutant pups (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1c</xref>). Bone formation was definitively examined by ELISA assays of serum procollagen type I N propeptide (PINP) levels (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1c</xref>), which is considered clinically as the most sensitive bone formation marker (<xref ref-type="bibr" rid="bib84">Samoszuk et al., 2008</xref>). Furthermore, histomorphometric analysis showed reduced mineralization apposition rate (MAR), and bone formation rate (BFR) in periosteum of the cortical bone of the <italic>Piezo1</italic> CKO mice (<xref ref-type="fig" rid="fig2">Figure 2e</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Reduction of cortical bone formation in the <italic>Piezo1/2</italic> DKO mutant mice or trabecular bone formation in both <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mice were too severe to allow accurate quantification (<xref ref-type="fig" rid="fig2">Figure 2e,f</xref>). In the <italic>Piezo1/2</italic> DKO mice, the secondary spongiosa was almost completely missing.</p><p>Reduction of bone formation in the <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutant mice was accompanied by increase in bone remodeling indicated by upregulated expression of osteoclast markers Cathepsin K (Ctsk) and Tartrate-resistant acid phosphatase (Acp5 or Trap) (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1e,f</xref>). However, earlier in development at E16.5, there was no difference in osteoclast marker expression (data not shown) suggesting that increased osteoclast differentiation may have resulted from the changes in osteoblast cells. Indeed, quantitative gene expression analysis by qRT-PCR further showed that while early and mature osteoblast marker expression were reduced, <italic>Tnfsf11</italic> (<italic>Rankl</italic>) and <italic>Acp5</italic> expression, indicative of osteoclast differentiation, were increased in the <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutant at P0 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1g</xref>). Expression of <italic>Tnfrsf11b</italic> (<italic>Opg)</italic>, which encodes a decoy receptor of Tnfsf11 to inhibit osteoclast differentiation, was also reduced. Therefore, reduced bone mass and density in the absence of Piezo channels is a combination of reduced bone formation and increased bone resorption, which resulted in not only bone fractures, but also reduced longitudinal bone growth and bone deformity such as bowing of the tibia (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>).</p><p>To understand the cellular mechanisms underlying the skeletal defects in the <italic>Piezo1/2 CKO</italic> mutant mice, we first examined chondrocyte and osteoblast differentiation. At E16.5 and P0, expression of the chondrocyte marker Sox9 and hypertrophic chondrocyte marker Col10a1 was similar in the wild-type control, <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO embryos (<xref ref-type="fig" rid="fig3">Figure 3a</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), suggesting cartilage formation and chondrocyte hypertrophy was not regulated by <italic>Piezo1/2</italic> in development. However, expression of the early osteoblast marker Sp7 was markedly reduced at E16.5 and P0 in the ossifying regions of the developing <italic>Piezo1</italic> CKO humerus and further reduced in the <italic>Piezo1/2</italic> DKO humerus (<xref ref-type="fig" rid="fig3">Figure 3a</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), suggesting that <italic>Piezo1/2</italic> are required to promote osteoblast differentiation in development. Bone mineralization and osteoblast maturation as indicated by von Kossa staining and secreted phosphoprotein 1 (Spp1, also known as Opn) immunofluorescent staining were also reduced in the trabecular and cortical bone areas at P0 (<xref ref-type="fig" rid="fig3">Figure 3d,e</xref>). When examined by BrdU labeling, we found that growth plate chondrocyte proliferation and the length of the proliferative regions were both reduced in the <italic>Piezo1</italic> CKO and further reduced in the <italic>Piezo1/2</italic> DKO mutant at E16.5 (<xref ref-type="fig" rid="fig3">Figure 3b</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Increased apoptosis was found in the bone and muscle of the <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutant at E16.5 by TUNEL assay (<xref ref-type="fig" rid="fig3">Figure 3c</xref>). These analyses indicate that Piezo1/2 MS channels are required for cartilage growth and bone formation in embryonic development, providing mechanistic insights into findings made in human populations that <italic>PIEZO1</italic> SNPs are associated with reduced body height and eBMD (<xref ref-type="bibr" rid="bib61">Marouli et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Morris et al., 2019</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Loss of <italic>Piezo1</italic> or both <italic>Piezo1/2</italic> in embryonic limb mesenchyme led to reduced cartilage growth and osteoblast differentiation.</title><p>(<bold>a</bold>) Immunofluorescent images of Sox9 and Sp7 expression in the humerus sections of E16.5 embryos. (<bold>b</bold>) Representative BrdU of humerus sections of E16.5 embryos. The percentage of BrdU<sup>+</sup> cells in the growth plate was quantified (n = 3, means ± SD). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, one-way ANOVA followed by Tukey’s multiple comparisons tests. Proliferative cartilage regions were indicated by double headed arrows (<xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). (<bold>c</bold>) Representative TUNEL staining of humerus sections of E16.5 embryos. TUNEL signals in the muscle were indicated by arrows. (<bold>d</bold>) von Kossa staining and (<bold>e</bold>) Spp1 immunostaining of humerus sections from P0 littermate pups. Reduced staining was indicated by arrows. All scale bars, 100 μm. DAPI (blue) stain the nucleus.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Quantification of cell proliferation.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig3-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Immunostaining of Sox9, Col10 and Sp7 in sections of humerus cartilage from P0 pups.</title><p>All scale bars: 100 μm. DAPI stains the nucleus.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Piezo 1 and 2 are required for bone formation and maintenance by mechanical forces</title><p>To understand more specifically the role of <italic>Piezo1/2</italic> in bone development, we removed <italic>Piezo1/2</italic> using the <italic>Sp7-Cre</italic> mouse line (<xref ref-type="bibr" rid="bib81">Rodda and McMahon, 2006</xref>; <xref ref-type="fig" rid="fig4">Figure 4a–e</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Interestingly, the <italic>Sp7-Cre; Piezo1<sup>f/f</sup></italic> (<italic>Piezo1</italic>CKO) and <italic>Sp7-Cre; Piezo1<sup>f/f</sup>; Piezo2<sup>f/f</sup></italic> (<italic>Piezo1/2</italic> DKO) mouse pups did not show limb bone fractures. However, multiple bone fractures were found in the ribs at P21 in the <italic>Piezo1CKO</italic> and <italic>Piezo1/2</italic> DKO mice, but not the <italic>Piezo2</italic> CKO mice (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). μCT analyses showed that loss of <italic>Piezo1</italic> or <italic>Piezo1/2</italic> in Sp7<sup>+</sup> cells led to reduced trabecular and cortical bones (<xref ref-type="fig" rid="fig4">Figure 4b</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>) and Sp7 expression (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). Reduction in bone mass was more severe in the <italic>Prrx1-Cre</italic>-driven mutants compared to the <italic>Sp7-Cre</italic>-driven ones (<xref ref-type="fig" rid="fig2">Figure 2d</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), suggesting that Piezo1/2 in Sp7<sup>-</sup> cells such as the muscle, tenocytes and chondrocytes may also promote to bone formation. These are consistent with previous studies showing muscle contraction promotes bone formation (<xref ref-type="bibr" rid="bib73">Nowlan et al., 2010a</xref>). In addition, we found that when cultured under osteogenic conditions, mechanical stress slightly increased <italic>Piezo1</italic> expression in the <italic>Prrx1</italic> lineage cells, not the <italic>Sp7</italic> lineage cells (<xref ref-type="fig" rid="fig4">Figure 4d</xref>). To further determine whether Piezo1/2 mediate the effects of mechanical stress in embryonic bone development, we decided to reduce both intrinsic and extrinsic mechanical forces by culturing mouse developing limb bud explants under static conditions, in which intact limb buds can grow and develop for several days (<xref ref-type="bibr" rid="bib88">Storm and Kingsley, 1999</xref>; <xref ref-type="bibr" rid="bib87">Smith et al., 2013</xref>; <xref ref-type="bibr" rid="bib71">Neubert et al., 1974</xref>; <xref ref-type="bibr" rid="bib20">Decker et al., 2014</xref>; <xref ref-type="fig" rid="fig5">Figure 5a,b</xref>, <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). We exploited this explant culture system to further interrogate the functions of Piezo1/2. Forelimb bud pairs were isolated from the left and right sides of E13.5 mouse embryos and treated for 4 days with PBS or Yoda, the only one molecule found to chemically regulate the opening of Piezo1 so far (<xref ref-type="bibr" rid="bib92">Syeda et al., 2015</xref>), respectively, to minimize possible developmental variability from embryo to embryo. Bone development was slower in explant culture and there was no trabecular bone formation (<xref ref-type="fig" rid="fig5">Figure 5a,b</xref>). However, Yoda1 promoted bone formation and osteoblast differentiation in the wild type, but not the <italic>Piezo1/2</italic> DKO limbs (<xref ref-type="fig" rid="fig5">Figure 5a</xref>), suggesting that Piezo1 was functional in the explant culture. Importantly, the drastic difference in bone formation between the wild-type control and the <italic>Sp7-Cre; Piezo1/2</italic> DKO limbs developed in utero was eliminated (compare <xref ref-type="fig" rid="fig5">Figure 5b</xref> with <xref ref-type="fig" rid="fig4">Figure 4a,c</xref>). We next asked whether in adult life, bone loss under unloading conditions is caused by lack of Piezo1/2 stimulation. We adopted a mouse unloading model of Botulinum Toxin A (BTX)-induced hind limb muscle paralysis, which has gained prominence for its direct clinical relevance to immobilized patients, due to upper or lower motor neuron damage, muscular dystrophies or therapeutic bed rest (<xref ref-type="bibr" rid="bib69">Morse et al., 2014</xref>; <xref ref-type="bibr" rid="bib94">Velders et al., 2008</xref>; <xref ref-type="bibr" rid="bib99">Warner et al., 2006</xref>). It has been shown that BTX injection causes loss of bone density, microstructure, and strength in both mice and rats. We therefore injected BTX into both the right quadriceps and the right calf muscles of 12 weeks old male mice. Left tibiae served as normal loading controls with only PBS injection to the same muscles. As a rapid and profound bone loss could be observed 1 week after BTX injection in male mice (<xref ref-type="bibr" rid="bib32">Grimston et al., 2007</xref>), the mice were euthanized 10 days after BTX injection, and the tibiae were analyzed by μCT as shown previously (<xref ref-type="bibr" rid="bib44">Judex et al., 2004</xref>). While BTX injection reduced bone mass in the wild-type mice, in the <italic>Sp7-Cre-</italic>driven <italic>Piezo1/2</italic> DKO mice, BTX injection did not cause significant bone loss, although the bone mass was lower compared to that of the wild-type controls (<xref ref-type="fig" rid="fig5">Figure 5c</xref>, <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). Taken together, Piezo1/2 are required for embryonic bone development and adult bone mass maintenance by mechanical forces.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Loss of <italic>Piezo1</italic> or <italic>Piezo1/2</italic> in osteoblastic cells driven by the <italic>Sp7-GFP::Cre</italic> shows reduced bone mass and rib fractures.</title><p>(<bold>a</bold>) Whole mount alizarin red and alcian blue staining of P21 mice with indicated genotypes. Dorsal view of the ribcages was shown in the lower panel. Arrows indicate bone fractures in the ribs. (<bold>b</bold>) Representative 2D μCT images of the femurs from P21 mice with indicated genotypes. The quantified parameters are shown in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. (<bold>c</bold>) Expression of Sp7-Cre::GFP in humerus sections of P0 pups with indicated genotypes. (<bold>d</bold>) tdTomato+ cells were sorted from long bones of the <italic>Prrx1-Cre;tdTomato<sup>fl/+</sup></italic> and <italic>Sp7-Cre;tdTomato<sup>fl/+</sup></italic> mice and cultured under osteogenic differentiation under static or fluid shear stress (FSS) condition. <italic>Piezo1</italic> and <italic>Piezo2</italic> expression were analyzed using RT-qPCR. (<bold>e</bold>) Serum PINP levels in 6 weeks old mice of indicated genotypes detected by ELISA. As all bones were affected by the <italic>Sp7-GFP::Cre</italic> driver, PINP levels were significantly reduced in both <italic>Piezo1</italic> or <italic>Piezo1/2</italic> mutants (n = 3–4, means ± SD). (<bold>f</bold>) RNA samples from the P0 humerus bone tissues of indicated <italic>Prrx1-Cre</italic>-driven mutants were subject to RNA seq. Heat-map analysis of differentially expressed genes with fold change increase &gt;2.82 fold and reduction to &lt;0.35 fold. <italic>Piezo1</italic> CKO or <italic>Piezo1/2</italic> DKO mutants showed similar alteration of gene expression genome wide. (<bold>g</bold>) KEGG pathway analysis of differentially expressed genes. Prominent reductions in Hippo and Wnt signaling were identified (boxed). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, one-way ANOVA followed by Tukey’s multiple comparisons tests when ANOVA was significant (<xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Differentially expressed genes and orginal numbers for quantification.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig4-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Gene ontology (GO) biological process analysis of differentially expressed genes.</title><p>Downregulations in osteoblast differentiation, ossification and mineralization were enriched (boxed).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig4-figsupp1-v2.tif"/></fig></fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Loss of <italic>Piezo1/2</italic> diminished reduction in bone formation caused by unloading in both embryonic development and adult life.</title><p>(<bold>a, b</bold>) Sections of the embryonic humerus from the limb bud dissected from E13.5 embryos and cultured for 4 days in BGJb medium under static conditions. Osteoblast differentiation was further determined by qRT-PCR anlysis of osteoblastic markers. (<bold>a</bold>) The right limb bud was treated with Yoda1 (400 nM), and the contralateral left limb bud was treated with equal volume of vehicle as control. Representative images of von Kossa or SPP1 staining of wild-type humerus from the cultured limbs. Scale bar: 100 μm. difference in osteoblast gene expression between limb bud pairs from the same embryo was shown on the right side. *p&lt;0.05, according to paired ratio t test. (<bold>b</bold>) Representative images of von Kossa stained wild type or <italic>Sp7-Cre-</italic>driven <italic>Piezo1/2 DKO</italic> sections of the cultured humerus. Gene expression was shown below. No significant difference was found between the cultured wild type and <italic>Piezo1/2</italic> DKO limbs. (<bold>c</bold>) Representative μCT images of the tibia metaphysis in an unloading model of BTX-induced muscle paralysis. The BTX-injected right leg and the PBS-injected contralateral left leg from male mice are shown. Scale Bar: 1 mm. The BV/TV and trabecular bone thickness of each inject mouse were analyzed and compared. *p&lt;0.05, according to paired ratio t test. The percentage of difference between BTX and PBS injected side over the PBS injection side was calculated and shown in the inserts. *p&lt;0.05, according to unpaired student t test (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Original numbers collected for quantification.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig5-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig5-v2.tif"/></fig></sec><sec id="s2-4"><title>Yap1 and β-catenin activities were reduced in the <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutant bones</title><p>Severe bone reduction observed in the <italic>Piezo1</italic> or <italic>Piezo1/2</italic> mutants provided an unprecedented opportunity for us to identify the signaling pathways in bone development that are regulated by Piezo1/2 channels gated by mechanical forces. We therefore isolated the developing humerus and femur bone tissues from the P0 wild type, <italic>Prrx1-Cre</italic> driven <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO pups and genome-wide gene expression was examined by performing RNA sequencing. The up- and down-regulated genes were subject to Gene Ontology (GO) enrichment analysis and KEGG pathway mapping (<xref ref-type="fig" rid="fig4">Figure 4f</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). We found that changes in reduced gene expression were enriched for osteoblast differentiation in the GO analysis and the Wnt/β-catenin (Ctnnb1) and Hippo/Yap1 signaling pathways in the KEGG pathway mapping. Wnt/Ctnnb1 signaling is essential for osteoblast differentiation (<xref ref-type="bibr" rid="bib19">Day et al., 2005</xref>; <xref ref-type="bibr" rid="bib35">Hill et al., 2005</xref>; <xref ref-type="bibr" rid="bib37">Hu et al., 2005</xref>; <xref ref-type="bibr" rid="bib30">Glass et al., 2005</xref>; <xref ref-type="bibr" rid="bib31">Gong et al., 2001</xref>), and Yap1 and Wwtr1 are essential effectors of mechanotransduction to regulate cell proliferation and differentiation (<xref ref-type="bibr" rid="bib33">Halder et al., 2012</xref>; <xref ref-type="bibr" rid="bib2">Aragona et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">Codelia et al., 2014</xref>; <xref ref-type="bibr" rid="bib96">Wada et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">Dupont et al., 2011</xref>). Loss of Yap1/Wwtr1 activities inhibits osteoblast differentiation in bone formation (<xref ref-type="bibr" rid="bib47">Kegelman et al., 2018</xref>; <xref ref-type="bibr" rid="bib76">Pan et al., 2018</xref>). We therefore focused our analyses on Wnt/Ctnnb1 and Hippo/Yap1 signaling. We found that Ctnnb1 and Yap1/Wwtr1 protein levels were both reduced in the bones of <italic>Prrx1-Cre-</italic>driven <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutants at P0 and more reduction was found in the <italic>Piezo 1/2</italic> DKO bone samples (<xref ref-type="fig" rid="fig6">Figure 6a,b</xref>, <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). In addition, by qRT-PCR analysis, we found that expression of transcriptional targets of both Yap1/Wwtr1 and Wnt/Ctnnb1 such as <italic>Ctgf (Ccn2)</italic>/<italic>Cyr61(Ccn1)</italic> and <italic>Tcf7</italic>/<italic>Lef1</italic>, respectively, were down-regulated in the <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutant bones (<xref ref-type="fig" rid="fig6">Figure 6c</xref>, <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). These results were further confirmed by in situ hybridization with a <italic>Ccn2</italic> probe using the RNAscope technology (<xref ref-type="fig" rid="fig6">Figure 6d</xref>). <italic>Ccn2</italic> expression was reduced in the developing humerus at E16.5 by removing <italic>Piezo1/2</italic>. These results show that Piezo1/2 activities may promote osteoblast differentiation by upregulating both Wnt/Ctnnb1 and Yap1 activities.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Loss of <italic>Piezo1/2</italic> reduced Yap1 and Wnt/Ctnnb1 signaling activities and osteoblast differentiation in vivo and in vitro.</title><p>(<bold>a</bold>) Immunofluorescent staining of Ctnnb1 and Yap1/Wwtr1 in the humerus sections from the P0 <italic>Prrx1-Cre</italic> driven <italic>Piezo1 and Piezo1/2</italic> mutants and littermate controls. (<bold>b</bold>) Western blot analyses of P0 femur bone tissue lysates from P0 pups. (<bold>c</bold>) qPCR analyses of gene expression from femur bone tissues of P0 pups (n = 3, means ± SD). (<bold>d</bold>) <italic>Ccn2</italic> expression by RNAScope analysis of humerus sections of E16.5 embryos. (<bold>e</bold>) Alkaline phosphatase staining (left) and qPCR analyses (right, n = 3, means ± SD) in the indicated BMSCs infected with Ad-GFP or Ad-Cre 5 days after osteogenic induction. (<bold>f</bold>) Alkaline phosphatase staining (left) and qPCR analyses (right, n = 3, means ± SD) in <italic>Piezo1<sup>f/f</sup>;Piezo2<sup>f/f</sup></italic> BMSCs treated with Piezo1 agonist (Yoda1) and antagonist (Gd<sup>3+</sup>) 6 days after osteogenic induction. The schematics of the induction process is shown on the top. All scale bars: 100 μm. DAPI (blue) stained the nucleus. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, two-tailed unpaired Student’s <italic>t</italic>-test (<bold>e</bold>) or one-way ANOVA followed by Tukey’s multiple comparisons tests when ANOVA was significant (<bold>c and f</bold>) (<xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Original numbers and Western blots.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig6-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Regulation of NFAT and CTNNB1 signaling by Piezo.</title><p>(<bold>a</bold>) Western Blotting analyses of Piezo1/2 in lysates of Ad-GFP or Ad-Cre infected Piezo1f/f; Piezo2f/f BMSCs. Piezo1 is expressed at higher levels than Piezo2 and Ad-Cre infection efficiently reduced Piezo1/2 protein levels. (<bold>b</bold>) Luciferase reporter assay of Hippo and Wnt pathway activities after Yoda1 and CsA treatment of HEK293T cells. The effects of Yoda1 treatment were largely cancelled by CsA treatment. N=3, data are shown as means ± SD (<xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref>).</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Original numbers and Western blots.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig6-figsupp1-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig6-figsupp1-v2.tif"/></fig></fig-group><p>Mesenchymal stem cells (MSCs) from both the periosteum and bone marrow, give rise to osteoblasts (<xref ref-type="bibr" rid="bib6">Bianco et al., 2010</xref>; <xref ref-type="bibr" rid="bib86">Schipani and Kronenberg, 2008</xref>). We therefore determined whether BMSCs where MSCs are found also employ Piezo1/2 to regulate their osteoblast differentiation. Mammalian cells are surrounded by a mechanical microenvironment with neighboring cells and characteristic ECM, which provide mechanical cues that influence diverse biological processes including cell fate decisions (<xref ref-type="bibr" rid="bib33">Halder et al., 2012</xref>; <xref ref-type="bibr" rid="bib41">Humphrey et al., 2014</xref>). It is known that stem cells or progenitor cells differentiate optimally into distinct cell types when cultured at ECM elasticities that match the physiological ECM stiffness of their corresponding natural niche. Specifically, it was found that MSCs preferentially differentiate into osteoblasts when cultured on stiff surface in a rigid ECM environment, instead of adipocytes when cultured in a soft ECM environment (<xref ref-type="bibr" rid="bib64">McBeath et al., 2004</xref>; <xref ref-type="bibr" rid="bib50">Kilian et al., 2010</xref>). The stiff surface of regular tissue culture dishes supports osteoblast differentiation of BMSCs, which expressed both <italic>Piezo1/2</italic>, but <italic>Piezo1</italic> expression was stronger (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1a</xref>). However, loss of <italic>Piezo1</italic> or <italic>Piezo1/2</italic> by Cre Adenovirus (Ad-Cre) infection of the <italic>Piezo1<sup>f/f</sup></italic> or <italic>Piezo1<sup>f/f</sup>; Piezo2<sup>f/f</sup></italic> BMSCs (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1a</xref>), respectively, led to reduced osteoblast differentiation and reduced Yap1/Wwtr1 and Wnt/Ctnnb1 signaling activities (<xref ref-type="fig" rid="fig6">Figure 6e</xref>, <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Consistent with this, treating wild-type BMSCs with Yoda1 increased osteoblast differentiation as well as Wnt/Ctnnb1 and Yap1 transcriptional activities (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1b</xref>, <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref>). Such osteogenic activity of Yoda1 was lost in the absence of <italic>Piezo1</italic>/<italic>2</italic> (<xref ref-type="fig" rid="fig6">Figure 6f</xref>, <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>), suggesting that Yoda1 activity in promoting osteoblast differentiation depends on Piezo1. In addition, blocking Ca<sup>2+</sup> influx with Gadolinium (Gd<sup>3+</sup>), a potent blocker of Calcium channels including the Piezos (<xref ref-type="bibr" rid="bib15">Coste et al., 2010</xref>), blocked osteoblast differentiation similar to loss of <italic>Piezo1/2</italic> (<xref ref-type="fig" rid="fig6">Figure 6f</xref>). These results suggest that Piezo1/2 depend on Ca<sup>2+</sup> influx and mediate mechanotransduction via the Wnt/Ctnnb1 and Yap1 pathways in regulating osteoblast differentiation of BMSCs.</p></sec><sec id="s2-5"><title>Piezo1/2 sense both FSS and matrix rigidity</title><p>It is known that BMSCs and osteoblast lineage cells senses both FSS and ECM rigidity, which play critical roles in the fate determination of BMSCs reviewed by <xref ref-type="bibr" rid="bib95">Vining and Mooney (2017)</xref>. A role for FSS as regulator of cell function has been recognized in different biological systems including the canalicula in bones (<xref ref-type="bibr" rid="bib7">Burger et al., 1995</xref>), where fluid flow is physiologically present. As a proof of concept study to test the roles of Piezo1 and Piezo2 in mechanotransduction in BMSCs, we first applied biomechanical stimulation via a simple rocking platform to monolayer BMSC cultures in vitro (<xref ref-type="bibr" rid="bib21">Delaine-Smith et al., 2012</xref>; <xref ref-type="bibr" rid="bib103">Wittkowske et al., 2016</xref>; <xref ref-type="bibr" rid="bib111">Zhou et al., 2010</xref>). The rocking ‘see-saw’ systems generate oscillatory FSS (<xref ref-type="bibr" rid="bib111">Zhou et al., 2010</xref>), which is capable of directing BMSCs toward osteogenic differentiation by increasing alkaline phosphatase (Alpl) activity and deposition of mineralized matrix (<xref ref-type="bibr" rid="bib21">Delaine-Smith et al., 2012</xref>; <xref ref-type="bibr" rid="bib103">Wittkowske et al., 2016</xref>). We found that FSS stimulated osteoblast differentiation of wild-type BMSCs while loss of <italic>Piezo1</italic>/2 completely abolished the response of BMSC to FSS in the osteogenic assay (<xref ref-type="fig" rid="fig7">Figure 7a</xref>, <xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>). Importantly, FSS upregulated protein levels of Ctnnb1 and Yap1, while levels of phosphorylated Ctnnb1 and Yap1, which are cytoplasmic and destined for degradation, were reduced by FSS in BMSCs, indicating that FSS activated both Ctnnb1 and Yap1 activities (<xref ref-type="fig" rid="fig7">Figure 7b</xref>). <italic>Piezo1</italic>/2 loss in BMSCs abolished osteogenic response to FSS, reduced Ctnnb1 and Yap1 protein levels and increased Ctnnb1 and Yap1 phosphorylation (<xref ref-type="fig" rid="fig7">Figure 7a,b</xref>). Interestingly, increased Yap1 phosphorylation was not accompanied by increase of phosphorylated and activated Stk4 (Mst1) or Lats1 kinases (<xref ref-type="fig" rid="fig7">Figure 7b</xref>), suggesting that FSS-stimulated Yap1 activation may be independent of the Stk3/4 and Lats kinase cascade that controls Yap1 phosphorylation in canonical Hippo signaling (<xref ref-type="bibr" rid="bib106">Wu et al., 2003</xref>; <xref ref-type="bibr" rid="bib38">Huang et al., 2005</xref>; <xref ref-type="bibr" rid="bib26">Edgar, 2006</xref>; <xref ref-type="bibr" rid="bib75">Pan, 2007</xref>). These results suggest that Piezo1/2 are key mechanical force sensors that relay FSS signals to promote osteoblast differentiation through Yap1 and Ctnnb1 signaling.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Piezo1 was required to sense mechanical forces generated by FSS and upregulate Yap1 and Ctnnb1 activities in primary mouse BMSCs.</title><p>(<bold>a</bold>) Alkaline phosphatase staining (left) and qPCR analyses (right) in BMSCs cultured with or without shaking during osteogenic induction (n = 3, means ± SD). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, one-way ANOVA followed by Tukey’s multiple comparisons tests (<xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>). (<bold>b</bold>) Western blotting analyses of cell lysates from BMSCs cultured under static or shaking conditions during osteogenic induction. (<bold>c</bold>) Representative images (left) of BMSCs with fluorescent GCaMP5G reporter at different time points after FSS. Scale bars: 80 μm. The fluorescent intensities of GCaMP5G were quantified (right) every 5 s (<xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>).</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Original Western blots and numbers collected for quantification.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig7-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Representative GFP images of the GCaMP5G Ca<sup>2+</sup> reporter in Ad-Cre infected BMSCs at different time points after Yoda1 treatment.</title><p>Ad-Cre infection of the <italic>PC::G5-tdT; Piezo1<sup>f/f</sup></italic> BMSCs-induced GCaMP5G reporter expression and simultaneous deletion of <italic>Piezo1.</italic> The fluorescent intensity of GCaMP5G was quantified (Right). Scale bar: 130 μm (<xref ref-type="supplementary-material" rid="fig7s1sdata1">Figure 7—figure supplement 1—source data 1</xref>).</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Original numbers collected for quantification.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig7-figsupp1-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig7-figsupp1-v2.tif"/></fig></fig-group><p>As Piezo1/2 are Calcium (Ca<sup>2+</sup>) permeable channels and Ca<sup>2+</sup> signaling plays crucial roles in bone biology (<xref ref-type="bibr" rid="bib110">Zayzafoon, 2006</xref>), we then determined whether Piezo1/2 regulate osteoblast differentiation through Ca<sup>2+</sup> influx. To determine whether <italic>Piezo1/2</italic> are required for mechanical force-induced Ca<sup>2+</sup> influx in the BMSCs, we employed the <italic>PC::G5-tdT</italic> mouse strain, which expresses the green fluorescent calcium indicator protein GCaMP5G and the tdTomato red fluorescent protein when induced by Cre recombinase (<xref ref-type="bibr" rid="bib29">Gee et al., 2014</xref>). The basal level Ca<sup>2+</sup> signal was stronger in the wild-type BMSCs compared with the <italic>Piezo1/2</italic> deficient BMSCs (<xref ref-type="fig" rid="fig6">Figure 6c</xref>, <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). More importantly, when BMSCs were subject to FSS, more robust Ca<sup>2+</sup> influx was observed in the wild-type BMSCs compared to the <italic>Piezo</italic>-deficient ones (<xref ref-type="fig" rid="fig7">Figure 7c</xref> and <xref ref-type="video" rid="video1">Video 1</xref>). Furthermore, Yoda1 treatment led to more robust Ca<sup>2+</sup> influx in the wild type, but not Ad-Cre induced <italic>Piezo1/2-</italic>deficient BMSCs (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>, <xref ref-type="video" rid="video2">Video 2</xref>, <xref ref-type="supplementary-material" rid="fig7s1sdata1">Figure 7—figure supplement 1—source data 1</xref>). These results together indicate that Piezo1/2 channels in BMSCs sense FSS-like mechanical forces to allow Ca<sup>2+</sup> influx, leading to osteoblast differentiation.</p><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-52779-video1.mp4"><label>Video 1.</label><caption><title>Pseudovideo recording of the GFP signals of the intracellular Ca<sup>2+</sup> sensor GCaMP5G after FSS stimulation.</title><p>Images were continuously taken at time intervals of 5 s, and this pseudovideo was made from the first parallel 30 images. Left: Ad-Cre virus infected primary BMSCs from the control <italic>PC::G5-tdT</italic> mice; Right: Ad-Cre virus infected primary BMSCs from the <italic>Piezo1<sup>fl/fl</sup>; PC::G5-tdT</italic> mice.</p></caption></media><media id="video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-52779-video2.mp4"><label>Video 2.</label><caption><title>Pseudovideo recording of the GFP signals of the intracellular Ca<sup>2+</sup> sensor GCaMP5G after Yoda1 treatment.</title><p>Images were continuously taken at time intervals of 5 s, and this pseudovideo was made from the first parallel 60 images. Left: Ad-Cre virus infected primary BMSCs from the control <italic>PC::G5-tdT</italic> mice; Right: Ad-Cre virus infected primary BMSCs from the <italic>Piezo1<sup>fl/fl</sup>; PC::G5-tdT</italic> mice.</p></caption></media><p>We next determined whether Piezo1/2 also sense mechanical stress induced by ECM rigidity, which is another major mechanical cue that promotes osteoblast differentiation and Yap1 activation (<xref ref-type="bibr" rid="bib33">Halder et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Dupont et al., 2011</xref>; <xref ref-type="bibr" rid="bib64">McBeath et al., 2004</xref>; <xref ref-type="bibr" rid="bib67">Meng et al., 2018</xref>). It is known that the plasma membrane stretches differentially when plated in matrices with different stiffness and cell spreading strongly correlates with matrix stiffness, osteoblast differentiation and Yap1 nuclear localization (<xref ref-type="bibr" rid="bib33">Halder et al., 2012</xref>; <xref ref-type="bibr" rid="bib24">Dupont et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Meng et al., 2018</xref>; <xref ref-type="bibr" rid="bib91">Sunyer et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Eyckmans et al., 2012</xref>). Using this system, we plated BMSCs on soft (1 kPa) or stiff (40 kPa) hydrogels to test whether Piezo1/2 are also required to sense matrix stiffness. While the wild-type BMSC have difficulty spreading on a soft matrix (1 kPa) with diffused Yap1 localization in both cytoplasmic and nuclear compartments, on a stiff matrix (40 kPa), they spread to much larger areas with strong nuclear Yap1 localization (<xref ref-type="fig" rid="fig8">Figure 8a</xref>). Importantly, the <italic>Piezo1/2-</italic>deficient BMSCs plated on a stiff matrix behaved more like the wild-type BMSCs plated on a soft matrix. They showed weaker intracellular Ca<sup>2+</sup> signaling (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="fig8s1sdata1">Figure 8—figure supplement 1—source data 1</xref>), were less spreading, contained less defined Yap1 nuclear localization (<xref ref-type="fig" rid="fig8">Figure 8a</xref>), and exhibited reduced Yap1 activities and osteoblast differentiation (<xref ref-type="fig" rid="fig8">Figure 8b</xref>). Osteogenic differentiation of BMSCs culture on the hydrogel was determined by ALP staining and quantifies as previously described (<xref ref-type="fig" rid="fig8">Figure 8b</xref>; <xref ref-type="bibr" rid="bib24">Dupont et al., 2011</xref>). These results indicate that Piezo1/2 also promote osteoblast differentiation by sensing matrix stiffness that is known to regulates Yap1 nuclear localization.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Piezo1 was required to sense ECM stiffness and upregulate Yap1 and Ctnnb1 activities in primary mouse BMSCs.</title><p>(<bold>a</bold>) Yap1 immunostaining of <italic>Piezo1<sup>f/f</sup>;Piezo2<sup>f/f</sup></italic> BMSCs seeded on matrices with the indicated stiffness after Ad-GFP or Ad-Cre infection. Scale bars: 100 μm. (<bold>b</bold>) BMSC were infected with the indicated Ad-virus, plated on stiff (40 kPa) or soft (1 kPa) substrates and induced to differentiate into osteoblasts for 6 days. Representative alkaline phosphatase stainings images were shown. Scale bar: 100 mm. As shown previously (<xref ref-type="bibr" rid="bib24">Dupont et al., 2011</xref>). Osteogenic differentiation was quantified by the alkaline-phosphatase-positive area determined with ImageJ as the number of blue pixels across the picture. This value was normalized to the number of cells (Hoechst/nuclei) for each picture (arbitrary units). RT-PCR anlaysis of BMSCs grown on the indicated hydrogels was shown below. (<bold>c</bold>) Alkaline phosphatase staining and qPCR analyses of primary mouse BMSCs treated with shaking with or without a Ppp3ca inhibitor CsA (n = 3, means ± SD). (<bold>d</bold>) Alkaline phosphatase staining and qPCR analyses of BMSCs treated with Yoda1 and CsA (n = 3, means ± SD). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, one-way ANOVA followed by Tukey’s multiple comparisons tests (<bold>b–d</bold>) (<xref ref-type="supplementary-material" rid="fig8sdata1">Figure 8—source data 1</xref>).</p><p><supplementary-material id="fig8sdata1"><label>Figure 8—source data 1.</label><caption><title>Original numbers for quantification.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig8-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title><italic>Piezo</italic> mutant primary BMSCs were defective in mechanotransduction.</title><p>(<bold>a</bold>) Representative images of the GCaMP5G reporter and the internal tdTomato fluorescent control in BMSCs of the indicated genotypes after Ad-Cre infection. The BMSCs were cultured on matrices with the indicated stiffness. While there was no difference in the tdTomato fluorescent intensity, Ca2<sup>+</sup> signaling activity indicated by GFP intensity was increased in cells on stiffer matrix and <italic>Piezo1-</italic>deficient BMSCs were less spreading with weaker GFP signals on both soft and stiff matrix. Scale bar: 100 μm. (<bold>b</bold>) Ptk2 (Fak) phosphorylation in the Ad-Cre-induced <italic>Piezo1/2</italic> deficient BMSCs was reduced compared to the Ad-GFP infected BMSCs, suggesting focal adhesion was reduced in the absence of <italic>Piezo1/2</italic>. (<bold>c</bold>) Fluorescent immunostaining of pPtk2 in mouse primary BMSCs. Activation of Piezo1 by Yoda1 treatment increased pPtk2 staining (<xref ref-type="supplementary-material" rid="fig8s1sdata1">Figure 8—figure supplement 1—source data 1</xref>).</p><p><supplementary-material id="fig8s1sdata1"><label>Figure 8—figure supplement 1—source data 1.</label><caption><title>Original Western blots.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig8-figsupp1-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig8-figsupp1-v2.tif"/></fig></fig-group><p>To determine whether Piezo1/2-dependent Ca<sup>2+</sup> signaling regulates Yap1 and Ctnnb1 activities, we turned our attention to the calcium and calmodulin-dependent heterodimeric serine/threonine phosphatase calcineurin (Ppp3ca), which is a critical intracellular Ca<sup>2+</sup> sensor. To test whether Ppp3ca is required in the Piezo1/2 initiated mechanotransduction pathway to promote osteoblast differentiation, we treated the mouse primary BMSCs with a commonly used Ppp3ca inhibitor, Cyclosporin A (CsA) (<xref ref-type="bibr" rid="bib55">Liu et al., 1991</xref>). CsA treatment abolished osteoblast differentiation as well as Yap1 and Ctnnb1 activation enhanced by FSS or Yoda1 treatment (<xref ref-type="fig" rid="fig8">Figure 8c,d</xref>, <xref ref-type="supplementary-material" rid="fig8sdata1">Figure 8—source data 1</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1b</xref>, <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref>). These results suggest that Ppp3ca may act downstream of Piezo1/2 in mechanotransduction to regulate Yap1 and Ctnnb1 activities during osteoblast differentiation.</p></sec><sec id="s2-6"><title>Piezo1/2 act through Ppp3ca to regulate concerted activation of NFATc1, YAP1 and CTNNB1</title><p>Transcription factors in the nuclear factor of activated T cells (NFAT) family are major Ppp3ca substrates that regulate gene expression (<xref ref-type="bibr" rid="bib53">Li et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Hogan et al., 2003</xref>). We next investigated the roles of Ppp3ca and Nfatc1 in mediating Piezo1/2 regulation of mechanotransduction, as expression of constitutively nuclear NFATc1 variant (NFATc1<sup>nuc</sup>) in osteoblast leads to high bone mass (<xref ref-type="bibr" rid="bib102">Winslow et al., 2006</xref>) and loss of Nfatc1/2 led to reduced osteoblast differentiation and bone formation (<xref ref-type="bibr" rid="bib102">Winslow et al., 2006</xref>; <xref ref-type="bibr" rid="bib51">Koga et al., 2005</xref>). We found that loss of <italic>Piezo1/2</italic> together, led to a strong increase of Nfatc1 phosphorylation in the developing bone (<xref ref-type="fig" rid="fig9">Figure 9a</xref>, <xref ref-type="supplementary-material" rid="fig9sdata1">Figure 9—source data 1</xref>). Loss of <italic>Piezo1</italic> alone also increased Nfatc1 phosphorylation, although to a lesser extent (<xref ref-type="fig" rid="fig9">Figure 9a</xref>). As Nfat transcription factors are highly phosphorylated and cytoplasmic in unstimulated cells, and an increase in intracellular Ca<sup>2+</sup> leads to Nfatc1 dephosphorylation by Ppp3ca and its subsequent nuclear translocation to activate downstream gene expression (<xref ref-type="bibr" rid="bib56">Liu et al., 1997</xref>; <xref ref-type="bibr" rid="bib63">Masuda et al., 1997</xref>; <xref ref-type="bibr" rid="bib5">Beals et al., 1997</xref>; <xref ref-type="bibr" rid="bib18">Crabtree and Olson, 2002</xref>), these results suggest that Piezo1/2 activate Nfatc1 by inhibiting its phosphorylation in the developing bone. To further determine whether PIEZO1/2 regulate NFATc1 transcriptional activities, we first tested whether activation of PIEZO1 by Yoda1 alters transcriptional activities of NFATc1 in a luciferase assay in the HEK 293 T cells, in which endogenous PIEZO1 is expressed and mediates mechanosensation (<xref ref-type="bibr" rid="bib22">Dubin et al., 2017</xref>; <xref ref-type="bibr" rid="bib4">Bae et al., 2013</xref>; <xref ref-type="fig" rid="fig9">Figure 9b</xref>, <xref ref-type="supplementary-material" rid="fig9sdata1">Figure 9—source data 1</xref>). Yoda1 treatment stimulated transcription activities of not only NFAT, but also YAP1 and CTNNB1, all of which were abolished by knocking down <italic>PIEZO1</italic> (<xref ref-type="fig" rid="fig9">Figure 9b</xref>). These results indicate that activation of PIEZO1 upregulates NFATc1, YAP1 or CTNNB1 transcriptional activities. As Ppp3ca inhibition by CsA treatment suppressed the cellular and molecular effects of FSS or Yoda1 treatment in BMSCs (<xref ref-type="fig" rid="fig8">Figure 8c, d</xref>), Nfatc1 activation by Ppp3ca likely mediated Piezo1-dependent Yap1 and Ctnnb1 activation. Indeed, transcriptional activities of NFAT, YAP1 and CTNNB1 were mutually enhanced, with the only exception that YAP1 did not seem to enhance NFAT activities in HEK293T cells (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1b</xref>, <xref ref-type="supplementary-material" rid="fig9s1sdata1">Figure 9—figure supplement 1—source data 1</xref>). To further understand the mechanism underlying YAP1 and CTNNB1 activation in concert with NFATc1, we first tested YAP1 and NFATc1 interaction by co-immunoprecipitation (Co-IP) assays and found such interaction was promoted by FSS or Yoda1 treatment, but inhibited by CsA or Gd<sup>3+</sup> treatment (<xref ref-type="fig" rid="fig9">Figure 9c</xref>, <xref ref-type="supplementary-material" rid="fig9sdata1">Figure 9—source data 1</xref>, <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1b</xref>, <xref ref-type="supplementary-material" rid="fig9s1sdata1">Figure 9—figure supplement 1—source data 1</xref>). These results suggest that PIEZO1-induced Ca<sup>2+</sup> signaling promoted NFATc1 interaction with YAP1. To further confirm that PIEZO1 may activate YAP1 by activating PPP3CA and NFATc1, we examined NFATc1 and YAP1 nuclear localization in HEK293 cells and found that both were robustly promoted by FSS (<xref ref-type="fig" rid="fig9">Figure 9d</xref>). In addition, overexpression of the catalytic subunit of PPP3CA promoted YAP1 dephosphorylation (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1c</xref>, <xref ref-type="supplementary-material" rid="fig9s1sdata1">Figure 9—figure supplement 1—source data 1</xref>). Moreover, Yoda1 treatment mimicked the effects of FSS treatment or PPP3CA expression (<xref ref-type="fig" rid="fig9">Figure 9e</xref>, <xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1c</xref>). Blocking Ca<sup>2+</sup> influx with Gd<sup>3+</sup> treatment or PPP3CA activity with CsA treatment both inhibited nuclear localization of NFATc1 and YAP1 induced by FSS or Yoda1 treatment (<xref ref-type="fig" rid="fig9">Figure 9e</xref>). Furthermore, NFATc1 interaction with YAP1 or CTNNB1 was synergistically promoted by the other, as presence of all three transcription factors robustly increased their interactions (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1d</xref>, <xref ref-type="supplementary-material" rid="fig9s1sdata1">Figure 9—figure supplement 1—source data 1</xref>). It is important to note that like NFATc1, YAP1 and CTNNB1 are also activated by dephosphorylation. We therefore tested whether the Piezo1-mediated mechanotransduction promotes osteoblast differentiation by a concerted dephosphorylation of endogenous Yap1 and Ctnnb1 in mouse primary BMSCs. Indeed, Yoda 1 treatment quickly reduced Yap1 and Ctnnb1 phosphorylation (<xref ref-type="fig" rid="fig9">Figure 9f</xref>). Such activity of Yoda1 was abolished in the <italic>Piezo1/2-</italic>deficient BMSCs (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1e</xref>). Conversely, blocking Ca<sup>2+</sup> influx by Gd<sup>3+</sup> treatment promoted Yap1 and Ctnnb1 phosphorylation while reducing their protein levels within 30 min (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1f</xref>). Furthermore, in the mouse primary BMSCs, Ppp3ca was found to bind not only Nfatc1, but also Yap1 and Ctnnb1. These interactions were enhanced by Yoda1 treatment and inhibited by CsA (<xref ref-type="fig" rid="fig9">Figure 9g</xref>, <xref ref-type="supplementary-material" rid="fig9sdata1">Figure 9—source data 1</xref>). Taken together, our data indicate that Ca<sup>2+</sup>/Ppp3ca signaling activated by Piezo1 leads to concerted activation of Yap1 and Ctnnb1 with Nfat, all of which act together to regulate transcription changes that promote osteoblast differentiation and bone formation.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Concerted activation of NFATc1, Yap1 and Ctnnb1 by Piezo channel activation.</title><p>(<bold>a</bold>) Western blotting analysis of NFATc1 expression in bone tissue lysates from P0 pups. The slower migrating phosphorylated NFATc1 forms were indicated by blue arrows. (<bold>b</bold>) Luciferase reporter assays of NFATc1 (left), YAP1 (middle) and Ctnnb1 (right) activities in HEK293T cells (n = 3, means ± SD). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, two-tailed unpaired Student’s <italic>t</italic>-test and one-way ANOVA followed by Tukey’s multiple comparisons tests when ANOVA was significant (<xref ref-type="supplementary-material" rid="fig9sdata1">Figure 9—source data 1</xref>). Yoda1 treatment promoted transcription activities of NFATc1, YAP1 and Ctnnb1, which were abolished by PIEZO1 knocking down. (<bold>c</bold>) Immunoprecipitation (IP) assays of HEK293T cell lysates with the indicated expression constructs. Shaking promoted NFATc1 and YAP1 binding. (<bold>d, e</bold>) Immunostaining of YAP1 and NFATc1 in HEK293 cells with indicated treatments. Activation of PIEZO1 with Yoda1 or FSS through shaking promoted nuclear localization of both YAP1 and NFATc1, which was blocked by Gd<sup>3+</sup> or CsA treatment. Scale bars, 100 μm. (<bold>f</bold>) Western blotting analyses of Yoda1 treated primary mouse BMSCs. Phosphorylated Ctnnb1 and Yap1 were quickly reduced. (<bold>g</bold>) IP assays of Ppp3ca binding to NFATc1, Yap1 and Ctnnb1 in mouse primary BMSCs. IP with IgG was a negative control. Yoda1 treatment promoted CnA binding to NFATc1, Yap1 and Ctnnb1, which was inhibited by CsA.</p><p><supplementary-material id="fig9sdata1"><label>Figure 9—source data 1.</label><caption><title>Original Western blots and data for quantification.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig9-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>PIEZO1 activation led to concerted activation of NFATc1, YAP1 and CTNNB1.</title><p>(<bold>a</bold>) Luciferase reporter assays of NFATc1 (pGL3-NFAT), YAP1 (8XGTIIC) and CTNNB1 (SUPERTOPFLASH) transcription activities in HEK293T cells. N<italic> = 3,</italic> data are shown as means ± SD. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, two-tailed unpaired Student’s <italic>t</italic>-test and one-way ANOVA followed by Tukey’s multiple comparisons tests when ANOVA was significant (<xref ref-type="supplementary-material" rid="fig9s1sdata1">Figure 9—figure supplement 1—source data 1</xref>). Expression one of NFATc1, YAP1 and CTNNB1 led to activation of the other two. The only exception is that YAP1 overexpression reducd NFATc1 activties. (<bold>b, d</bold>) Immunoprecipitation (IP) assays of HEK293T cell lysates with the indicated expression constructs. (<bold>b</bold>) Yoda1 treatment (40 μM, 4 hr) promoted complex formation of NFATc1 and YAP1, which was inhibited by CsA or Gd<sup>3+</sup> treatment. (<bold>c</bold>) Western blotting assay of HEK 293 T cells transfected with HA-tagged YAP1 and S-tagged PPP3CA as indicated. DMSO (vehicle) or Yoda1 (40 μM) treatment was performed 24 hr after transfection for 4 hr. Arrow indicates endogenous PPP3CA. (<bold>d</bold>) Expression of NFATc1, YAP1 and CTNNB1 together promoted their complex formation. (<bold>e</bold>) Western blotting analyses of <italic>Piezo1/2</italic> deficient BMSCs treated with Yoda1. Yoda1 treatment failed to reduce phosphorylation of Ctnnb1 and Yap1. Ppp3ca: Catalytic subunit of CaN. (<bold>f</bold>) Western blotting analyses of wild-type primary BMSCs treated by Gd<sup>3+</sup>. Increased Nfatc1 phosphorylation (blue arrow), as well as increased phosphorylation of Yap1 and Ctnnb1 was observed (<xref ref-type="supplementary-material" rid="fig9s1sdata1">Figure 9—figure supplement 1—source data 1</xref>).</p><p><supplementary-material id="fig9s1sdata1"><label>Figure 9—figure supplement 1—source data 1.</label><caption><title>Original Western blots.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig9-figsupp1-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig9-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-7"><title>Enhanced Ctnnb1 activities partially rescued the bone defects of <italic>Piezo1/2</italic> bone mutants</title><p>The well-established function of Wnt/Ctnnb1 signaling activities in both bone formation and maintenance led us to test whether reduced bone formation in the <italic>Piezo1/2</italic> mutants could be rescued by enhancing the Wnt/Ctnnb1 activities. We injected pregnant females and new born mouse pups with BIO, a potent specific inhibitor for GSK3, a kinase that promotes Ctnnb1 degradation (<xref ref-type="bibr" rid="bib85">Sato et al., 2004</xref>; <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1a</xref>, <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1</xref>; <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>). We found that BIO treatment increased long bone length and bone mass with reduced bone fractures in the <italic>Piezo1/2</italic> DKO mice (<xref ref-type="fig" rid="fig10">Figure 10a</xref>, <xref ref-type="supplementary-material" rid="fig10sdata1">Figure 10—source data 1</xref>, <xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1a,b</xref>). Further analyses showed that BIO treatment enhanced Sp7 and Spp1 expression while Ctsk expression was reduced (<xref ref-type="fig" rid="fig10">Figure 10b</xref>). Thus, increased Ctnnb1 activities enhanced osteoblast differentiation and maturation while osteoclast differentiation was inhibited. To test whether Ctnnb1 and Yap1 also enhances each other’s activity in BMSCs, we treated the BMSCs with BIO or XMU-MP-1, an inhibitor of Hippo kinase Stk3/4 (<xref ref-type="bibr" rid="bib28">Fan et al., 2016</xref>), and found that while BIO increased Ctnnb1 protein levels and reduced Ctnnb1 phosphorylation as expected, it also increased Yap1 protein levels and reduced Yap1 phosphorylation (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1c</xref>). Likewise, reduction of Yap1 phosphorylation caused by XMU-MP-1 treatment was also accompanied by increase in total and non-phosphorylated Ctnnb1 protein levels. In addition, blocking Yap1 transcription activity by Verteporfin (VP) (<xref ref-type="bibr" rid="bib57">Liu-Chittenden et al., 2012</xref>) reduced the effects of BIO in promoting both Ctnnb1 and Yap1 levels, suggesting that Ctnnb1 requires Yap1 activity to be fully upregulated (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1c</xref>). Consistently, BIO treatment of BMSCs in vitro partially rescued reduction of osteoblast differentiation due to <italic>Piezo1</italic>/<italic>2</italic> loss (<xref ref-type="fig" rid="fig10s1">Figure 10—figure supplement 1d</xref>). However, while Ctnnb1 protein levels were increased by BIO treatment, the increase of Yap1 was less appreciable (<xref ref-type="fig" rid="fig10">Figure 10c</xref>), suggesting that while Ctnnb1 activation is essential for osteoblast differentiation and can promote Yap1 activation, Yap1 is also regulated by Piezo1/2 by Ctnnb1-independent pathways and it is the concerted activation of NFATc1, Yap1 and Ctnnb1 that constitutes a fully functional mechanotransduction pathway downstream of Piezo channels in promoting bone formation.</p><fig-group><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>GSK3 inhibitor BIO partially rescued the bone development defects in the <italic>Piezo1/2</italic> mutants.</title><p>(<bold>a</bold>) Representative cross section images and quantification of μCT scans of the femurs from P21 mice. N = 4. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, two-tailed unpaired Student’s <italic>t</italic>-test and one-way ANOVA followed by Tukey’s multiple comparisons tests when ANOVA was significant. Data are shown as means ± SD (<xref ref-type="supplementary-material" rid="fig10sdata1">Figure 10—source data 1</xref>). (<bold>b</bold>) Immunostaining of humerus sections from P0 mouse pups. (<bold>c</bold>) Representative immunofluorecent images of Yap1 and Ctnnb1 staining of humerus sections from P0 mouse pups with the indicated genotypes. All scale bars: 100 μm. DAPI (blue) stained the nucleus.</p><p><supplementary-material id="fig10sdata1"><label>Figure 10—source data 1.</label><caption><title>Original data for quantification.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-52779-fig10-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig10-v2.tif"/></fig><fig id="fig10s1" position="float" specific-use="child-fig"><label>Figure 10—figure supplement 1.</label><caption><title>BIO injection partially rescued the reduced bone mass phenotypes in <italic>Piezo</italic> mutants.</title><p>(<bold>a</bold>) Alizarin red and alcine blue staining of the limbs from P21 mice with the indicated genotypes after PBS or BIO injection. The injection procedure is schematically shown on the top. The bone fracture numbers and femur length were quantified (n = 4). Scale bar: 1 cm. (<bold>b</bold>) von Kossa staining of humerus sections from P0 mice. Scale bar, 100 μm. BIO treatment increased mineralization of <italic>Piezo1/2</italic> mutants. (<bold>c</bold>) Western blot analyses of lysates from primary BMSC cultured with indicated treatment. BIO (500 nM), Verteporfin (VP) (200 μg/μL), and XMU-MP-1 (2 μM), Cells were collected 3 hr after treatment. Protein bands in the blot were quantified by densitometry and analyzed using ImageJ. The first number indicated relative grayscale values to DMSO treated samples. The second number indicated the ratio of each protein level to β-actin. (<bold>d</bold>) Alkaline phosphatase staining and qPCR analyses of Ad-GFP or Ad-Cre infected <italic>Piezo1/2</italic> conditional mutant BMSCs that had been treated with PBS or BIO in vitro. N = 3, data are shown as means ± SD. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, two-tailed unpaired Student’s <italic>t</italic>-test and one-way ANOVA followed by Tukey’s multiple comparisons tests when ANOVA was significant (<bold>a, b, c, d</bold>; <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig10-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here, we have identified the mechanically activated cation channels.</p><p>Piezo1 and 2 as essential mechanosensors that promote osteoblast differentiation in both embryonic development and adult bone homeostasis. We have also identified a Piezo1/2-initiated mechanotransduction pathway in bone development. While Piezo2 is dispensable for bone development, it shares redundant functions with Piezo1. We show that Piezo1 and 2 are required to sense FSS and matrix rigidity, two crucial mechanical cues that promote osteoblast differentiation and bone formation, through intracellular Ca<sup>2+</sup> signaling that regulates the concerted activation of NFAT, Yap1, and Ctnnb1 in controlling osteoblast cell fate. These findings fill a major knowledge gap in understanding how external mechanical forces, molecular force sensors, intracellular biological signaling pathways and nuclear transcriptional regulation drive final cellular outcomes are likely to act in skeleton and other tissues and organs. Human PIEZO1 single nucleotide polymorphisms (SNPs) are associated with body height reduction (<xref ref-type="bibr" rid="bib61">Marouli et al., 2017</xref>) and may be osteoporosis based on a recent GWAS of UK Biobank (<xref ref-type="bibr" rid="bib68">Morris et al., 2019</xref>). Piezo1/2 are also the first type of MS channels documented to underlie a human disease linked to mechanical pathologies including a number of blood disorders and problems with proprioception (<xref ref-type="bibr" rid="bib62">Martinac, 2012</xref>; <xref ref-type="bibr" rid="bib16">Coste et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Murthy et al., 2017</xref>; <xref ref-type="bibr" rid="bib11">Chesler et al., 2016</xref>). Therefore, our findings provide molecular insights into the integration between mechanical stimulation and biochemical signaling pathways in developmental and homeotic events in skeletal and other tissues and organs. It is interesting to note that our observations are consistent and supported by recently published work showing that Piezo1 is required in osteoblasts and osteocytes for bone formation or resorption in postnatal mice (<xref ref-type="bibr" rid="bib90">Sun et al., 2019</xref>; <xref ref-type="bibr" rid="bib54">Li et al., 2019</xref>).</p><p>The Wolff's law developed in the 19th century, that bone adapts to pressure, or a lack of it reflects the physiological importance of mechanotransduction in bone health. Great strides have been made to understand the cellular responses to mechanical loading since then, but little is known about how mechanical stimuli are sensed and transduced at molecular levels. ECM-cell and cell-cell interactions are fundamentally important components of the mechanoenvironment essential for bone formation and function. Much of the past attention has been focused on biochemical interactions in the mechanoenvironment. In this regard, the integrin signaling pathway and the downstream actomyosin cytoskeleton have been extensively studied and recognized as major players in assessment of the mechanics, by which cells initiate a series of mechanoregulatory processes (<xref ref-type="bibr" rid="bib41">Humphrey et al., 2014</xref>). Our genetic and biochemical studies of the Piezo1/2 channel-dependent mechanotransduction provide an additional mechanism for sensing the mechanoenvironment and initiation of mechanotransduction. Outside the bone, PIEZO1 activates integrin-FAK (Ptk2) signaling in glioblastoma cells (<xref ref-type="bibr" rid="bib10">Chen et al., 2018</xref>) and vascular endothelial cells (<xref ref-type="bibr" rid="bib65">McHugh et al., 2012</xref>; <xref ref-type="bibr" rid="bib1">Albarrán-Juárez et al., 2018</xref>). However, Piezo1-dependent mechanotransduction in endothelial cells could also be integrin-independent (<xref ref-type="bibr" rid="bib1">Albarrán-Juárez et al., 2018</xref>). As integrin signaling is required for osteoblast differentiation during bone formation (<xref ref-type="bibr" rid="bib60">Marie et al., 2014</xref>) and <italic>Piezo1/2</italic> is required for cell spreading and Ptk2 activation in BMSCs (<xref ref-type="fig" rid="fig8">Figure 8a,b</xref>, <xref ref-type="supplementary-material" rid="fig8sdata1">Figure 8—source data 1</xref>, <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1b,c</xref>), it will be important to further examine integrin-independent and integrin-dependent Piezo1/2 activities in mechanotransduction of skeletal cells. It has been shown that PIEZO1 channels sense force directly transmitted through the bilayer and they are activated by bilayer tension in bleb membranes largely free of cytoskeleton gating at lower pressures (<xref ref-type="bibr" rid="bib17">Cox et al., 2016</xref>). Therefore, it appears that removal of the cortical cytoskeleton and the mechanoprotection it provides sensitizes PIEZO1 channels. This raises the possibility that actomyosin cytoskeleton could also be part of a feedback adaptation process that dampens cellular responses to mechanical loading.</p><p>A major finding in this study is the Piezo1/2-dependent activation of Ppp3ca and concerted activation of the NFAT-Yap1-Ctnnb1 transcription factor network. Yap1 and Wwtr1 are essential effectors of mechanotransduced regulation of cell proliferation and differentiation (<xref ref-type="bibr" rid="bib33">Halder et al., 2012</xref>; <xref ref-type="bibr" rid="bib2">Aragona et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">Codelia et al., 2014</xref>; <xref ref-type="bibr" rid="bib96">Wada et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">Dupont et al., 2011</xref>). The Wnt/Ctnnb1 signaling pathway plays critical roles in regulating osteoblast differentiation. Our findings here raise the possibility that Yap1/Wwtr1 could also be activated quickly by MS channels like Piezo1/2 in a noncanonical pathway, in addition to currently known Yap1 regulators including focal adhesion, actomyosin cytoskeleton and Hippo/Lats kinase cascade (<xref ref-type="bibr" rid="bib77">Panciera et al., 2017</xref>). Furthermore, such regulation was executed together with Ctnnb1 activation, suggesting that Wnt/Ctnnb1 activity can also be activated by mechanotransduction via Yap1 and may mediate some of Yap1 activity in promoting bone formation. It is interesting to note that the AP-1 transcription factor (Fos–Jun dimers) is a major transcriptional partner of both NFAT (<xref ref-type="bibr" rid="bib59">Macián et al., 2001</xref>) and YAP1/WWTR1 (<xref ref-type="bibr" rid="bib109">Zanconato et al., 2015</xref>). Composite cis-regulatory elements containing NFAT:AP-1 or TEAD (the DNA binding partner of YAP1/WWTR1):AP-1 motifs are found in the regulatory regions of many target genes. Cooperative binding to these composite cis-regulatory elements have been found between NFAT or YAP1/WWTR1 with AP-1. Our findings here specifically advanced current understanding of Yap1 activation in mechanotransduction by connecting Piezo1/2 mediated Ca<sup>2+</sup> signaling with a signaling cascade leading to downstream actomyosin cytoskeleton rearrangement and a concerted activation of key transcription factors including Yap1, Ctnnb1 and NFAT, all of which have been demonstrated to play key roles in promoting osteoblast differentiation. In light of the NFAT and Yap1 interactions we found here, it will be important to further test the role of AP-1 in NFAT interaction with YAP1; to find out whether cis-regulatory elements binding NFAT, AP-1 and TEAD in close vicinity form super enhancers and whether the genes they control are enriched in transcriptional responses to mechanical forces.</p><p>It is well established that fluid mechanical stimulation provides important mechanical stimuli to regulate bone development and regeneration in vitro and in vivo. FSS is known to acutely increase intracellular calcium concentrations in BMSCs, promote cell proliferation and upregulate osteogenic gene expression (<xref ref-type="bibr" rid="bib52">Li et al., 2004</xref>). The important roles of intracellular calcium in osteoblast differentiation has been studied extensively (<xref ref-type="bibr" rid="bib110">Zayzafoon, 2006</xref>; <xref ref-type="bibr" rid="bib25">Eapen et al., 2010</xref>; <xref ref-type="bibr" rid="bib43">Ishikawa et al., 2011</xref>; <xref ref-type="bibr" rid="bib12">Choi et al., 2018</xref>). For instance, it is shown that Pannexin 3 functions as an ER Ca<sup>2+</sup> channel to promote osteoblast differentiation. Pharmacological reduction or increase of intracellular Ca<sup>2+</sup> concentration have been used to alter signaling pathways that regulate osteoblast differentiation. Our findings that Piezo1/2 regulate osteoblast differentiation by regulating Ppp3ca/NFAT- dependent YAP1 and Ctnnb1 activities advance our current understanding of mechanically stimulated Ca<sup>2+</sup> signaling in bone cells. The vertebrate bone is a Ca<sup>2+</sup> reservoir and highly regulated by both extra- and intracellular Ca<sup>2+</sup> homeostasis, which depends to a large extent on Ca<sup>2+</sup> channels. Several types of Ca<sup>2+</sup> channels exist. However, despite the established functions of Ca<sup>2+</sup> influx and calcineurin/NFAT signaling in promoting osteoblast differentiation and bone formation (<xref ref-type="bibr" rid="bib102">Winslow et al., 2006</xref>; <xref ref-type="bibr" rid="bib51">Koga et al., 2005</xref>; <xref ref-type="bibr" rid="bib89">Sun et al., 2005</xref>; <xref ref-type="bibr" rid="bib9">Cao et al., 2017</xref>), the physiological Ca<sup>2+</sup> entry mechanisms that evoke calcineurin/NFAT activation were largely unexplored in the past. The members of the TRPV and TRPP family of ion channels are involved in the extracellular calcium homeostasis and/or intracellular Ca<sup>2+</sup> signaling in response to mechanical stimuli in bone cells. However, physiological regulation of these ion channels in bone development and their roles in Ca<sup>2+</sup> signaling remain unclear, hampering mechanistic understanding of their functions at the cellular and molecular levels.</p><p>The Piezo1/2-dependent Ca<sup>2+</sup> signaling cascade in bone development we have identified opens the door to further understanding of many critical biological and medical processes in the skeletal system and beyond, given the importance of mechanotransduction and NFAT, Yap1, Ctnnb1 transcription factors in normal functions and diseases of many tissues and organs. For instance, how other Ca<sup>2+</sup>/Calmodulin signaling targets such as CAMKII act in the PIEZO1/2 initiated mechanotransduction should be investigated. In addition, despite the crucial functions of NFATc1 in osteoclast differentiation, the mechanisms that modulate Ca<sup>2+</sup> oscillations during early osteoclastogenesis are still largely unknown. Although joint formation has been found to require movement and Piezo2 linage cells were found in the developing joints (<xref ref-type="fig" rid="fig1">Figure 1d</xref>), we did not observe abnormalities in joint formation in the <italic>Piezo1</italic> CKO and <italic>Piezo1/2</italic> DKO mutants. However, abnormal loading leads to cartilage damage and osteoarthritis as well as pathological bone alterations that may result in fracture when accumulated (<xref ref-type="bibr" rid="bib3">Astur et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Keaveny et al., 1999</xref>). Along this line, severe bone loss in astronauts due to the microgravity environment in space is a major obstacle of long-term space mission. In our preliminary study, expression of <italic>PIEZO1</italic> and <italic>PIEZO2</italic> in human BMSCs obtained from 11 male subjects showed a significant negative correlation with age (<xref ref-type="fig" rid="fig11">Figure 11</xref>, <xref ref-type="supplementary-material" rid="fig11sdata1">Figure 11—source data 1</xref>), suggesting that reduction of PIEZO channels might also contribute to bone aging. Further dissection of the Piezo1/2 function in a cell-type and age specific manner is likely to provide new insights into the underlying cellular and molecular mechanisms of mechanical forces in development and health.</p><fig id="fig11" position="float"><label>Figure 11.</label><caption><title>Expression of <italic>POEZO1/2</italic> in human BMSCs.</title><p>QRT-PCR results using the cDNA of human BMSCs from 11 male subjects, between 12 to 75 years old. <italic>PIEZO1/2</italic> Expression levels were normalized to GAPDH expression. The correlation between the expression of <italic>PIEZO1</italic> or <italic>PIEZO2</italic> and age was then calculated by Spearman’s correlation in Microsoft Excel (<xref ref-type="supplementary-material" rid="fig11sdata1">Figure 11—source data 1</xref>).</p><p><supplementary-material id="fig11sdata1"><label>Figure 11—source data 1.</label><caption><title>Original numbers collected for quantification.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-52779-fig11-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-52779-fig11-v2.tif"/></fig></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Gene (<italic>M. musculus</italic>)</td><td><italic>Piezo1</italic></td><td/><td>Gene ID: 234839</td><td/></tr><tr><td>Gene (<italic>M. musculus</italic>)</td><td><italic>Piezo2</italic></td><td/><td>Gene ID: 667742</td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td>C57BL/6J Wild type mice</td><td>Jackson laboratory</td><td>Cat# JAX:000664, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td><italic>Piezo1-tdTomato</italic> mice</td><td>Jackson laboratory</td><td>Cat# JAX:029214, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:029214">IMSR_JAX:029214</ext-link></td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td><italic>Piezo1<sup>fl/fl</sup></italic> mice</td><td>Jackson laboratory</td><td>Cat# JAX:029213, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:029213">MSR_JAX:029213</ext-link></td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td><italic>Piezo2<sup>fl/fl</sup></italic> mice</td><td>Jackson laboratory</td><td>Cat# JAX:027720, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:027720">IMSR_JAX:027720</ext-link></td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td><italic>Piezo2-GFP-IRES-Cre</italic> mice</td><td>Jackson laboratory</td><td>Cat# JAX:027719, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:027719">IMSR_JAX:027719</ext-link></td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td><italic>Ai9</italic> mice</td><td>Jackson laboratory</td><td>Cat# JAX:007909, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:007909">IMSR_JAX:007909</ext-link></td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td><italic>Prrx1-Cre</italic> mice</td><td>Jackson laboratory</td><td>Cat# JAX:005584, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:005584">IMSR_JAX:005584</ext-link></td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td><italic>Sp7-GFP::Cre</italic> mice</td><td>Jackson laboratory</td><td>Cat# JAX:006361, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:006361">IMSR_JAX:006361</ext-link></td><td/></tr><tr><td>Strain, strain background (C57BL/6J, Female and male)</td><td><italic>PC::GCaMP5G-tdTomato</italic> mice</td><td>Jackson laboratory</td><td>Cat# JAX:024477, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:024477">IMSR_JAX:024477</ext-link></td><td/></tr><tr><td>Cell line <break/>(<italic>Homo sapiens</italic>)</td><td>HEK 293T</td><td>ATCC</td><td>Cat# ACS-4500, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_4V93">CVCL_4V93</ext-link></td><td/></tr><tr><td>Transfected <break/>construct (<italic>M. musculus</italic>)</td><td>mPiezo1 siRNA</td><td>Sigma-Aldrich</td><td>Cat# SASI_ <break/>Hs01_00208584</td><td/></tr><tr><td>Transfected <break/>construct <break/>(<italic>M. musculus</italic>)</td><td>siRNA Universal Negative Control</td><td>Sigma-Aldrich</td><td>Cat# SIC001</td><td/></tr><tr><td>Biological <break/>sample <break/>(<italic>M. musculus</italic>)</td><td>Primary BMSCs</td><td/><td/><td>Freshly isolated from <italic>M. musculus</italic></td></tr><tr><td>Antibody</td><td>Anti-RFP <break/>(Rabbit polyclonal)</td><td>Rockland</td><td>Cat# 600-401-379, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2209751">AB_2209751</ext-link></td><td>1:200 (IHC), 1:1000 (WB)</td></tr><tr><td>Antibody</td><td>Anti-Sp7 <break/>(Rabbit polyclonal)</td><td>Abcam</td><td valign="top">Cat# ab22552, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2194492">AB_2194492</ext-link></td><td>1:600 (IHC), 1:2000 (WB)</td></tr><tr><td>Antibody</td><td>Anti-SO9 <break/>(Rabbit polyclonal)</td><td>Millipore</td><td valign="top">Cat# AB5535, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2239761">AB_2239761</ext-link></td><td>1:500 (IHC)</td></tr><tr><td>Antibody</td><td>Anti-OPN <break/>(Goat polyclonal)</td><td valign="top">R and D systems</td><td valign="top">Cat# AF808, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2194992">AB_2194992</ext-link></td><td valign="top">1:200 (IHC)</td></tr><tr><td>Antibody</td><td>Anti-Ctsk <break/>(Rabbit polyclonal)</td><td valign="top">Abclonal</td><td valign="top">Cat# A1782, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2763824">AB_2763824</ext-link></td><td valign="top">1:100 (IHC)</td></tr><tr><td>Antibody</td><td>Anti-Trap <break/>(Rabbit polyclonal)</td><td valign="top">Abclonal</td><td valign="top">Cat# A2528, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2764419">AB_2764419</ext-link></td><td valign="top">1:100 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">Anti-BrdU <break/>(mouse monoclonal)</td><td valign="top">Biolengd</td><td valign="top">Cat# 317902, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_604040">AB_604040</ext-link></td><td valign="top">1:100 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Col10a1 (Rabbit polyclonal)</td><td valign="top">Abclonal</td><td valign="top">Cat# A6889, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2767448">AB_2767448</ext-link></td><td valign="top">1:100 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">Anti-YAP/TAZ (Rabbit monoclonal)</td><td valign="top">CST</td><td valign="top">Cat# 8418, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10950494">AB_10950494</ext-link></td><td valign="top">1:300 (IF), 1:200 (IHC), 1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-β-catenin (mouse monoclonal)</td><td valign="top">BD Biosciences</td><td valign="top">Cat# 610154, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_397555">AB_397555</ext-link></td><td valign="top">1:400 (IHC), 1:2000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-β-catenin (Rabbit polyclonal)</td><td valign="top">Abclonal</td><td valign="top">Cat# A0316, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2757122">AB_2757122</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-NFAT2 (Rabbit polyclonal)</td><td valign="top">Abclonal</td><td valign="top">Cat# A1539, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2762296">AB_2762296</ext-link></td><td valign="top">1:200 (IF), 1:100 (IHC), 1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Phospho-YAP (Ser127) (Rabbit polyclonal)</td><td valign="top">CST</td><td valign="top">Cat# 4911, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2218913">AB_2218913</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Phospho-β-catenin (Thr41/Ser45) (Rabbit polyclonal)</td><td valign="top">CST</td><td valign="top">Cat# 9565, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_331731">AB_331731</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Non-phospho (Active) β-Catenin (Ser33/37/Thr41) (D13A1) Rabbit mAb</td><td valign="top">CST</td><td valign="top">Cat# 8814S, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11127203">AB_11127203</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">β-Actin (8H10D10) Mouse mAb</td><td valign="top">CST</td><td valign="top">Cat# 3700, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2242334">AB_2242334</ext-link></td><td valign="top">1:50,000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-LATS1 (Goat polyclonal)</td><td valign="top">Santa Cruz</td><td valign="top">Cat# sc-9388, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2133367">AB_2133367</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Phospho-LATS1 (Thr1079) (Rabbit monoclonal)</td><td valign="top">CST</td><td valign="top">Cat# 8654, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10971635">AB_10971635</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-FAK (mouse monoclonal)</td><td valign="top">Santa Cruz</td><td valign="top">Cat# sc-271126, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10614323">AB_10614323</ext-link></td><td valign="top">1:500 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Phospho-FAK (pY397) (mouse monoclonal)</td><td valign="top">BD Biosciences</td><td valign="top">Cat# 611806, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_399286">AB_399286</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Mst1 (Rabbit monoclonal)</td><td valign="top">CST</td><td valign="top">Cat# 14946, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2798654">AB_2798654</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Phospho-Mst1 (Thr183) (Rabbit monoclonal)</td><td valign="top">CST</td><td valign="top">Cat# 49332, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2799355">AB_2799355</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-RUNX2 (Rabbit polyclonal)</td><td valign="top">ABclonal</td><td valign="top">Cat# A2851, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2764676">AB_2764676</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-CTGF (Rabbit polyclonal)</td><td valign="top">ABclonal</td><td valign="top">Cat# A11067, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2758390">AB_2758390</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Calcineurin (Rabbit polyclonal)</td><td valign="top">Abclonal</td><td valign="top">Cat# A1063, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2758155">AB_2758155</ext-link></td><td valign="top">1:1000 (WB), 1:200 (IP)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Flag (M2) (mouse monoclonal)</td><td valign="top">Sigma</td><td valign="top">Cat# F1804, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_262044">AB_262044</ext-link></td><td valign="top">1:2000 (WB), 1:1000 (IP)</td></tr><tr><td>Antibody</td><td valign="top">Anti-HA (3F10) (Rat monoclonal)</td><td valign="top">Roche</td><td valign="top">Cat# 11867423001, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_390918">AB_390918</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-c-Myc (9E10) (Mouse monoclonal)</td><td valign="top">Santa Cruz</td><td valign="top">Cat# sc-40, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_627268">AB_627268</ext-link></td><td valign="top">1:1000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-GAPDH (Rabbit monoclonal)</td><td valign="top">CST</td><td valign="top">Cat# 5174, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10622025">AB_10622025</ext-link></td><td valign="top">1:3000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Anti-DIG-AP conjugate (Sheep)</td><td valign="top">Roche</td><td valign="top">Cat# 11093274910, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_514497">AB_514497</ext-link></td><td valign="top">1:500 (ISH)</td></tr><tr><td>Antibody</td><td valign="top">Alexa Fluor 488 donkey anti-mouse (polyclonal)</td><td valign="top">Life Technologies</td><td valign="top">Cat# A-21202, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_141607">AB_141607</ext-link></td><td valign="top">1:500 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">Alexa Fluor 488 donkey anti-rabbit (polyclonal)</td><td valign="top">Life Technologies</td><td valign="top">Cat# A-21206, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535792">AB_2535792</ext-link></td><td valign="top">1:500 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">Alexa Fluor 488 donkey anti-goat (polyclonal)</td><td valign="top">Life Technologies</td><td valign="top">Cat# A-11055, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534102">AB_2534102</ext-link></td><td valign="top">1:500 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">Alexa Fluor 568 donkey anti-mouse (polyclonal)</td><td valign="top">Life Technologies</td><td valign="top">Cat# A10037, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534013">AB_2534013</ext-link></td><td valign="top">1:500 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">Alexa Fluor 568 donkey anti-rabbit (polyclonal)</td><td valign="top">Life Technologies</td><td valign="top">Cat# A10042, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534017">AB_2534017</ext-link></td><td valign="top">1:500 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">Alexa Fluor 568 donkey anti-goat (polyclonal)</td><td valign="top">Life Technologies</td><td valign="top">Cat# A-11057, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_142581">AB_142581</ext-link></td><td valign="top">1:500 (IHC)</td></tr><tr><td>Antibody</td><td valign="top">ECL Donkey anti-rabbit</td><td valign="top">GE Healthcare Life Science</td><td valign="top">Cat# NA9340-1ml, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_772191">AB_772191</ext-link></td><td valign="top">1:5000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">ECL Sheep anti-mouse</td><td valign="top">GE Healthcare Life Science</td><td valign="top">Cat# NA9310-1ml, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_772193">AB_772193</ext-link></td><td valign="top">1:5000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Bovine anti-goat IgG HRP</td><td valign="top">Santa Cruz</td><td valign="top">Cat# sc-2350, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_634811">AB_634811</ext-link></td><td valign="top">1:5000 (WB)</td></tr><tr><td>Antibody</td><td valign="top">Donkey Anti-Rat IgG Antibody</td><td valign="top">Sigma</td><td valign="top">Cat# AP189P, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11214462">AB_11214462</ext-link></td><td valign="top">1:5000 (WB)</td></tr><tr><td>Recombinant DNA reagent</td><td>pcDNA3.0-YAP-HA (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>pcDNA3.0-NFATc1-Flag (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>pcDNA3.0-β-catenin-Myc (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>pGL3-NFAT luciferase (plasmid)</td><td>Addgene</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_17870">Addgene_17870</ext-link></td><td/></tr><tr><td>Recombinant DNA reagent</td><td>8XGTIIC-luciferase (plasmid)</td><td>Addgene</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_34615">Addgene_34615</ext-link></td><td/></tr><tr><td>Recombinant DNA reagent</td><td>Super 8X TOPFlash (plasmid)</td><td>Addgene</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_12456">Addgene_12456</ext-link></td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pTK-Renilla (plasmid)</td><td>Promega</td><td>Cat# E2241</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pcDNA3.0-Calcineurin A-S (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Sequence-based reagent</td><td/><td/><td/><td>Primers listed in supplemental table</td></tr><tr><td>Commercial assay or kit</td><td>Gel Extraction Kit</td><td>Omega</td><td>Cat# D2500</td><td/></tr><tr><td>Commercial assay or kit</td><td>RNAscope 2.5 HD Reagent Kit</td><td>ACD</td><td>Cat# 322350</td><td/></tr><tr><td>Commercial assay or kit</td><td>RNAscope Probe Mm-<italic>Piezo1</italic></td><td>ACD</td><td>Cat# 500511</td><td/></tr><tr><td>Commercial assay or kit</td><td>RNAscope <break/>Probe Mm-<italic>Ctgf</italic></td><td>ACD</td><td>Cat# 314541</td><td/></tr><tr><td>Commercial assay or kit</td><td>1-Step NBT/BCIP Substrate Solution</td><td>Life Technologies</td><td>Cat# 34042</td><td/></tr><tr><td>Commercial assay or kit</td><td>Ion 550 Chip Kit</td><td>Life Technologies</td><td>Cat# A34541</td><td/></tr><tr><td>Commercial assay or kit</td><td>Ion AmpliSeq Transcriptome Mouse Gene Expression Panel, Chef-Ready Kit</td><td>Life Technologies</td><td>Cat# A36412</td><td/></tr><tr><td>Commercial assay or kit</td><td>Dual-Luciferase Reporter Assay</td><td>Promega</td><td>Cat# E1910</td><td/></tr><tr><td>Commercial assay or kit</td><td>Lipofectamine 3000</td><td>Life Technologies</td><td>Cat# L3000001</td><td/></tr><tr><td>Commercial assay or kit</td><td>RAT/Mouse P1NP ELISA kit</td><td>Immunodiagnostic Systems Inc</td><td>Cat# AC33F1</td><td/></tr><tr><td>Commercial assay or kit</td><td>Alexa Fluor 594 Tyramide SuperBoostTM Kit</td><td>Life Technologies</td><td>Cat# B40944</td><td/></tr><tr><td>Commercial assay or kit</td><td>Masson’s Trichrome</td><td>Abcam</td><td>Cat# ab150686</td><td/></tr><tr><td>Commercial assay or kit</td><td>TRAP staining kit</td><td>Sigma-Aldrich</td><td>Cat# 387A</td><td/></tr><tr><td>Commercial assay or kit</td><td>TUNEL kit</td><td>Life Technologies</td><td>Cat# C10617</td><td/></tr><tr><td>Commercial assay or kit</td><td>FAST SYBR Green Master Mix</td><td>Life Technologies</td><td>Cat# 4385612</td><td/></tr><tr><td>Commercial assay or kit</td><td>High-Capacity cDNA Reverse Transcription Kit</td><td>Life <break/>Technologies</td><td>Cat# 4374966</td><td/></tr><tr><td valign="top"> Chemical compound, drug</td><td valign="top">DIG RNA labeling mix</td><td valign="top">Roche</td><td valign="top">Cat# 11277073910</td><td valign="top"/></tr><tr><td valign="top">Chemical <break/>compound, drug</td><td valign="top">Protector RNase inhibitor</td><td valign="top">Roche</td><td valign="top">Cat# 03335399001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">T7 RNA polymerase</td><td valign="top">Roche</td><td valign="top">Cat# 10881767001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">T3 RNA polymerase</td><td valign="top">Roche</td><td valign="top">Cat# 11031163001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">LiCl</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# L4408</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Phusion High-Fidelity DNA Polymerase</td><td valign="top">New England Biolabs</td><td valign="top">Cat# M0530</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Proteinase K</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# P2308</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Glutaraldehyde solution</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# G5882</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Yeast tRNA</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# R8759</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Blocking reagent</td><td valign="top">Roche</td><td valign="top">Cat# 11096176001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">BM-purple</td><td valign="top">Roche</td><td valign="top">Cat# 11442074001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Alizarin Red S</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# A5533</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Alcian Blue</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# A9186</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">RNAzol RT</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# R4533</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Calcein</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# C0875</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Sliver nitrate</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# S8157</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Sodium thiosulfate</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# 72049</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">BGjb medium</td><td valign="top">Life Technologies</td><td valign="top">Cat# 12591038</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Yoda1</td><td valign="top">TOCRIS</td><td valign="top">Cat# 5586</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Cyclosporin A</td><td valign="top">LC Laboratories</td><td valign="top">Cat# LC-C-6000</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Gadolinium (III) chloride</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# 439770</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">β-glycerophosphate</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# G9422</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">L-ascorbic acid</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# A5960</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Sulfo-SANPAH</td><td valign="top">Life Technologies</td><td valign="top">Cat# 22589</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Collagen I, Rat tail</td><td valign="top">Corning</td><td valign="top">Cat# 354236</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">BIO</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# B1686</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">40% (w/v) acrylamide stock solution</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# A4058</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">2% (w/v) bis-acrylamide stock solution</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# M1533</td><td valign="top"/></tr><tr><td>Software, algorithm</td><td>GraphPad Prism</td><td>GraphPad Prism</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>ImageJ</td><td>ImageJ</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003070">SCR_003070</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>DAVID</td><td>DAVID</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001881">SCR_001881</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>Photoshop</td><td>Adobe</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014199">SCR_014199</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>Transcriptome Analysis Console</td><td>Life Technologies</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016519">SCR_016519</ext-link></td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse lines</title><p>All animal experiments were carried out according to protocols approved by the Harvard Medical School Institutional Animal Care and Use Committee. Mice described in the literature and purchased from the Jackson Laboratories: <italic>Piezo1<sup>P1-tdT</sup></italic> (stock# 029214) (<xref ref-type="bibr" rid="bib79">Ranade et al., 2014</xref>), <italic>Piezo2-EGFP-IRES-Cre</italic> (<italic>Piezo2<sup>tm1.1(cre)Apat</sup></italic>, stock# 027719) (<xref ref-type="bibr" rid="bib104">Woo et al., 2014</xref>), <italic>Piezo1<sup>f/f</sup></italic> (stock# 029213) (<xref ref-type="bibr" rid="bib8">Cahalan et al., 2015</xref>), <italic>Piezo2<sup>f/f</sup></italic> (stock# 027720) (<xref ref-type="bibr" rid="bib104">Woo et al., 2014</xref>), <italic>Prrx1-Cre</italic> (stock# 005584) (<xref ref-type="bibr" rid="bib58">Logan et al., 2002</xref>), <italic>Sp7-GFP::Cre</italic> (stock# 006361) (<xref ref-type="bibr" rid="bib81">Rodda and McMahon, 2006</xref>), <italic>Polr2a<sup>Tn(pb-CAG-GCaMP5g,-tdTomato)Tvrd</sup></italic> (<italic>PC::G5-tdT,</italic> stock# 024477) (<xref ref-type="bibr" rid="bib29">Gee et al., 2014</xref>), <italic>Ai9</italic> (<italic>Rosa26-TdTomato</italic>, stock# 007909). For embryos or neonatal mice, both male and female were used in the analyses as sex could not be clearly identified in embryos or neonatal mice. Sex-matched littermate mice were compared in postnatal mice at day 21. Three or more littermate groups were examined and representative images are shown.</p></sec><sec id="s4-2"><title>RNA in situ hybridization</title><p>Whole mount RNA in situ hybridization was performed using digoxygenin-labeled anti-sense RNA probes as described before (<xref ref-type="bibr" rid="bib101">Wilkinson and Nieto, 1993</xref>). The probes sequences were as described previously (mPiezo1 cDNA: base pairs 292–1054 of NM_001037298.1; mPiezo2 cDNA: base pairs 8,229–9298 of NM_001039485) (<xref ref-type="bibr" rid="bib107">Wu et al., 2016</xref>). Tissue sections were subjected to in situ hybrization with the RNA Scope technology according to the manufacturer’s instruction (Advanced Cell Diagnostics).</p></sec><sec id="s4-3"><title>Immunohistochemistry staining</title><p>Embryos and early-postnatal specimens were fixed in 4% (wt/vol) paraformaldehyde in phosphate-buffered saline (PBS) and processed for cryostat sections, which were blocked in 10% donkey serum and 0.1% Triton X-100 in PBS and Immunohistochemistry was performed with primary antibodies and secondary antibodies. Cryostat sections were mounted in mounting medium with DAPI from Vector laboratories (H-1200).</p></sec><sec id="s4-4"><title>Quantification of osteoblast differentiation by alkaline phosphatase staining</title><p>Osteoblast differentiation was assayed by alkaline phosphatase (ALP) staining and quantified with ImageJ software as previously described (<xref ref-type="bibr" rid="bib24">Dupont et al., 2011</xref>). For each sample, at least five low magnification (X20) pictures were taken for each sample, and osteogenic differentiation was quantified by the ALP<sup>+</sup> area determined with ImageJ as the number of blue pixels across the picture. This value was normalized to the number of cells (Hoechst/nuclei) for each picture (arbitrary units).</p></sec><sec id="s4-5"><title>Skeletal preparation and μCT scanning</title><p>Alcian blue staining for cartilage and Alizarin red staining for mineralized tissues were performed as described (<xref ref-type="bibr" rid="bib108">Yang et al., 2003</xref>). μCT scanning of long bones was performed using a SCANCO μCT 35 according to standard procedures.</p></sec><sec id="s4-6"><title>Bone histomorphometric analysis</title><p>Four weeks old wild type and <italic>Prrx1-Cre-</italic>driven <italic>Piezo1</italic> CKO or <italic>Piezo1/2</italic> DKO mice were subcutaneously injected with 20 mg/kg Calcein (Sigma) on days 4 and 1 before euthanization, respectively. Histomorphometric measurements were carried out semiautomatically with the OsteoMeasure image analyzer (OsteoMetric). Dynamic parameters including the mineralizing surface per bone surface (MS/BS) (percentage) and the bone formation rate per bone volume (BFR/BV) (percentage per year) were quantified. Analyses of bones from 3 mice per group were performed.</p></sec><sec id="s4-7"><title>Von Kossa staining and Masson’s Trichrome staining</title><p>For von Kossa staining, cryostat sections were stained with 1% silver nitrate solution under a 60 W lamp for 1 hr. Slides were rinsed three times in distilled water. Sodium thiosulfate 5% was added to the slides for 5 min. Slides were rinsed three times in distilled water and counterstained with 0.1% nuclear fast red. Slides were rinsed three times in distilled water before mounted in mounting medium. For Masson’s Trichrome staining, the sections were re-fixed in Bouin’s solution for 1 hr at 56°C and then stained sequentially with Weigert’s iron hematoxylin solution, Biebrish scarlet-acid fuchsin solution, and aniline blue solution. Collagen is stained blue.</p></sec><sec id="s4-8"><title>TUNEL assay</title><p>TUNEL assay was performed using a kit (Click-iT Plus TUNEL Assay for In Situ Apoptosis Detection, Life Technologies) according to the manufacturer’s protocol.</p></sec><sec id="s4-9"><title>PINP ELISA analysis</title><p>Serum PINP levels were measured using a commercial kit from Immunodiagnostic Systems, according to the manufacturer’s instructions.</p></sec><sec id="s4-10"><title>Cell culture</title><p>Mouse bone marrow stromal cells (BMSCs) were isolated as previously described with minor modifications (<xref ref-type="bibr" rid="bib49">Khan et al., 2018</xref>). Briefly, femur and tibia bones were cut and the bone marrow was extracted under sterile conditions, dissociated and suspended in PBS and centrifuged immediately for 5 min at 300 g. The resulting pellet was suspended in culture medium (α-MEM supplemented with penicillin-streptomycin solution, sodium bicarbonate and 10% fetal bovine serum). BMSCs were cultured at 37°C and 5% CO<sub>2</sub>. The third passage cells were used for experiments. BMSCs were seeded and cultured in 12-well plates with osteogenic differentiation medium to induce osteoblast differentiation as described previously (<xref ref-type="bibr" rid="bib80">Regard et al., 2013</xref>). HEK293T cells were maintained under standard conditions (DMEM supplemented with 10% FBS and 100 U/mL penicillin/streptomycin).</p></sec><sec id="s4-11"><title>Mouse embryonic limb bud culture for bone and joint development</title><p>Mouse limbs were dissected from E13.5 embryos in PBS. The limbs were cultured as previously described (<xref ref-type="bibr" rid="bib88">Storm and Kingsley, 1999</xref>). Briefly, the dissected fetal limbs were placed on a metal grid at the air-fluid interface with BGJb medium supplemented with 50 U/ml penicillin/streptomycin. Yoda1 (400 nM) was supplemented into the medium culturing right limbs, and equal volume of vehicle was supplemented into the medium culturing the left limbs (control). The limbs were maintained at 37°C in a 5% CO<sub>2</sub> incubator. The medium was changed every 2 days. The cultured limbs were harvested and subjected to analyses 4 days after being cultured.</p></sec><sec id="s4-12"><title>Transfection</title><p>After the cells attached to the culture dish and formed a monolayer with 70–80% confluency, the Ad-Cre or Ad-GFP virus (1:2000) was added to the medium. After 24 hr, the medium was changed, and the cells were cultured for another 24 hr before next step experiments. siRNA transfection was performed with Lipofectamine RNAi-MAX (Life Technologies) according to the manufacturer’s instructions. siRNA (Piezo1: SASI_Hs01_00208584) and MISSION siRNA Universal Negative Control were purchased from Sigma. The following luciferase reporters, Ctnnb1 reporter Super 8X TOPFlash (#12456), Yap1 reporter 8XGTIIC (#34615) and NFATc1 reporter pGL3-NFAT (#17870), were purchased from Addgene.</p></sec><sec id="s4-13"><title>Mechanical loading</title><p>Oscillating fluid flow was generated using a horizontal bidirectional shaker (260350, Boekel Scientific Rocker II). BMSCs were cultured in osteogenic medium for 2 days followed by shaking (25 RPM; 20°; 12 hr shaking and 12 hr static) for 3 days (<xref ref-type="bibr" rid="bib103">Wittkowske et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Choi et al., 2019</xref>). Cell culture on hydrogels of different stiffness was performed as described (<xref ref-type="bibr" rid="bib67">Meng et al., 2018</xref>; <xref ref-type="bibr" rid="bib93">Tse and Engler, 2010</xref>).</p></sec><sec id="s4-14"><title>Unloading by BOTOX-induced paralysis</title><p>12-week-old wild type and <italic>Sp7-Cre</italic> driven Piezo1/2 DKO male mice were anesthetized by isoflurane and then injected with 0.5U botulinum toxin (BTX, List Biological Laboratories) into both the right quadriceps and the right calf muscles. This treatment is a tibial unloading model by muscle paralysis and disuse. 24 hr after BTX injection, mice were unable to use their right hind limb. Left tibiae served as normal loading controls. Since a rapid and profound bone loss could be observed 1 week after BTX injection (<xref ref-type="bibr" rid="bib32">Grimston et al., 2007</xref>), the mice were euthanized 10 days after injection and the tibiae were analyzed by μCT. A 0.8 mm thick section spanning the proximal tibia metaphysis was analyzed as shown in previous studies (<xref ref-type="bibr" rid="bib44">Judex et al., 2004</xref>).</p></sec><sec id="s4-15"><title>Quantitative real-time PCR</title><p>Total RNA from mouse humerus and femur tissues bone tissue devoid of bone marrow was prepared using the TRIZOL reagent (Life Technologies) or RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocols. cDNA was synthesized from total RNA (1–3 μg) using SuperScript II Reverse Transcriptase with random primer (Life Technologies). QRT-PCR were performed using SYBR Select Master Mix on StepOnePlus thermal cycler from Applied Biosystems. Expression levels were always given relative to glyceraldehyde 3-phosphate dehydrogenase (Gapdh). The primer sequences of the genes are provided in the <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>.</p></sec><sec id="s4-16"><title>RNA sequencing</title><p>Total RNA was isolated from humerus and femur tissue tissues at P0 pups as described above. The libraries were constructed using Ion AmpliSeq Transcriptome Mouse Gene Expression Panel, Chef-Ready Kit according to the manufacturer’s protocols. The library qualities were checked by running on a BioAnalyzer 2100 and the concentrations were determined from the analysis profiles. Six barcoded libraries were pooled together on an equimolar basis and run using the Ion 550 Chip Kit. Genes with a change fold ≥2.82 or≤−0.35 were identified as differentially expressed genes and analyzed using the DAVID Bioinformatics Resources 6.8 (<xref ref-type="bibr" rid="bib39">Huang et al., 2007</xref>).</p></sec><sec id="s4-17"><title>Calcium imaging</title><p>Primary BMSCs from the <italic>PC::G5-tdT</italic> or <italic>Piezo1<sup>f/f</sup>; PC::G5-tdT</italic> mice were cultured as described above. GFP signal of GCaMP5G was excited at 480/505 nm and fluorescence emission was collected at 525 nm. Images were continuously taken by a Leica DM IRB microscope at time intervals of 5 s. Cells were stimulated either with shear force or Yoda1 (40 μM). All experiments were performed at room temperature (25°C). Fluorescence time series were analyzed using Image J software and converted to ΔF/F<sub>0</sub> (ΔF/F<sub>0</sub> = (F − F<sub>0</sub>)/F<sub>0</sub>), where F<sub>0</sub> is the baseline fluorescence intensity.</p></sec><sec id="s4-18"><title>Luciferase reporter assay</title><p>To measure the activity of YAP1/WWTR1, Wnt/Ctnnb1, and NFAT signaling, cells seeded in 96-well plates were cotransfected with the luciferase reporters of 8XGTIIC, 8XSuper Top-Flash or pGL3-NFAT, respectively, with pTK-<italic>Renilla</italic> (Promega) and effector plasmids. Luciferase activity was measured with a dual-luciferase reporter assay kit (Promega) according to the manufacturer’s instructions.</p></sec><sec id="s4-19"><title>co-immunoprecipitation and immunoblotting</title><p>Bone tissues or cells were prepared using a lysis buffer [20 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium orthovanadate] or RIPA buffer (Santa Cruz Biotechnology), respectively, containing protease inhibitor mixture (Roche). Immnoprecipitates or total cell lysates were analyzed by Western blotting according to standard procedures.</p></sec><sec id="s4-20"><title>Small molecule treatment</title><p>BIO was prepared as described previously (<xref ref-type="bibr" rid="bib85">Sato et al., 2004</xref>). Pregnant females were injected with Bio by intraperitoneal injection at a concentration of 2 μM every day from E15.5 and the postnatal mice were injected every other day. Equivalent volumes of vehicle were injected as control. Yoda1 (100 nM), Gd<sup>3+</sup> (100 nM), CsA (100 ng/mL) or Bio (1 μM) were added in cell culture medium after two days of osteogenic induction.</p></sec><sec id="s4-21"><title>Statistical analysis</title><p>All data analysis in this study was carried out using GraphPad Prism 7 (GraphPad Software). Quantifications were done from at least three independent experimental groups. Statistical analysis between groups was performed by two-tailed Student’s <italic>t</italic> test to determine significance when only two groups were compared. One-way ANOVA with Tukey’s post-hoc tests were used to compare differences between multiple groups. p-Values of less than 0.05 and 0.01 were considered significant. Error bars on all graphs are presented as the SD of the mean unless otherwise indicated.</p></sec><sec id="s4-22"><title>Study approval</title><p>The procedures for all animal experiments were reviewed and approved by the Harvard Medical School Institutional Animal Care and Use Committee.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to the Yang lab for stimulating discussions. YY, YF, YL, QC and PY are supported by the NIH grants R01DE025866 and R01AR070877. Taifeng Zhou, Xiaolei Zhang and Jiachen Lin are supported by visiting graduate student fellowships from the China Scholarship Council of the Chinese Ministry of Education.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con9"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con10"><p>Investigation</p></fn><fn fn-type="con" id="con11"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con12"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con13"><p>Resources, Supervision</p></fn><fn fn-type="con" id="con14"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con15"><p>Resources, Supervision, Funding acquisition, Investigation, Project administration</p></fn><fn fn-type="con" id="con16"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Investigation, Methodology, Project administration</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the NIH. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#IS00000121-3) of the Harvard Medical School. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Harvard Medical School.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Original numbers collected for quantification.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-52779-data1-v2.xlsx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Quantified results of μCT scanning of the tibia bones from the wild-types control and <italic>Sp7-Cre-</italic>driven <italic>Piezo1</italic> and <italic>Piezo1/2</italic> mutant mice (<xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref>).</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-52779-supp1-v2.docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>The sequences of oligo primers used in RT-PCR.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-52779-supp2-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-52779-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>RNAseq source data for Figure 4 has been deposited in GEO under the accession number GSE139121. All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Taifeng</surname><given-names>Zhou</given-names></name><name><surname>Yuchen</surname><given-names>Liu</given-names></name><name><surname>Yingzi</surname><given-names>Yang</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>RNA seq of femur and humerus bone tissues from Prx1cre driven Piezo1/2 mutant pups at the age of P0</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139121">GSE139121</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albarrán-Juárez</surname> <given-names>J</given-names></name><name><surname>Iring</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Joseph</surname> <given-names>S</given-names></name><name><surname>Grimm</surname> <given-names>M</given-names></name><name><surname>Strilic</surname> <given-names>B</given-names></name><name><surname>Wettschureck</surname> <given-names>N</given-names></name><name><surname>Althoff</surname> <given-names>TF</given-names></name><name><surname>Offermanns</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Piezo1 and G<sub>q</sub>/G<sub>11</sub> promote endothelial inflammation depending on flow pattern and integrin activation</article-title><source>Journal of Experimental Medicine</source><volume>215</volume><fpage>2655</fpage><lpage>2672</lpage><pub-id pub-id-type="doi">10.1084/jem.20180483</pub-id><pub-id pub-id-type="pmid">30194266</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aragona</surname> <given-names>M</given-names></name><name><surname>Panciera</surname> <given-names>T</given-names></name><name><surname>Manfrin</surname> <given-names>A</given-names></name><name><surname>Giulitti</surname> <given-names>S</given-names></name><name><surname>Michielin</surname> <given-names>F</given-names></name><name><surname>Elvassore</surname> <given-names>N</given-names></name><name><surname>Dupont</surname> <given-names>S</given-names></name><name><surname>Piccolo</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors</article-title><source>Cell</source><volume>154</volume><fpage>1047</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.07.042</pub-id><pub-id pub-id-type="pmid">23954413</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astur</surname> <given-names>DC</given-names></name><name><surname>Zanatta</surname> <given-names>F</given-names></name><name><surname>Arliani</surname> <given-names>GG</given-names></name><name><surname>Moraes</surname> <given-names>ER</given-names></name><name><surname>Pochini</surname> <given-names>AC</given-names></name><name><surname>Ejnisman</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Stress fractures: definition, diagnosis and treatment</article-title><source>Revista Brasileira De Ortopedia</source><volume>51</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1016/j.rboe.2015.12.008</pub-id><pub-id pub-id-type="pmid">26962487</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname> <given-names>C</given-names></name><name><surname>Gottlieb</surname> <given-names>PA</given-names></name><name><surname>Sachs</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Human PIEZO1: removing inactivation</article-title><source>Biophysical Journal</source><volume>105</volume><fpage>880</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2013.07.019</pub-id><pub-id pub-id-type="pmid">23972840</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beals</surname> <given-names>CR</given-names></name><name><surname>Clipstone</surname> <given-names>NA</given-names></name><name><surname>Ho</surname> <given-names>SN</given-names></name><name><surname>Crabtree</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction</article-title><source>Genes &amp; Development</source><volume>11</volume><fpage>824</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1101/gad.11.7.824</pub-id><pub-id pub-id-type="pmid">9106655</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco</surname> <given-names>P</given-names></name><name><surname>Robey</surname> <given-names>PG</given-names></name><name><surname>Saggio</surname> <given-names>I</given-names></name><name><surname>Riminucci</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>&quot;Mesenchymal&quot; stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease</article-title><source>Human Gene Therapy</source><volume>21</volume><fpage>1057</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1089/hum.2010.136</pub-id><pub-id pub-id-type="pmid">20649485</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname> <given-names>EH</given-names></name><name><surname>Klein-Nulend</surname> <given-names>J</given-names></name><name><surname>van der Plas</surname> <given-names>A</given-names></name><name><surname>Nijweide</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Function of osteocytes in bone--their role in mechanotransduction</article-title><source>The Journal of Nutrition</source><volume>125</volume><fpage>2020S</fpage><lpage>2023</lpage><pub-id pub-id-type="doi">10.1093/jn/125.suppl_7.2020S</pub-id><pub-id pub-id-type="pmid">7602386</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahalan</surname> <given-names>SM</given-names></name><name><surname>Lukacs</surname> <given-names>V</given-names></name><name><surname>Ranade</surname> <given-names>SS</given-names></name><name><surname>Chien</surname> <given-names>S</given-names></name><name><surname>Bandell</surname> <given-names>M</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Piezo1 links mechanical forces to red blood cell volume</article-title><source>eLife</source><volume>4</volume><elocation-id>e07370</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.07370</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>C</given-names></name><name><surname>Ren</surname> <given-names>Y</given-names></name><name><surname>Barnett</surname> <given-names>AS</given-names></name><name><surname>Mirando</surname> <given-names>AJ</given-names></name><name><surname>Rouse</surname> <given-names>D</given-names></name><name><surname>Mun</surname> <given-names>SH</given-names></name><name><surname>Park-Min</surname> <given-names>KH</given-names></name><name><surname>McNulty</surname> <given-names>AL</given-names></name><name><surname>Guilak</surname> <given-names>F</given-names></name><name><surname>Karner</surname> <given-names>CM</given-names></name><name><surname>Hilton</surname> <given-names>MJ</given-names></name><name><surname>Pitt</surname> <given-names>GS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Increased Ca2+ signaling through CaV1.2 promotes bone formation and prevents estrogen deficiency-induced bone loss</article-title><source>JCI Insight</source><volume>2</volume><elocation-id>95512</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.95512</pub-id><pub-id pub-id-type="pmid">29202453</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Wanggou</surname> <given-names>S</given-names></name><name><surname>Bodalia</surname> <given-names>A</given-names></name><name><surname>Zhu</surname> <given-names>M</given-names></name><name><surname>Dong</surname> <given-names>W</given-names></name><name><surname>Fan</surname> <given-names>JJ</given-names></name><name><surname>Yin</surname> <given-names>WC</given-names></name><name><surname>Min</surname> <given-names>HK</given-names></name><name><surname>Hu</surname> <given-names>M</given-names></name><name><surname>Draghici</surname> <given-names>D</given-names></name><name><surname>Dou</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Coutinho</surname> <given-names>FJ</given-names></name><name><surname>Whetstone</surname> <given-names>H</given-names></name><name><surname>Kushida</surname> <given-names>MM</given-names></name><name><surname>Dirks</surname> <given-names>PB</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Hui</surname> <given-names>CC</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>LY</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A feedforward mechanism mediated by mechanosensitive ion channel PIEZO1 and tissue mechanics promotes glioma aggression</article-title><source>Neuron</source><volume>100</volume><fpage>799</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.09.046</pub-id><pub-id pub-id-type="pmid">30344046</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chesler</surname> <given-names>AT</given-names></name><name><surname>Szczot</surname> <given-names>M</given-names></name><name><surname>Bharucha-Goebel</surname> <given-names>D</given-names></name><name><surname>Čeko</surname> <given-names>M</given-names></name><name><surname>Donkervoort</surname> <given-names>S</given-names></name><name><surname>Laubacher</surname> <given-names>C</given-names></name><name><surname>Hayes</surname> <given-names>LH</given-names></name><name><surname>Alter</surname> <given-names>K</given-names></name><name><surname>Zampieri</surname> <given-names>C</given-names></name><name><surname>Stanley</surname> <given-names>C</given-names></name><name><surname>Innes</surname> <given-names>AM</given-names></name><name><surname>Mah</surname> <given-names>JK</given-names></name><name><surname>Grosmann</surname> <given-names>CM</given-names></name><name><surname>Bradley</surname> <given-names>N</given-names></name><name><surname>Nguyen</surname> <given-names>D</given-names></name><name><surname>Foley</surname> <given-names>AR</given-names></name><name><surname>Le Pichon</surname> <given-names>CE</given-names></name><name><surname>Bönnemann</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The role of PIEZO2 in human mechanosensation</article-title><source>The New England Journal of Medicine</source><volume>375</volume><fpage>1355</fpage><lpage>1364</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1602812</pub-id><pub-id pub-id-type="pmid">27653382</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>H</given-names></name><name><surname>Srikanth</surname> <given-names>S</given-names></name><name><surname>Atti</surname> <given-names>E</given-names></name><name><surname>Pirih</surname> <given-names>FQ</given-names></name><name><surname>Nervina</surname> <given-names>JM</given-names></name><name><surname>Gwack</surname> <given-names>Y</given-names></name><name><surname>Tetradis</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deletion of Orai1 leads to bone loss aggravated with aging and impairs function of osteoblast lineage cells</article-title><source>Bone Reports</source><volume>8</volume><fpage>147</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.bonr.2018.03.007</pub-id><pub-id pub-id-type="pmid">29955633</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>D</given-names></name><name><surname>Park</surname> <given-names>E</given-names></name><name><surname>Jung</surname> <given-names>E</given-names></name><name><surname>Cha</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Yu</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>PM</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Hong</surname> <given-names>YJ</given-names></name><name><surname>Koh</surname> <given-names>CJ</given-names></name><name><surname>Cho</surname> <given-names>CW</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Li Jeon</surname> <given-names>N</given-names></name><name><surname>Wong</surname> <given-names>AK</given-names></name><name><surname>Shin</surname> <given-names>L</given-names></name><name><surname>Kumar</surname> <given-names>SR</given-names></name><name><surname>Bermejo-Moreno</surname> <given-names>I</given-names></name><name><surname>Srinivasan</surname> <given-names>RS</given-names></name><name><surname>Cho</surname> <given-names>IT</given-names></name><name><surname>Hong</surname> <given-names>YK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Piezo1 incorporates mechanical force signals into the genetic program that governs lymphatic valve development and maintenance</article-title><source>JCI Insight</source><volume>4</volume><elocation-id>125068</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.125068</pub-id><pub-id pub-id-type="pmid">30676326</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codelia</surname> <given-names>VA</given-names></name><name><surname>Sun</surname> <given-names>G</given-names></name><name><surname>Irvine</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of YAP by mechanical strain through jnk and hippo signaling</article-title><source>Current Biology</source><volume>24</volume><fpage>2012</fpage><lpage>2017</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2014.07.034</pub-id><pub-id pub-id-type="pmid">25127217</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coste</surname> <given-names>B</given-names></name><name><surname>Mathur</surname> <given-names>J</given-names></name><name><surname>Schmidt</surname> <given-names>M</given-names></name><name><surname>Earley</surname> <given-names>TJ</given-names></name><name><surname>Ranade</surname> <given-names>S</given-names></name><name><surname>Petrus</surname> <given-names>MJ</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels</article-title><source>Science</source><volume>330</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1126/science.1193270</pub-id><pub-id pub-id-type="pmid">20813920</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coste</surname> <given-names>B</given-names></name><name><surname>Xiao</surname> <given-names>B</given-names></name><name><surname>Santos</surname> <given-names>JS</given-names></name><name><surname>Syeda</surname> <given-names>R</given-names></name><name><surname>Grandl</surname> <given-names>J</given-names></name><name><surname>Spencer</surname> <given-names>KS</given-names></name><name><surname>Kim</surname> <given-names>SE</given-names></name><name><surname>Schmidt</surname> <given-names>M</given-names></name><name><surname>Mathur</surname> <given-names>J</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Montal</surname> <given-names>M</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Piezo proteins are pore-forming subunits of mechanically activated channels</article-title><source>Nature</source><volume>483</volume><fpage>176</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1038/nature10812</pub-id><pub-id pub-id-type="pmid">22343900</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname> <given-names>CD</given-names></name><name><surname>Bae</surname> <given-names>C</given-names></name><name><surname>Ziegler</surname> <given-names>L</given-names></name><name><surname>Hartley</surname> <given-names>S</given-names></name><name><surname>Nikolova-Krstevski</surname> <given-names>V</given-names></name><name><surname>Rohde</surname> <given-names>PR</given-names></name><name><surname>Ng</surname> <given-names>CA</given-names></name><name><surname>Sachs</surname> <given-names>F</given-names></name><name><surname>Gottlieb</surname> <given-names>PA</given-names></name><name><surname>Martinac</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Removal of the mechanoprotective influence of the cytoskeleton reveals PIEZO1 is gated by bilayer tension</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10366</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10366</pub-id><pub-id pub-id-type="pmid">26785635</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crabtree</surname> <given-names>GR</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>NFAT signaling: choreographing the social lives of cells</article-title><source>Cell</source><volume>109</volume><fpage>S67</fpage><lpage>S79</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(02)00699-2</pub-id><pub-id pub-id-type="pmid">11983154</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname> <given-names>TF</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Garrett-Beal</surname> <given-names>L</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis</article-title><source>Developmental Cell</source><volume>8</volume><fpage>739</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.03.016</pub-id><pub-id pub-id-type="pmid">15866164</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname> <given-names>RS</given-names></name><name><surname>Koyama</surname> <given-names>E</given-names></name><name><surname>Enomoto-Iwamoto</surname> <given-names>M</given-names></name><name><surname>Maye</surname> <given-names>P</given-names></name><name><surname>Rowe</surname> <given-names>D</given-names></name><name><surname>Zhu</surname> <given-names>S</given-names></name><name><surname>Schultz</surname> <given-names>PG</given-names></name><name><surname>Pacifici</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mouse limb skeletal growth and synovial joint development are coordinately enhanced by kartogenin</article-title><source>Developmental Biology</source><volume>395</volume><fpage>255</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2014.09.011</pub-id><pub-id pub-id-type="pmid">25238962</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaine-Smith</surname> <given-names>RM</given-names></name><name><surname>MacNeil</surname> <given-names>S</given-names></name><name><surname>Reilly</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Matrix production and collagen structure are enhanced in two types of osteogenic progenitor cells by a simple fluid shear stress stimulus</article-title><source>European Cells and Materials</source><volume>24</volume><fpage>162</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.22203/eCM.v024a12</pub-id><pub-id pub-id-type="pmid">22865228</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Murthy</surname> <given-names>S</given-names></name><name><surname>Lewis</surname> <given-names>AH</given-names></name><name><surname>Brosse</surname> <given-names>L</given-names></name><name><surname>Cahalan</surname> <given-names>SM</given-names></name><name><surname>Grandl</surname> <given-names>J</given-names></name><name><surname>Coste</surname> <given-names>B</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endogenous Piezo1 can confound mechanically activated channel identification and characterization</article-title><source>Neuron</source><volume>94</volume><fpage>266</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.039</pub-id><pub-id pub-id-type="pmid">28426961</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname> <given-names>RL</given-names></name><name><surname>Turner</surname> <given-names>CH</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Mechanotransduction and the functional response of bone to mechanical strain</article-title><source>Calcified Tissue International</source><volume>57</volume><fpage>344</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1007/BF00302070</pub-id><pub-id pub-id-type="pmid">8564797</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname> <given-names>S</given-names></name><name><surname>Morsut</surname> <given-names>L</given-names></name><name><surname>Aragona</surname> <given-names>M</given-names></name><name><surname>Enzo</surname> <given-names>E</given-names></name><name><surname>Giulitti</surname> <given-names>S</given-names></name><name><surname>Cordenonsi</surname> <given-names>M</given-names></name><name><surname>Zanconato</surname> <given-names>F</given-names></name><name><surname>Le Digabel</surname> <given-names>J</given-names></name><name><surname>Forcato</surname> <given-names>M</given-names></name><name><surname>Bicciato</surname> <given-names>S</given-names></name><name><surname>Elvassore</surname> <given-names>N</given-names></name><name><surname>Piccolo</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Role of YAP/TAZ in mechanotransduction</article-title><source>Nature</source><volume>474</volume><fpage>179</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1038/nature10137</pub-id><pub-id pub-id-type="pmid">21654799</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eapen</surname> <given-names>A</given-names></name><name><surname>Sundivakkam</surname> <given-names>P</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Ravindran</surname> <given-names>S</given-names></name><name><surname>Ramachandran</surname> <given-names>A</given-names></name><name><surname>Tiruppathi</surname> <given-names>C</given-names></name><name><surname>George</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Calcium-mediated stress kinase activation by DMP1 promotes osteoblast differentiation</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>36339</fpage><lpage>36351</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.145607</pub-id><pub-id pub-id-type="pmid">20841352</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>From cell structure to transcription: hippo forges a new path</article-title><source>Cell</source><volume>124</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.01.005</pub-id><pub-id pub-id-type="pmid">16439203</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eyckmans</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>GL</given-names></name><name><surname>Chen</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Adhesive and mechanical regulation of mesenchymal stem cell differentiation in human bone marrow and periosteum-derived progenitor cells</article-title><source>Biology Open</source><volume>1</volume><fpage>1058</fpage><lpage>1068</lpage><pub-id pub-id-type="doi">10.1242/bio.20122162</pub-id><pub-id pub-id-type="pmid">23213385</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>F</given-names></name><name><surname>He</surname> <given-names>Z</given-names></name><name><surname>Kong</surname> <given-names>LL</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Yuan</surname> <given-names>Q</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Ye</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Sun</surname> <given-names>X</given-names></name><name><surname>Geng</surname> <given-names>J</given-names></name><name><surname>Yuan</surname> <given-names>L</given-names></name><name><surname>Hong</surname> <given-names>L</given-names></name><name><surname>Xiao</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Sun</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>P</given-names></name><name><surname>Huang</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Ji</surname> <given-names>Z</given-names></name><name><surname>Wu</surname> <given-names>Q</given-names></name><name><surname>Xia</surname> <given-names>NS</given-names></name><name><surname>Gray</surname> <given-names>NS</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Yun</surname> <given-names>CH</given-names></name><name><surname>Deng</surname> <given-names>X</given-names></name><name><surname>Zhou</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration</article-title><source>Science Translational Medicine</source><volume>8</volume><elocation-id>352ra108</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aaf2304</pub-id><pub-id pub-id-type="pmid">27535619</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gee</surname> <given-names>JM</given-names></name><name><surname>Smith</surname> <given-names>NA</given-names></name><name><surname>Fernandez</surname> <given-names>FR</given-names></name><name><surname>Economo</surname> <given-names>MN</given-names></name><name><surname>Brunert</surname> <given-names>D</given-names></name><name><surname>Rothermel</surname> <given-names>M</given-names></name><name><surname>Morris</surname> <given-names>SC</given-names></name><name><surname>Talbot</surname> <given-names>A</given-names></name><name><surname>Palumbos</surname> <given-names>S</given-names></name><name><surname>Ichida</surname> <given-names>JM</given-names></name><name><surname>Shepherd</surname> <given-names>JD</given-names></name><name><surname>West</surname> <given-names>PJ</given-names></name><name><surname>Wachowiak</surname> <given-names>M</given-names></name><name><surname>Capecchi</surname> <given-names>MR</given-names></name><name><surname>Wilcox</surname> <given-names>KS</given-names></name><name><surname>White</surname> <given-names>JA</given-names></name><name><surname>Tvrdik</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Imaging activity in neurons and Glia with a Polr2a-based and cre-dependent GCaMP5G-IRES-tdTomato reporter mouse</article-title><source>Neuron</source><volume>83</volume><fpage>1058</fpage><lpage>1072</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.07.024</pub-id><pub-id pub-id-type="pmid">25155958</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname> <given-names>DA</given-names></name><name><surname>Bialek</surname> <given-names>P</given-names></name><name><surname>Ahn</surname> <given-names>JD</given-names></name><name><surname>Starbuck</surname> <given-names>M</given-names></name><name><surname>Patel</surname> <given-names>MS</given-names></name><name><surname>Clevers</surname> <given-names>H</given-names></name><name><surname>Taketo</surname> <given-names>MM</given-names></name><name><surname>Long</surname> <given-names>F</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name><name><surname>Lang</surname> <given-names>RA</given-names></name><name><surname>Karsenty</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation</article-title><source>Developmental Cell</source><volume>8</volume><fpage>751</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.02.017</pub-id><pub-id pub-id-type="pmid">15866165</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>Y</given-names></name><name><surname>Slee</surname> <given-names>RB</given-names></name><name><surname>Fukai</surname> <given-names>N</given-names></name><name><surname>Rawadi</surname> <given-names>G</given-names></name><name><surname>Roman-Roman</surname> <given-names>S</given-names></name><name><surname>Reginato</surname> <given-names>AM</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Cundy</surname> <given-names>T</given-names></name><name><surname>Glorieux</surname> <given-names>FH</given-names></name><name><surname>Lev</surname> <given-names>D</given-names></name><name><surname>Zacharin</surname> <given-names>M</given-names></name><name><surname>Oexle</surname> <given-names>K</given-names></name><name><surname>Marcelino</surname> <given-names>J</given-names></name><name><surname>Suwairi</surname> <given-names>W</given-names></name><name><surname>Heeger</surname> <given-names>S</given-names></name><name><surname>Sabatakos</surname> <given-names>G</given-names></name><name><surname>Apte</surname> <given-names>S</given-names></name><name><surname>Adkins</surname> <given-names>WN</given-names></name><name><surname>Allgrove</surname> <given-names>J</given-names></name><name><surname>Arslan-Kirchner</surname> <given-names>M</given-names></name><name><surname>Batch</surname> <given-names>JA</given-names></name><name><surname>Beighton</surname> <given-names>P</given-names></name><name><surname>Black</surname> <given-names>GC</given-names></name><name><surname>Boles</surname> <given-names>RG</given-names></name><name><surname>Boon</surname> <given-names>LM</given-names></name><name><surname>Borrone</surname> <given-names>C</given-names></name><name><surname>Brunner</surname> <given-names>HG</given-names></name><name><surname>Carle</surname> <given-names>GF</given-names></name><name><surname>Dallapiccola</surname> <given-names>B</given-names></name><name><surname>De Paepe</surname> <given-names>A</given-names></name><name><surname>Floege</surname> <given-names>B</given-names></name><name><surname>Halfhide</surname> <given-names>ML</given-names></name><name><surname>Hall</surname> <given-names>B</given-names></name><name><surname>Hennekam</surname> <given-names>RC</given-names></name><name><surname>Hirose</surname> <given-names>T</given-names></name><name><surname>Jans</surname> <given-names>A</given-names></name><name><surname>Jüppner</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>CA</given-names></name><name><surname>Keppler-Noreuil</surname> <given-names>K</given-names></name><name><surname>Kohlschuetter</surname> <given-names>A</given-names></name><name><surname>LaCombe</surname> <given-names>D</given-names></name><name><surname>Lambert</surname> <given-names>M</given-names></name><name><surname>Lemyre</surname> <given-names>E</given-names></name><name><surname>Letteboer</surname> <given-names>T</given-names></name><name><surname>Peltonen</surname> <given-names>L</given-names></name><name><surname>Ramesar</surname> <given-names>RS</given-names></name><name><surname>Romanengo</surname> <given-names>M</given-names></name><name><surname>Somer</surname> <given-names>H</given-names></name><name><surname>Steichen-Gersdorf</surname> <given-names>E</given-names></name><name><surname>Steinmann</surname> <given-names>B</given-names></name><name><surname>Sullivan</surname> <given-names>B</given-names></name><name><surname>Superti-Furga</surname> <given-names>A</given-names></name><name><surname>Swoboda</surname> <given-names>W</given-names></name><name><surname>van den Boogaard</surname> <given-names>MJ</given-names></name><name><surname>Van Hul</surname> <given-names>W</given-names></name><name><surname>Vikkula</surname> <given-names>M</given-names></name><name><surname>Votruba</surname> <given-names>M</given-names></name><name><surname>Zabel</surname> <given-names>B</given-names></name><name><surname>Garcia</surname> <given-names>T</given-names></name><name><surname>Baron</surname> <given-names>R</given-names></name><name><surname>Olsen</surname> <given-names>BR</given-names></name><name><surname>Warman</surname> <given-names>ML</given-names></name><collab>Osteoporosis-Pseudoglioma Syndrome Collaborative Group</collab></person-group><year iso-8601-date="2001">2001</year><article-title>LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development</article-title><source>Cell</source><volume>107</volume><fpage>513</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00571-2</pub-id><pub-id pub-id-type="pmid">11719191</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimston</surname> <given-names>SK</given-names></name><name><surname>Silva</surname> <given-names>MJ</given-names></name><name><surname>Civitelli</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Bone loss after temporarily induced muscle paralysis by botox is not fully recovered after 12 weeks</article-title><source>Annals of the New York Academy of Sciences</source><volume>1116</volume><fpage>444</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1196/annals.1402.009</pub-id><pub-id pub-id-type="pmid">17584988</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halder</surname> <given-names>G</given-names></name><name><surname>Dupont</surname> <given-names>S</given-names></name><name><surname>Piccolo</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transduction of mechanical and cytoskeletal cues by YAP and TAZ</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>13</volume><fpage>591</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1038/nrm3416</pub-id><pub-id pub-id-type="pmid">22895435</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>BK</given-names></name><name><surname>Herring</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Paralysis and growth of the musculoskeletal system in the embryonic chick</article-title><source>Journal of Morphology</source><volume>206</volume><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1002/jmor.1052060105</pub-id><pub-id pub-id-type="pmid">2246789</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname> <given-names>TP</given-names></name><name><surname>Später</surname> <given-names>D</given-names></name><name><surname>Taketo</surname> <given-names>MM</given-names></name><name><surname>Birchmeier</surname> <given-names>W</given-names></name><name><surname>Hartmann</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Canonical wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes</article-title><source>Developmental Cell</source><volume>8</volume><fpage>727</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.02.013</pub-id><pub-id pub-id-type="pmid">15866163</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname> <given-names>PG</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Nardone</surname> <given-names>J</given-names></name><name><surname>Rao</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Transcriptional regulation by calcium, Calcineurin, and NFAT</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>2205</fpage><lpage>2232</lpage><pub-id pub-id-type="doi">10.1101/gad.1102703</pub-id><pub-id pub-id-type="pmid">12975316</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>H</given-names></name><name><surname>Hilton</surname> <given-names>MJ</given-names></name><name><surname>Tu</surname> <given-names>X</given-names></name><name><surname>Yu</surname> <given-names>K</given-names></name><name><surname>Ornitz</surname> <given-names>DM</given-names></name><name><surname>Long</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Sequential roles of hedgehog and wnt signaling in osteoblast development</article-title><source>Development</source><volume>132</volume><fpage>49</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1242/dev.01564</pub-id><pub-id pub-id-type="pmid">15576404</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>S</given-names></name><name><surname>Barrera</surname> <given-names>J</given-names></name><name><surname>Matthews</surname> <given-names>K</given-names></name><name><surname>Pan</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating yorkie, the <italic>Drosophila</italic> homolog of YAP</article-title><source>Cell</source><volume>122</volume><fpage>421</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.06.007</pub-id><pub-id pub-id-type="pmid">16096061</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>DW</given-names></name><name><surname>Sherman</surname> <given-names>BT</given-names></name><name><surname>Tan</surname> <given-names>Q</given-names></name><name><surname>Kir</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>Bryant</surname> <given-names>D</given-names></name><name><surname>Guo</surname> <given-names>Y</given-names></name><name><surname>Stephens</surname> <given-names>R</given-names></name><name><surname>Baseler</surname> <given-names>MW</given-names></name><name><surname>Lane</surname> <given-names>HC</given-names></name><name><surname>Lempicki</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists</article-title><source>Nucleic Acids Research</source><volume>35</volume><fpage>W169</fpage><lpage>W175</lpage><pub-id pub-id-type="doi">10.1093/nar/gkm415</pub-id><pub-id pub-id-type="pmid">17576678</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>C</given-names></name><name><surname>Ogawa</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mechanotransduction in bone repair and regeneration</article-title><source>The FASEB Journal</source><volume>24</volume><fpage>3625</fpage><lpage>3632</lpage><pub-id pub-id-type="doi">10.1096/fj.10-157370</pub-id><pub-id pub-id-type="pmid">20505115</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphrey</surname> <given-names>JD</given-names></name><name><surname>Dufresne</surname> <given-names>ER</given-names></name><name><surname>Schwartz</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mechanotransduction and extracellular matrix homeostasis</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>15</volume><fpage>802</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1038/nrm3896</pub-id><pub-id pub-id-type="pmid">25355505</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingber</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cellular mechanotransduction: putting all the pieces together again</article-title><source>The FASEB Journal</source><volume>20</volume><fpage>811</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1096/fj.05-5424rev</pub-id><pub-id pub-id-type="pmid">16675838</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname> <given-names>M</given-names></name><name><surname>Iwamoto</surname> <given-names>T</given-names></name><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Doyle</surname> <given-names>A</given-names></name><name><surname>Fukumoto</surname> <given-names>S</given-names></name><name><surname>Yamada</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Pannexin 3 functions as an ER ca(2+) channel, hemichannel, and gap junction to promote osteoblast differentiation</article-title><source>The Journal of Cell Biology</source><volume>193</volume><fpage>1257</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1083/jcb.201101050</pub-id><pub-id pub-id-type="pmid">21690309</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judex</surname> <given-names>S</given-names></name><name><surname>Garman</surname> <given-names>R</given-names></name><name><surname>Squire</surname> <given-names>M</given-names></name><name><surname>Busa</surname> <given-names>B</given-names></name><name><surname>Donahue</surname> <given-names>LR</given-names></name><name><surname>Rubin</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Genetically linked site-specificity of disuse osteoporosis</article-title><source>Journal of Bone and Mineral Research</source><volume>19</volume><fpage>607</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1359/JBMR.040110</pub-id><pub-id pub-id-type="pmid">15005848</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsianou</surname> <given-names>MA</given-names></name><name><surname>Skondra</surname> <given-names>FG</given-names></name><name><surname>Gargalionis</surname> <given-names>AN</given-names></name><name><surname>Piperi</surname> <given-names>C</given-names></name><name><surname>Basdra</surname> <given-names>EK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The role of transient receptor potential polycystin channels in bone diseases</article-title><source>Annals of Translational Medicine</source><volume>6</volume><elocation-id>246</elocation-id><pub-id pub-id-type="doi">10.21037/atm.2018.04.10</pub-id><pub-id pub-id-type="pmid">30069448</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keaveny</surname> <given-names>TM</given-names></name><name><surname>Wachtel</surname> <given-names>EF</given-names></name><name><surname>Kopperdahl</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mechanical behavior of human trabecular bone after overloading</article-title><source>Journal of Orthopaedic Research</source><volume>17</volume><fpage>346</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1002/jor.1100170308</pub-id><pub-id pub-id-type="pmid">10376722</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kegelman</surname> <given-names>CD</given-names></name><name><surname>Mason</surname> <given-names>DE</given-names></name><name><surname>Dawahare</surname> <given-names>JH</given-names></name><name><surname>Horan</surname> <given-names>DJ</given-names></name><name><surname>Vigil</surname> <given-names>GD</given-names></name><name><surname>Howard</surname> <given-names>SS</given-names></name><name><surname>Robling</surname> <given-names>AG</given-names></name><name><surname>Bellido</surname> <given-names>TM</given-names></name><name><surname>Boerckel</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Skeletal cell YAP and TAZ combinatorially promote bone development</article-title><source>The FASEB Journal</source><volume>32</volume><fpage>2706</fpage><lpage>2721</lpage><pub-id pub-id-type="doi">10.1096/fj.201700872R</pub-id><pub-id pub-id-type="pmid">29401582</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname> <given-names>DJ</given-names></name><name><surname>Jacobs</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The role of mechanical signals in regulating chondrogenesis and osteogenesis of mesenchymal stem cells</article-title><source>Birth Defects Research Part C: Embryo Today: Reviews</source><volume>90</volume><fpage>75</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1002/bdrc.20173</pub-id><pub-id pub-id-type="pmid">20301221</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname> <given-names>SK</given-names></name><name><surname>Yadav</surname> <given-names>PS</given-names></name><name><surname>Elliott</surname> <given-names>G</given-names></name><name><surname>Hu</surname> <given-names>DZ</given-names></name><name><surname>Xu</surname> <given-names>R</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Induced <italic>gnas</italic><sup><italic>R201H</italic></sup> expression from the endogenous <italic>gnas</italic> locus causes fibrous dysplasia by up-regulating Wnt/β-catenin signaling</article-title><source>PNAS</source><volume>115</volume><fpage>E418</fpage><lpage>E427</lpage><pub-id pub-id-type="doi">10.1073/pnas.1714313114</pub-id><pub-id pub-id-type="pmid">29158412</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilian</surname> <given-names>KA</given-names></name><name><surname>Bugarija</surname> <given-names>B</given-names></name><name><surname>Lahn</surname> <given-names>BT</given-names></name><name><surname>Mrksich</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Geometric cues for directing the differentiation of mesenchymal stem cells</article-title><source>PNAS</source><volume>107</volume><fpage>4872</fpage><lpage>4877</lpage><pub-id pub-id-type="doi">10.1073/pnas.0903269107</pub-id><pub-id pub-id-type="pmid">20194780</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname> <given-names>T</given-names></name><name><surname>Matsui</surname> <given-names>Y</given-names></name><name><surname>Asagiri</surname> <given-names>M</given-names></name><name><surname>Kodama</surname> <given-names>T</given-names></name><name><surname>de Crombrugghe</surname> <given-names>B</given-names></name><name><surname>Nakashima</surname> <given-names>K</given-names></name><name><surname>Takayanagi</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>NFAT and osterix cooperatively regulate bone formation</article-title><source>Nature Medicine</source><volume>11</volume><fpage>880</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1038/nm1270</pub-id><pub-id pub-id-type="pmid">16041384</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>YJ</given-names></name><name><surname>Batra</surname> <given-names>NN</given-names></name><name><surname>You</surname> <given-names>L</given-names></name><name><surname>Meier</surname> <given-names>SC</given-names></name><name><surname>Coe</surname> <given-names>IA</given-names></name><name><surname>Yellowley</surname> <given-names>CE</given-names></name><name><surname>Jacobs</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Oscillatory fluid flow affects human marrow stromal cell proliferation and differentiation</article-title><source>Journal of Orthopaedic Research</source><volume>22</volume><fpage>1283</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1016/j.orthres.2004.04.002</pub-id><pub-id pub-id-type="pmid">15475210</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Rao</surname> <given-names>A</given-names></name><name><surname>Hogan</surname> <given-names>PG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Interaction of calcineurin with substrates and targeting proteins</article-title><source>Trends in Cell Biology</source><volume>21</volume><fpage>91</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2010.09.011</pub-id><pub-id pub-id-type="pmid">21115349</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Han</surname> <given-names>L</given-names></name><name><surname>Nookaew</surname> <given-names>I</given-names></name><name><surname>Mannen</surname> <given-names>E</given-names></name><name><surname>Silva</surname> <given-names>MJ</given-names></name><name><surname>Almeida</surname> <given-names>M</given-names></name><name><surname>Xiong</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Stimulation of Piezo1 by mechanical signals promotes bone anabolism</article-title><source>eLife</source><volume>8</volume><elocation-id>e49631</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.49631</pub-id><pub-id pub-id-type="pmid">31588901</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Farmer</surname> <given-names>JD</given-names></name><name><surname>Lane</surname> <given-names>WS</given-names></name><name><surname>Friedman</surname> <given-names>J</given-names></name><name><surname>Weissman</surname> <given-names>I</given-names></name><name><surname>Schreiber</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes</article-title><source>Cell</source><volume>66</volume><fpage>807</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(91)90124-H</pub-id><pub-id pub-id-type="pmid">1715244</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Koyano-Nakagawa</surname> <given-names>N</given-names></name><name><surname>Amasaki</surname> <given-names>Y</given-names></name><name><surname>Saito-Ohara</surname> <given-names>F</given-names></name><name><surname>Ikeuchi</surname> <given-names>T</given-names></name><name><surname>Imai</surname> <given-names>S</given-names></name><name><surname>Takano</surname> <given-names>T</given-names></name><name><surname>Arai</surname> <given-names>N</given-names></name><name><surname>Yokota</surname> <given-names>T</given-names></name><name><surname>Arai</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Calcineurin-dependent nuclear translocation of a murine transcription factor NFATx: molecular cloning and functional characterization</article-title><source>Molecular Biology of the Cell</source><volume>8</volume><fpage>157</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1091/mbc.8.1.157</pub-id><pub-id pub-id-type="pmid">9017603</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu-Chittenden</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Shim</surname> <given-names>JS</given-names></name><name><surname>Chen</surname> <given-names>Q</given-names></name><name><surname>Lee</surname> <given-names>SJ</given-names></name><name><surname>Anders</surname> <given-names>RA</given-names></name><name><surname>Liu</surname> <given-names>JO</given-names></name><name><surname>Pan</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP</article-title><source>Genes &amp; Development</source><volume>26</volume><fpage>1300</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1101/gad.192856.112</pub-id><pub-id pub-id-type="pmid">22677547</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname> <given-names>M</given-names></name><name><surname>Martin</surname> <given-names>JF</given-names></name><name><surname>Nagy</surname> <given-names>A</given-names></name><name><surname>Lobe</surname> <given-names>C</given-names></name><name><surname>Olson</surname> <given-names>EN</given-names></name><name><surname>Tabin</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Expression of cre recombinase in the developing mouse limb bud driven by a prxl enhancer</article-title><source>Genesis</source><volume>33</volume><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1002/gene.10092</pub-id><pub-id pub-id-type="pmid">12112875</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macián</surname> <given-names>F</given-names></name><name><surname>López-Rodríguez</surname> <given-names>C</given-names></name><name><surname>Rao</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Partners in transcription: nfat and AP-1</article-title><source>Oncogene</source><volume>20</volume><fpage>2476</fpage><lpage>2489</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1204386</pub-id><pub-id pub-id-type="pmid">11402342</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marie</surname> <given-names>PJ</given-names></name><name><surname>Haÿ</surname> <given-names>E</given-names></name><name><surname>Saidak</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Integrin and cadherin signaling in bone: role and potential therapeutic targets</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>25</volume><fpage>567</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2014.06.009</pub-id><pub-id pub-id-type="pmid">25034128</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marouli</surname> <given-names>E</given-names></name><name><surname>Graff</surname> <given-names>M</given-names></name><name><surname>Medina-Gomez</surname> <given-names>C</given-names></name><name><surname>Lo</surname> <given-names>KS</given-names></name><name><surname>Wood</surname> <given-names>AR</given-names></name><name><surname>Kjaer</surname> <given-names>TR</given-names></name><name><surname>Fine</surname> <given-names>RS</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Schurmann</surname> <given-names>C</given-names></name><name><surname>Highland</surname> <given-names>HM</given-names></name><name><surname>Rüeger</surname> <given-names>S</given-names></name><name><surname>Thorleifsson</surname> <given-names>G</given-names></name><name><surname>Justice</surname> <given-names>AE</given-names></name><name><surname>Lamparter</surname> <given-names>D</given-names></name><name><surname>Stirrups</surname> <given-names>KE</given-names></name><name><surname>Turcot</surname> <given-names>V</given-names></name><name><surname>Young</surname> <given-names>KL</given-names></name><name><surname>Winkler</surname> <given-names>TW</given-names></name><name><surname>Esko</surname> <given-names>T</given-names></name><name><surname>Karaderi</surname> <given-names>T</given-names></name><name><surname>Locke</surname> <given-names>AE</given-names></name><name><surname>Masca</surname> <given-names>NG</given-names></name><name><surname>Ng</surname> <given-names>MC</given-names></name><name><surname>Mudgal</surname> <given-names>P</given-names></name><name><surname>Rivas</surname> <given-names>MA</given-names></name><name><surname>Vedantam</surname> <given-names>S</given-names></name><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Abecasis</surname> <given-names>G</given-names></name><name><surname>Aben</surname> <given-names>KK</given-names></name><name><surname>Adair</surname> <given-names>LS</given-names></name><name><surname>Alam</surname> <given-names>DS</given-names></name><name><surname>Albrecht</surname> <given-names>E</given-names></name><name><surname>Allin</surname> <given-names>KH</given-names></name><name><surname>Allison</surname> <given-names>M</given-names></name><name><surname>Amouyel</surname> <given-names>P</given-names></name><name><surname>Appel</surname> <given-names>EV</given-names></name><name><surname>Arveiler</surname> <given-names>D</given-names></name><name><surname>Asselbergs</surname> <given-names>FW</given-names></name><name><surname>Auer</surname> <given-names>PL</given-names></name><name><surname>Balkau</surname> <given-names>B</given-names></name><name><surname>Banas</surname> <given-names>B</given-names></name><name><surname>Bang</surname> <given-names>LE</given-names></name><name><surname>Benn</surname> <given-names>M</given-names></name><name><surname>Bergmann</surname> <given-names>S</given-names></name><name><surname>Bielak</surname> <given-names>LF</given-names></name><name><surname>Blüher</surname> <given-names>M</given-names></name><name><surname>Boeing</surname> <given-names>H</given-names></name><name><surname>Boerwinkle</surname> <given-names>E</given-names></name><name><surname>Böger</surname> <given-names>CA</given-names></name><name><surname>Bonnycastle</surname> <given-names>LL</given-names></name><name><surname>Bork-Jensen</surname> <given-names>J</given-names></name><name><surname>Bots</surname> <given-names>ML</given-names></name><name><surname>Bottinger</surname> <given-names>EP</given-names></name><name><surname>Bowden</surname> <given-names>DW</given-names></name><name><surname>Brandslund</surname> <given-names>I</given-names></name><name><surname>Breen</surname> <given-names>G</given-names></name><name><surname>Brilliant</surname> <given-names>MH</given-names></name><name><surname>Broer</surname> <given-names>L</given-names></name><name><surname>Burt</surname> <given-names>AA</given-names></name><name><surname>Butterworth</surname> <given-names>AS</given-names></name><name><surname>Carey</surname> <given-names>DJ</given-names></name><name><surname>Caulfield</surname> <given-names>MJ</given-names></name><name><surname>Chambers</surname> <given-names>JC</given-names></name><name><surname>Chasman</surname> <given-names>DI</given-names></name><name><surname>Chen</surname> <given-names>YI</given-names></name><name><surname>Chowdhury</surname> <given-names>R</given-names></name><name><surname>Christensen</surname> <given-names>C</given-names></name><name><surname>Chu</surname> <given-names>AY</given-names></name><name><surname>Cocca</surname> <given-names>M</given-names></name><name><surname>Collins</surname> <given-names>FS</given-names></name><name><surname>Cook</surname> <given-names>JP</given-names></name><name><surname>Corley</surname> <given-names>J</given-names></name><name><surname>Galbany</surname> <given-names>JC</given-names></name><name><surname>Cox</surname> <given-names>AJ</given-names></name><name><surname>Cuellar-Partida</surname> <given-names>G</given-names></name><name><surname>Danesh</surname> <given-names>J</given-names></name><name><surname>Davies</surname> <given-names>G</given-names></name><name><surname>de Bakker</surname> <given-names>PI</given-names></name><name><surname>de Borst</surname> <given-names>GJ</given-names></name><name><surname>de Denus</surname> <given-names>S</given-names></name><name><surname>de Groot</surname> <given-names>MC</given-names></name><name><surname>de Mutsert</surname> <given-names>R</given-names></name><name><surname>Deary</surname> <given-names>IJ</given-names></name><name><surname>Dedoussis</surname> <given-names>G</given-names></name><name><surname>Demerath</surname> <given-names>EW</given-names></name><name><surname>den Hollander</surname> <given-names>AI</given-names></name><name><surname>Dennis</surname> <given-names>JG</given-names></name><name><surname>Di Angelantonio</surname> <given-names>E</given-names></name><name><surname>Drenos</surname> <given-names>F</given-names></name><name><surname>Du</surname> <given-names>M</given-names></name><name><surname>Dunning</surname> <given-names>AM</given-names></name><name><surname>Easton</surname> <given-names>DF</given-names></name><name><surname>Ebeling</surname> <given-names>T</given-names></name><name><surname>Edwards</surname> <given-names>TL</given-names></name><name><surname>Ellinor</surname> <given-names>PT</given-names></name><name><surname>Elliott</surname> <given-names>P</given-names></name><name><surname>Evangelou</surname> <given-names>E</given-names></name><name><surname>Farmaki</surname> <given-names>AE</given-names></name><name><surname>Faul</surname> <given-names>JD</given-names></name><name><surname>Feitosa</surname> <given-names>MF</given-names></name><name><surname>Feng</surname> <given-names>S</given-names></name><name><surname>Ferrannini</surname> <given-names>E</given-names></name><name><surname>Ferrario</surname> <given-names>MM</given-names></name><name><surname>Ferrieres</surname> <given-names>J</given-names></name><name><surname>Florez</surname> <given-names>JC</given-names></name><name><surname>Ford</surname> <given-names>I</given-names></name><name><surname>Fornage</surname> <given-names>M</given-names></name><name><surname>Franks</surname> <given-names>PW</given-names></name><name><surname>Frikke-Schmidt</surname> <given-names>R</given-names></name><name><surname>Galesloot</surname> <given-names>TE</given-names></name><name><surname>Gan</surname> <given-names>W</given-names></name><name><surname>Gandin</surname> <given-names>I</given-names></name><name><surname>Gasparini</surname> <given-names>P</given-names></name><name><surname>Giedraitis</surname> <given-names>V</given-names></name><name><surname>Giri</surname> <given-names>A</given-names></name><name><surname>Girotto</surname> <given-names>G</given-names></name><name><surname>Gordon</surname> <given-names>SD</given-names></name><name><surname>Gordon-Larsen</surname> <given-names>P</given-names></name><name><surname>Gorski</surname> <given-names>M</given-names></name><name><surname>Grarup</surname> <given-names>N</given-names></name><name><surname>Grove</surname> <given-names>ML</given-names></name><name><surname>Gudnason</surname> <given-names>V</given-names></name><name><surname>Gustafsson</surname> <given-names>S</given-names></name><name><surname>Hansen</surname> <given-names>T</given-names></name><name><surname>Harris</surname> <given-names>KM</given-names></name><name><surname>Harris</surname> <given-names>TB</given-names></name><name><surname>Hattersley</surname> <given-names>AT</given-names></name><name><surname>Hayward</surname> <given-names>C</given-names></name><name><surname>He</surname> <given-names>L</given-names></name><name><surname>Heid</surname> <given-names>IM</given-names></name><name><surname>Heikkilä</surname> <given-names>K</given-names></name><name><surname>Helgeland</surname> <given-names>Ø</given-names></name><name><surname>Hernesniemi</surname> <given-names>J</given-names></name><name><surname>Hewitt</surname> <given-names>AW</given-names></name><name><surname>Hocking</surname> <given-names>LJ</given-names></name><name><surname>Hollensted</surname> <given-names>M</given-names></name><name><surname>Holmen</surname> <given-names>OL</given-names></name><name><surname>Hovingh</surname> <given-names>GK</given-names></name><name><surname>Howson</surname> <given-names>JM</given-names></name><name><surname>Hoyng</surname> <given-names>CB</given-names></name><name><surname>Huang</surname> <given-names>PL</given-names></name><name><surname>Hveem</surname> <given-names>K</given-names></name><name><surname>Ikram</surname> <given-names>MA</given-names></name><name><surname>Ingelsson</surname> <given-names>E</given-names></name><name><surname>Jackson</surname> <given-names>AU</given-names></name><name><surname>Jansson</surname> <given-names>JH</given-names></name><name><surname>Jarvik</surname> <given-names>GP</given-names></name><name><surname>Jensen</surname> <given-names>GB</given-names></name><name><surname>Jhun</surname> <given-names>MA</given-names></name><name><surname>Jia</surname> <given-names>Y</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Johansson</surname> <given-names>S</given-names></name><name><surname>Jørgensen</surname> <given-names>ME</given-names></name><name><surname>Jørgensen</surname> <given-names>T</given-names></name><name><surname>Jousilahti</surname> <given-names>P</given-names></name><name><surname>Jukema</surname> <given-names>JW</given-names></name><name><surname>Kahali</surname> <given-names>B</given-names></name><name><surname>Kahn</surname> <given-names>RS</given-names></name><name><surname>Kähönen</surname> <given-names>M</given-names></name><name><surname>Kamstrup</surname> <given-names>PR</given-names></name><name><surname>Kanoni</surname> <given-names>S</given-names></name><name><surname>Kaprio</surname> <given-names>J</given-names></name><name><surname>Karaleftheri</surname> <given-names>M</given-names></name><name><surname>Kardia</surname> <given-names>SL</given-names></name><name><surname>Karpe</surname> <given-names>F</given-names></name><name><surname>Kee</surname> <given-names>F</given-names></name><name><surname>Keeman</surname> <given-names>R</given-names></name><name><surname>Kiemeney</surname> <given-names>LA</given-names></name><name><surname>Kitajima</surname> <given-names>H</given-names></name><name><surname>Kluivers</surname> <given-names>KB</given-names></name><name><surname>Kocher</surname> <given-names>T</given-names></name><name><surname>Komulainen</surname> <given-names>P</given-names></name><name><surname>Kontto</surname> <given-names>J</given-names></name><name><surname>Kooner</surname> <given-names>JS</given-names></name><name><surname>Kooperberg</surname> <given-names>C</given-names></name><name><surname>Kovacs</surname> <given-names>P</given-names></name><name><surname>Kriebel</surname> <given-names>J</given-names></name><name><surname>Kuivaniemi</surname> <given-names>H</given-names></name><name><surname>Küry</surname> <given-names>S</given-names></name><name><surname>Kuusisto</surname> <given-names>J</given-names></name><name><surname>La Bianca</surname> <given-names>M</given-names></name><name><surname>Laakso</surname> <given-names>M</given-names></name><name><surname>Lakka</surname> <given-names>TA</given-names></name><name><surname>Lange</surname> <given-names>EM</given-names></name><name><surname>Lange</surname> <given-names>LA</given-names></name><name><surname>Langefeld</surname> <given-names>CD</given-names></name><name><surname>Langenberg</surname> <given-names>C</given-names></name><name><surname>Larson</surname> <given-names>EB</given-names></name><name><surname>Lee</surname> <given-names>IT</given-names></name><name><surname>Lehtimäki</surname> <given-names>T</given-names></name><name><surname>Lewis</surname> <given-names>CE</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Li-Gao</surname> <given-names>R</given-names></name><name><surname>Lin</surname> <given-names>H</given-names></name><name><surname>Lin</surname> <given-names>LA</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Lind</surname> <given-names>L</given-names></name><name><surname>Lindström</surname> <given-names>J</given-names></name><name><surname>Linneberg</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Lophatananon</surname> <given-names>A</given-names></name><name><surname>Luan</surname> <given-names>J</given-names></name><name><surname>Lubitz</surname> <given-names>SA</given-names></name><name><surname>Lyytikäinen</surname> <given-names>LP</given-names></name><name><surname>Mackey</surname> <given-names>DA</given-names></name><name><surname>Madden</surname> <given-names>PA</given-names></name><name><surname>Manning</surname> <given-names>AK</given-names></name><name><surname>Männistö</surname> <given-names>S</given-names></name><name><surname>Marenne</surname> <given-names>G</given-names></name><name><surname>Marten</surname> <given-names>J</given-names></name><name><surname>Martin</surname> <given-names>NG</given-names></name><name><surname>Mazul</surname> <given-names>AL</given-names></name><name><surname>Meidtner</surname> <given-names>K</given-names></name><name><surname>Metspalu</surname> <given-names>A</given-names></name><name><surname>Mitchell</surname> <given-names>P</given-names></name><name><surname>Mohlke</surname> <given-names>KL</given-names></name><name><surname>Mook-Kanamori</surname> <given-names>DO</given-names></name><name><surname>Morgan</surname> <given-names>A</given-names></name><name><surname>Morris</surname> <given-names>AD</given-names></name><name><surname>Morris</surname> <given-names>AP</given-names></name><name><surname>Müller-Nurasyid</surname> <given-names>M</given-names></name><name><surname>Munroe</surname> <given-names>PB</given-names></name><name><surname>Nalls</surname> <given-names>MA</given-names></name><name><surname>Nauck</surname> <given-names>M</given-names></name><name><surname>Nelson</surname> <given-names>CP</given-names></name><name><surname>Neville</surname> <given-names>M</given-names></name><name><surname>Nielsen</surname> <given-names>SF</given-names></name><name><surname>Nikus</surname> <given-names>K</given-names></name><name><surname>Njølstad</surname> <given-names>PR</given-names></name><name><surname>Nordestgaard</surname> <given-names>BG</given-names></name><name><surname>Ntalla</surname> <given-names>I</given-names></name><name><surname>O'Connel</surname> <given-names>JR</given-names></name><name><surname>Oksa</surname> <given-names>H</given-names></name><name><surname>Loohuis</surname> <given-names>LM</given-names></name><name><surname>Ophoff</surname> <given-names>RA</given-names></name><name><surname>Owen</surname> <given-names>KR</given-names></name><name><surname>Packard</surname> <given-names>CJ</given-names></name><name><surname>Padmanabhan</surname> <given-names>S</given-names></name><name><surname>Palmer</surname> <given-names>CN</given-names></name><name><surname>Pasterkamp</surname> <given-names>G</given-names></name><name><surname>Patel</surname> <given-names>AP</given-names></name><name><surname>Pattie</surname> <given-names>A</given-names></name><name><surname>Pedersen</surname> <given-names>O</given-names></name><name><surname>Peissig</surname> <given-names>PL</given-names></name><name><surname>Peloso</surname> <given-names>GM</given-names></name><name><surname>Pennell</surname> <given-names>CE</given-names></name><name><surname>Perola</surname> <given-names>M</given-names></name><name><surname>Perry</surname> <given-names>JA</given-names></name><name><surname>Perry</surname> <given-names>JR</given-names></name><name><surname>Person</surname> <given-names>TN</given-names></name><name><surname>Pirie</surname> <given-names>A</given-names></name><name><surname>Polasek</surname> <given-names>O</given-names></name><name><surname>Posthuma</surname> <given-names>D</given-names></name><name><surname>Raitakari</surname> <given-names>OT</given-names></name><name><surname>Rasheed</surname> <given-names>A</given-names></name><name><surname>Rauramaa</surname> <given-names>R</given-names></name><name><surname>Reilly</surname> <given-names>DF</given-names></name><name><surname>Reiner</surname> <given-names>AP</given-names></name><name><surname>Renström</surname> <given-names>F</given-names></name><name><surname>Ridker</surname> <given-names>PM</given-names></name><name><surname>Rioux</surname> <given-names>JD</given-names></name><name><surname>Robertson</surname> <given-names>N</given-names></name><name><surname>Robino</surname> <given-names>A</given-names></name><name><surname>Rolandsson</surname> <given-names>O</given-names></name><name><surname>Rudan</surname> <given-names>I</given-names></name><name><surname>Ruth</surname> <given-names>KS</given-names></name><name><surname>Saleheen</surname> <given-names>D</given-names></name><name><surname>Salomaa</surname> <given-names>V</given-names></name><name><surname>Samani</surname> <given-names>NJ</given-names></name><name><surname>Sandow</surname> <given-names>K</given-names></name><name><surname>Sapkota</surname> <given-names>Y</given-names></name><name><surname>Sattar</surname> <given-names>N</given-names></name><name><surname>Schmidt</surname> <given-names>MK</given-names></name><name><surname>Schreiner</surname> <given-names>PJ</given-names></name><name><surname>Schulze</surname> <given-names>MB</given-names></name><name><surname>Scott</surname> <given-names>RA</given-names></name><name><surname>Segura-Lepe</surname> <given-names>MP</given-names></name><name><surname>Shah</surname> <given-names>S</given-names></name><name><surname>Sim</surname> <given-names>X</given-names></name><name><surname>Sivapalaratnam</surname> <given-names>S</given-names></name><name><surname>Small</surname> <given-names>KS</given-names></name><name><surname>Smith</surname> <given-names>AV</given-names></name><name><surname>Smith</surname> <given-names>JA</given-names></name><name><surname>Southam</surname> <given-names>L</given-names></name><name><surname>Spector</surname> <given-names>TD</given-names></name><name><surname>Speliotes</surname> <given-names>EK</given-names></name><name><surname>Starr</surname> <given-names>JM</given-names></name><name><surname>Steinthorsdottir</surname> <given-names>V</given-names></name><name><surname>Stringham</surname> <given-names>HM</given-names></name><name><surname>Stumvoll</surname> <given-names>M</given-names></name><name><surname>Surendran</surname> <given-names>P</given-names></name><name><surname>'t Hart</surname> <given-names>LM</given-names></name><name><surname>Tansey</surname> <given-names>KE</given-names></name><name><surname>Tardif</surname> <given-names>JC</given-names></name><name><surname>Taylor</surname> <given-names>KD</given-names></name><name><surname>Teumer</surname> <given-names>A</given-names></name><name><surname>Thompson</surname> <given-names>DJ</given-names></name><name><surname>Thorsteinsdottir</surname> <given-names>U</given-names></name><name><surname>Thuesen</surname> <given-names>BH</given-names></name><name><surname>Tönjes</surname> <given-names>A</given-names></name><name><surname>Tromp</surname> <given-names>G</given-names></name><name><surname>Trompet</surname> <given-names>S</given-names></name><name><surname>Tsafantakis</surname> <given-names>E</given-names></name><name><surname>Tuomilehto</surname> <given-names>J</given-names></name><name><surname>Tybjaerg-Hansen</surname> <given-names>A</given-names></name><name><surname>Tyrer</surname> <given-names>JP</given-names></name><name><surname>Uher</surname> <given-names>R</given-names></name><name><surname>Uitterlinden</surname> <given-names>AG</given-names></name><name><surname>Ulivi</surname> <given-names>S</given-names></name><name><surname>van der Laan</surname> <given-names>SW</given-names></name><name><surname>Van Der Leij</surname> <given-names>AR</given-names></name><name><surname>van Duijn</surname> <given-names>CM</given-names></name><name><surname>van Schoor</surname> <given-names>NM</given-names></name><name><surname>van Setten</surname> <given-names>J</given-names></name><name><surname>Varbo</surname> <given-names>A</given-names></name><name><surname>Varga</surname> <given-names>TV</given-names></name><name><surname>Varma</surname> <given-names>R</given-names></name><name><surname>Edwards</surname> <given-names>DR</given-names></name><name><surname>Vermeulen</surname> <given-names>SH</given-names></name><name><surname>Vestergaard</surname> <given-names>H</given-names></name><name><surname>Vitart</surname> <given-names>V</given-names></name><name><surname>Vogt</surname> <given-names>TF</given-names></name><name><surname>Vozzi</surname> <given-names>D</given-names></name><name><surname>Walker</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>F</given-names></name><name><surname>Wang</surname> <given-names>CA</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Wareham</surname> <given-names>NJ</given-names></name><name><surname>Warren</surname> <given-names>HR</given-names></name><name><surname>Wessel</surname> <given-names>J</given-names></name><name><surname>Willems</surname> <given-names>SM</given-names></name><name><surname>Wilson</surname> <given-names>JG</given-names></name><name><surname>Witte</surname> <given-names>DR</given-names></name><name><surname>Woods</surname> <given-names>MO</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Yaghootkar</surname> <given-names>H</given-names></name><name><surname>Yao</surname> <given-names>J</given-names></name><name><surname>Yao</surname> <given-names>P</given-names></name><name><surname>Yerges-Armstrong</surname> <given-names>LM</given-names></name><name><surname>Young</surname> <given-names>R</given-names></name><name><surname>Zeggini</surname> <given-names>E</given-names></name><name><surname>Zhan</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Zhao</surname> <given-names>JH</given-names></name><name><surname>Zhao</surname> <given-names>W</given-names></name><name><surname>Zhao</surname> <given-names>W</given-names></name><name><surname>Zheng</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Boehnke</surname> <given-names>M</given-names></name><name><surname>Kathiresan</surname> <given-names>S</given-names></name><name><surname>McCarthy</surname> <given-names>MI</given-names></name><name><surname>Willer</surname> <given-names>CJ</given-names></name><name><surname>Stefansson</surname> <given-names>K</given-names></name><name><surname>Borecki</surname> <given-names>IB</given-names></name><name><surname>Liu</surname> <given-names>DJ</given-names></name><name><surname>North</surname> <given-names>KE</given-names></name><name><surname>Heard-Costa</surname> <given-names>NL</given-names></name><name><surname>Pers</surname> <given-names>TH</given-names></name><name><surname>Lindgren</surname> <given-names>CM</given-names></name><name><surname>Oxvig</surname> <given-names>C</given-names></name><name><surname>Kutalik</surname> <given-names>Z</given-names></name><name><surname>Rivadeneira</surname> <given-names>F</given-names></name><name><surname>Loos</surname> <given-names>RJ</given-names></name><name><surname>Frayling</surname> <given-names>TM</given-names></name><name><surname>Hirschhorn</surname> <given-names>JN</given-names></name><name><surname>Deloukas</surname> <given-names>P</given-names></name><name><surname>Lettre</surname> <given-names>G</given-names></name><collab>EPIC-InterAct Consortium</collab><collab>CHD Exome+ Consortium</collab><collab>ExomeBP Consortium</collab><collab>T2D-Genes Consortium</collab><collab>GoT2D Genes Consortium</collab><collab>Global Lipids Genetics Consortium</collab><collab>ReproGen Consortium</collab><collab>MAGIC Investigators</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Rare and low-frequency coding variants alter human adult height</article-title><source>Nature</source><volume>542</volume><fpage>186</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/nature21039</pub-id><pub-id pub-id-type="pmid">28146470</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinac</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mechanosensitive ion channels: an evolutionary and scientific tour de force in mechanobiology</article-title><source>Channels</source><volume>6</volume><fpage>211</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.4161/chan.22047</pub-id><pub-id pub-id-type="pmid">22940794</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname> <given-names>ES</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Imamura</surname> <given-names>R</given-names></name><name><surname>Imai</surname> <given-names>SI</given-names></name><name><surname>Arai</surname> <given-names>KI</given-names></name><name><surname>Arai</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Control of NFATx1 nuclear translocation by a calcineurin-regulated inhibitory domain</article-title><source>Molecular and Cellular Biology</source><volume>17</volume><fpage>2066</fpage><lpage>2075</lpage><pub-id pub-id-type="doi">10.1128/MCB.17.4.2066</pub-id><pub-id pub-id-type="pmid">9121455</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBeath</surname> <given-names>R</given-names></name><name><surname>Pirone</surname> <given-names>DM</given-names></name><name><surname>Nelson</surname> <given-names>CM</given-names></name><name><surname>Bhadriraju</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment</article-title><source>Developmental Cell</source><volume>6</volume><fpage>483</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1016/S1534-5807(04)00075-9</pub-id><pub-id pub-id-type="pmid">15068789</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McHugh</surname> <given-names>BJ</given-names></name><name><surname>Murdoch</surname> <given-names>A</given-names></name><name><surname>Haslett</surname> <given-names>C</given-names></name><name><surname>Sethi</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Loss of the integrin-activating transmembrane protein Fam38A (Piezo1) promotes a switch to a reduced integrin-dependent mode of cell migration</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e40346</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0040346</pub-id><pub-id pub-id-type="pmid">22792288</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname> <given-names>LA</given-names></name><name><surname>Campbell</surname> <given-names>VA</given-names></name><name><surname>Prendergast</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Involvement of stretch-activated ion channels in strain-regulated glycosaminoglycan synthesis in mesenchymal stem cell-seeded 3D scaffolds</article-title><source>Journal of Biomechanics</source><volume>41</volume><fpage>2055</fpage><lpage>2059</lpage><pub-id pub-id-type="doi">10.1016/j.jbiomech.2008.03.027</pub-id><pub-id pub-id-type="pmid">18501365</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname> <given-names>Z</given-names></name><name><surname>Qiu</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>KC</given-names></name><name><surname>Kumar</surname> <given-names>A</given-names></name><name><surname>Placone</surname> <given-names>JK</given-names></name><name><surname>Fang</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>KC</given-names></name><name><surname>Lu</surname> <given-names>S</given-names></name><name><surname>Pan</surname> <given-names>M</given-names></name><name><surname>Hong</surname> <given-names>AW</given-names></name><name><surname>Moroishi</surname> <given-names>T</given-names></name><name><surname>Luo</surname> <given-names>M</given-names></name><name><surname>Plouffe</surname> <given-names>SW</given-names></name><name><surname>Diao</surname> <given-names>Y</given-names></name><name><surname>Ye</surname> <given-names>Z</given-names></name><name><surname>Park</surname> <given-names>HW</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Yu</surname> <given-names>FX</given-names></name><name><surname>Chien</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>CY</given-names></name><name><surname>Ren</surname> <given-names>B</given-names></name><name><surname>Engler</surname> <given-names>AJ</given-names></name><name><surname>Guan</surname> <given-names>KL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RAP2 mediates mechanoresponses of the hippo pathway</article-title><source>Nature</source><volume>560</volume><fpage>655</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0444-0</pub-id><pub-id pub-id-type="pmid">30135582</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>JA</given-names></name><name><surname>Kemp</surname> <given-names>JP</given-names></name><name><surname>Youlten</surname> <given-names>SE</given-names></name><name><surname>Laurent</surname> <given-names>L</given-names></name><name><surname>Logan</surname> <given-names>JG</given-names></name><name><surname>Chai</surname> <given-names>RC</given-names></name><name><surname>Vulpescu</surname> <given-names>NA</given-names></name><name><surname>Forgetta</surname> <given-names>V</given-names></name><name><surname>Kleinman</surname> <given-names>A</given-names></name><name><surname>Mohanty</surname> <given-names>ST</given-names></name><name><surname>Sergio</surname> <given-names>CM</given-names></name><name><surname>Quinn</surname> <given-names>J</given-names></name><name><surname>Nguyen-Yamamoto</surname> <given-names>L</given-names></name><name><surname>Luco</surname> <given-names>AL</given-names></name><name><surname>Vijay</surname> <given-names>J</given-names></name><name><surname>Simon</surname> <given-names>MM</given-names></name><name><surname>Pramatarova</surname> <given-names>A</given-names></name><name><surname>Medina-Gomez</surname> <given-names>C</given-names></name><name><surname>Trajanoska</surname> <given-names>K</given-names></name><name><surname>Ghirardello</surname> <given-names>EJ</given-names></name><name><surname>Butterfield</surname> <given-names>NC</given-names></name><name><surname>Curry</surname> <given-names>KF</given-names></name><name><surname>Leitch</surname> <given-names>VD</given-names></name><name><surname>Sparkes</surname> <given-names>PC</given-names></name><name><surname>Adoum</surname> <given-names>AT</given-names></name><name><surname>Mannan</surname> <given-names>NS</given-names></name><name><surname>Komla-Ebri</surname> <given-names>DSK</given-names></name><name><surname>Pollard</surname> <given-names>AS</given-names></name><name><surname>Dewhurst</surname> <given-names>HF</given-names></name><name><surname>Hassall</surname> <given-names>TAD</given-names></name><name><surname>Beltejar</surname> <given-names>MG</given-names></name><name><surname>Adams</surname> <given-names>DJ</given-names></name><name><surname>Vaillancourt</surname> <given-names>SM</given-names></name><name><surname>Kaptoge</surname> <given-names>S</given-names></name><name><surname>Baldock</surname> <given-names>P</given-names></name><name><surname>Cooper</surname> <given-names>C</given-names></name><name><surname>Reeve</surname> <given-names>J</given-names></name><name><surname>Ntzani</surname> <given-names>EE</given-names></name><name><surname>Evangelou</surname> <given-names>E</given-names></name><name><surname>Ohlsson</surname> <given-names>C</given-names></name><name><surname>Karasik</surname> <given-names>D</given-names></name><name><surname>Rivadeneira</surname> <given-names>F</given-names></name><name><surname>Kiel</surname> <given-names>DP</given-names></name><name><surname>Tobias</surname> <given-names>JH</given-names></name><name><surname>Gregson</surname> <given-names>CL</given-names></name><name><surname>Harvey</surname> <given-names>NC</given-names></name><name><surname>Grundberg</surname> <given-names>E</given-names></name><name><surname>Goltzman</surname> <given-names>D</given-names></name><name><surname>Adams</surname> <given-names>DJ</given-names></name><name><surname>Lelliott</surname> <given-names>CJ</given-names></name><name><surname>Hinds</surname> <given-names>DA</given-names></name><name><surname>Ackert-Bicknell</surname> <given-names>CL</given-names></name><name><surname>Hsu</surname> <given-names>YH</given-names></name><name><surname>Maurano</surname> <given-names>MT</given-names></name><name><surname>Croucher</surname> <given-names>PI</given-names></name><name><surname>Williams</surname> <given-names>GR</given-names></name><name><surname>Bassett</surname> <given-names>JHD</given-names></name><name><surname>Evans</surname> <given-names>DM</given-names></name><name><surname>Richards</surname> <given-names>JB</given-names></name><collab>23 and Me Research Team</collab></person-group><year iso-8601-date="2019">2019</year><article-title>An atlas of genetic influences on osteoporosis in humans and mice</article-title><source>Nature Genetics</source><volume>51</volume><fpage>258</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0302-x</pub-id><pub-id pub-id-type="pmid">30598549</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morse</surname> <given-names>A</given-names></name><name><surname>McDonald</surname> <given-names>MM</given-names></name><name><surname>Kelly</surname> <given-names>NH</given-names></name><name><surname>Melville</surname> <given-names>KM</given-names></name><name><surname>Schindeler</surname> <given-names>A</given-names></name><name><surname>Kramer</surname> <given-names>I</given-names></name><name><surname>Kneissel</surname> <given-names>M</given-names></name><name><surname>van der Meulen</surname> <given-names>MC</given-names></name><name><surname>Little</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mechanical load increases in bone formation via a sclerostin-independent pathway</article-title><source>Journal of Bone and Mineral Research</source><volume>29</volume><fpage>2456</fpage><lpage>2467</lpage><pub-id pub-id-type="doi">10.1002/jbmr.2278</pub-id><pub-id pub-id-type="pmid">24821585</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname> <given-names>SE</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Piezos thrive under pressure: mechanically activated ion channels in health and disease</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>771</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.92</pub-id><pub-id pub-id-type="pmid">28974772</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neubert</surname> <given-names>D</given-names></name><name><surname>Merker</surname> <given-names>HJ</given-names></name><name><surname>Tapken</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>Comparative studies on the prenatal development of mouse extremities in vivo and in organ culture</article-title><source>Naunyn-Schmiedeberg's Archives of Pharmacology</source><volume>286</volume><fpage>251</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1007/BF00498309</pub-id><pub-id pub-id-type="pmid">4281885</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicole</surname> <given-names>S</given-names></name><name><surname>Diaz</surname> <given-names>CC</given-names></name><name><surname>Frugier</surname> <given-names>T</given-names></name><name><surname>Melki</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Spinal muscular atrophy: recent advances and future prospects</article-title><source>Muscle &amp; Nerve</source><volume>26</volume><fpage>4</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/mus.10110</pub-id><pub-id pub-id-type="pmid">12115944</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowlan</surname> <given-names>NC</given-names></name><name><surname>Sharpe</surname> <given-names>J</given-names></name><name><surname>Roddy</surname> <given-names>KA</given-names></name><name><surname>Prendergast</surname> <given-names>PJ</given-names></name><name><surname>Murphy</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010a</year><article-title>Mechanobiology of embryonic skeletal development: insights from animal models</article-title><source>Birth Defects Research Part C: Embryo Today: Reviews</source><volume>90</volume><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1002/bdrc.20184</pub-id><pub-id pub-id-type="pmid">20860060</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowlan</surname> <given-names>NC</given-names></name><name><surname>Bourdon</surname> <given-names>C</given-names></name><name><surname>Dumas</surname> <given-names>G</given-names></name><name><surname>Tajbakhsh</surname> <given-names>S</given-names></name><name><surname>Prendergast</surname> <given-names>PJ</given-names></name><name><surname>Murphy</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010b</year><article-title>Developing bones are differentially affected by compromised skeletal muscle formation</article-title><source>Bone</source><volume>46</volume><fpage>1275</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2009.11.026</pub-id><pub-id pub-id-type="pmid">19948261</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Hippo signaling in organ size control</article-title><source>Genes &amp; Development</source><volume>21</volume><fpage>886</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1101/gad.1536007</pub-id><pub-id pub-id-type="pmid">17437995</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>JX</given-names></name><name><surname>Xiong</surname> <given-names>L</given-names></name><name><surname>Zhao</surname> <given-names>K</given-names></name><name><surname>Zeng</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Tang</surname> <given-names>FL</given-names></name><name><surname>Sun</surname> <given-names>D</given-names></name><name><surname>Guo</surname> <given-names>HH</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Cui</surname> <given-names>S</given-names></name><name><surname>Xia</surname> <given-names>WF</given-names></name><name><surname>Mei</surname> <given-names>L</given-names></name><name><surname>Xiong</surname> <given-names>WC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling</article-title><source>Bone Research</source><volume>6</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1038/s41413-018-0018-7</pub-id><pub-id pub-id-type="pmid">29872550</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panciera</surname> <given-names>T</given-names></name><name><surname>Azzolin</surname> <given-names>L</given-names></name><name><surname>Cordenonsi</surname> <given-names>M</given-names></name><name><surname>Piccolo</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanobiology of YAP and TAZ in physiology and disease</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>758</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.87</pub-id><pub-id pub-id-type="pmid">28951564</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parpaite</surname> <given-names>T</given-names></name><name><surname>Coste</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Piezo channels</article-title><source>Current Biology</source><volume>27</volume><fpage>R250</fpage><lpage>R252</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2017.01.048</pub-id><pub-id pub-id-type="pmid">28376327</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranade</surname> <given-names>SS</given-names></name><name><surname>Qiu</surname> <given-names>Z</given-names></name><name><surname>Woo</surname> <given-names>SH</given-names></name><name><surname>Hur</surname> <given-names>SS</given-names></name><name><surname>Murthy</surname> <given-names>SE</given-names></name><name><surname>Cahalan</surname> <given-names>SM</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Mathur</surname> <given-names>J</given-names></name><name><surname>Bandell</surname> <given-names>M</given-names></name><name><surname>Coste</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>YS</given-names></name><name><surname>Chien</surname> <given-names>S</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Piezo1, a mechanically activated ion channel, is required for vascular development in mice</article-title><source>PNAS</source><volume>111</volume><fpage>10347</fpage><lpage>10352</lpage><pub-id pub-id-type="doi">10.1073/pnas.1409233111</pub-id><pub-id pub-id-type="pmid">24958852</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regard</surname> <given-names>JB</given-names></name><name><surname>Malhotra</surname> <given-names>D</given-names></name><name><surname>Gvozdenovic-Jeremic</surname> <given-names>J</given-names></name><name><surname>Josey</surname> <given-names>M</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Weinstein</surname> <given-names>LS</given-names></name><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Shore</surname> <given-names>EM</given-names></name><name><surname>Kaplan</surname> <given-names>FS</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Activation of hedgehog signaling by loss of GNAS causes heterotopic ossification</article-title><source>Nature Medicine</source><volume>19</volume><fpage>1505</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1038/nm.3314</pub-id><pub-id pub-id-type="pmid">24076664</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodda</surname> <given-names>SJ</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Distinct roles for hedgehog and canonical wnt signaling in specification, differentiation and maintenance of osteoblast progenitors</article-title><source>Development</source><volume>133</volume><fpage>3231</fpage><lpage>3244</lpage><pub-id pub-id-type="doi">10.1242/dev.02480</pub-id><pub-id pub-id-type="pmid">16854976</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez</surname> <given-names>JI</given-names></name><name><surname>Palacios</surname> <given-names>J</given-names></name><name><surname>García-Alix</surname> <given-names>A</given-names></name><name><surname>Pastor</surname> <given-names>I</given-names></name><name><surname>Paniagua</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1988">1988a</year><article-title>Effects of immobilization on fetal bone development a morphometric study in newborns with congenital neuromuscular diseases with intrauterine onset</article-title><source>Calcified Tissue International</source><volume>43</volume><fpage>335</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1007/BF02553275</pub-id><pub-id pub-id-type="pmid">3146421</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez</surname> <given-names>JI</given-names></name><name><surname>Garcia-Alix</surname> <given-names>A</given-names></name><name><surname>Palacios</surname> <given-names>J</given-names></name><name><surname>Paniagua</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1988">1988b</year><article-title>Changes in the long bones due to fetal immobility caused by neuromuscular disease a radiographic and histological study</article-title><source>The Journal of Bone &amp; Joint Surgery</source><volume>70</volume><fpage>1052</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.2106/00004623-198870070-00014</pub-id><pub-id pub-id-type="pmid">3403574</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samoszuk</surname> <given-names>M</given-names></name><name><surname>Leuther</surname> <given-names>M</given-names></name><name><surname>Hoyle</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Role of serum P1NP measurement for monitoring treatment response in osteoporosis</article-title><source>Biomarkers in Medicine</source><volume>2</volume><fpage>495</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.2217/17520363.2.5.495</pub-id><pub-id pub-id-type="pmid">20477426</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname> <given-names>N</given-names></name><name><surname>Meijer</surname> <given-names>L</given-names></name><name><surname>Skaltsounis</surname> <given-names>L</given-names></name><name><surname>Greengard</surname> <given-names>P</given-names></name><name><surname>Brivanlou</surname> <given-names>AH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Maintenance of pluripotency in human and mouse embryonic stem cells through activation of wnt signaling by a pharmacological GSK-3-specific inhibitor</article-title><source>Nature Medicine</source><volume>10</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nm979</pub-id><pub-id pub-id-type="pmid">14702635</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schipani</surname> <given-names>E</given-names></name><name><surname>Kronenberg</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2008">2008</year><source>StemBook</source><publisher-loc>Cambridge</publisher-loc><publisher-name>Harvard Stem Cell Institute</publisher-name></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>EL</given-names></name><name><surname>Kanczler</surname> <given-names>JM</given-names></name><name><surname>Oreffo</surname> <given-names>ROC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A new take on an old story: chick limb organ culture for skeletal niche development and regenerative medicine evaluation</article-title><source>European Cells and Materials</source><volume>26</volume><fpage>91</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.22203/eCM.v026a07</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storm</surname> <given-names>EE</given-names></name><name><surname>Kingsley</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>GDF5 coordinates bone and joint formation during digit development</article-title><source>Developmental Biology</source><volume>209</volume><fpage>11</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9241</pub-id><pub-id pub-id-type="pmid">10208739</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>L</given-names></name><name><surname>Blair</surname> <given-names>HC</given-names></name><name><surname>Peng</surname> <given-names>Y</given-names></name><name><surname>Zaidi</surname> <given-names>N</given-names></name><name><surname>Adebanjo</surname> <given-names>OA</given-names></name><name><surname>Wu</surname> <given-names>XB</given-names></name><name><surname>Wu</surname> <given-names>XY</given-names></name><name><surname>Iqbal</surname> <given-names>J</given-names></name><name><surname>Epstein</surname> <given-names>S</given-names></name><name><surname>Abe</surname> <given-names>E</given-names></name><name><surname>Moonga</surname> <given-names>BS</given-names></name><name><surname>Zaidi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Calcineurin regulates bone formation by the osteoblast</article-title><source>PNAS</source><volume>102</volume><fpage>17130</fpage><lpage>17135</lpage><pub-id pub-id-type="doi">10.1073/pnas.0508480102</pub-id><pub-id pub-id-type="pmid">16286645</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>W</given-names></name><name><surname>Chi</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Ling</surname> <given-names>S</given-names></name><name><surname>Tan</surname> <given-names>Y</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Jiang</surname> <given-names>F</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Zhong</surname> <given-names>G</given-names></name><name><surname>Cao</surname> <given-names>D</given-names></name><name><surname>Jin</surname> <given-names>X</given-names></name><name><surname>Zhao</surname> <given-names>D</given-names></name><name><surname>Gao</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Xiao</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The mechanosensitive Piezo1 channel is required for bone formation</article-title><source>eLife</source><volume>8</volume><elocation-id>e47454</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.47454</pub-id><pub-id pub-id-type="pmid">31290742</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunyer</surname> <given-names>R</given-names></name><name><surname>Jin</surname> <given-names>AJ</given-names></name><name><surname>Nossal</surname> <given-names>R</given-names></name><name><surname>Sackett</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fabrication of hydrogels with steep stiffness gradients for studying cell mechanical response</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e46107</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0046107</pub-id><pub-id pub-id-type="pmid">23056241</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syeda</surname> <given-names>R</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Coste</surname> <given-names>B</given-names></name><name><surname>Mathur</surname> <given-names>J</given-names></name><name><surname>Huynh</surname> <given-names>T</given-names></name><name><surname>Matzen</surname> <given-names>J</given-names></name><name><surname>Lao</surname> <given-names>J</given-names></name><name><surname>Tully</surname> <given-names>DC</given-names></name><name><surname>Engels</surname> <given-names>IH</given-names></name><name><surname>Petrassi</surname> <given-names>HM</given-names></name><name><surname>Schumacher</surname> <given-names>AM</given-names></name><name><surname>Montal</surname> <given-names>M</given-names></name><name><surname>Bandell</surname> <given-names>M</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chemical activation of the mechanotransduction channel Piezo1</article-title><source>eLife</source><volume>4</volume><elocation-id>e07369</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.07369</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname> <given-names>JR</given-names></name><name><surname>Engler</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Preparation of hydrogel substrates with tunable mechanical properties</article-title><source>Current Protocols in Cell Biology</source><volume>47</volume><fpage>10.16.1</fpage><lpage>10.1610</lpage><pub-id pub-id-type="doi">10.1002/0471143030.cb1016s47</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velders</surname> <given-names>M</given-names></name><name><surname>Legerlotz</surname> <given-names>K</given-names></name><name><surname>Falconer</surname> <given-names>SJ</given-names></name><name><surname>Stott</surname> <given-names>NS</given-names></name><name><surname>McMahon</surname> <given-names>CD</given-names></name><name><surname>Smith</surname> <given-names>HK</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Effect of botulinum toxin A-induced paralysis and exercise training on mechanosensing and signalling gene expression in juvenile rat gastrocnemius muscle</article-title><source>Experimental Physiology</source><volume>93</volume><fpage>1273</fpage><lpage>1283</lpage><pub-id pub-id-type="doi">10.1113/expphysiol.2008.043174</pub-id><pub-id pub-id-type="pmid">18603602</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vining</surname> <given-names>KH</given-names></name><name><surname>Mooney</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanical forces direct stem cell behaviour in development and regeneration</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>18</volume><fpage>728</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1038/nrm.2017.108</pub-id><pub-id pub-id-type="pmid">29115301</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname> <given-names>K</given-names></name><name><surname>Itoga</surname> <given-names>K</given-names></name><name><surname>Okano</surname> <given-names>T</given-names></name><name><surname>Yonemura</surname> <given-names>S</given-names></name><name><surname>Sasaki</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hippo pathway regulation by cell morphology and stress fibers</article-title><source>Development</source><volume>138</volume><fpage>3907</fpage><lpage>3914</lpage><pub-id pub-id-type="doi">10.1242/dev.070987</pub-id><pub-id pub-id-type="pmid">21831922</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>F</given-names></name><name><surname>Flanagan</surname> <given-names>J</given-names></name><name><surname>Su</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>LC</given-names></name><name><surname>Bui</surname> <given-names>S</given-names></name><name><surname>Nielson</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Vo</surname> <given-names>HT</given-names></name><name><surname>Ma</surname> <given-names>XJ</given-names></name><name><surname>Luo</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues</article-title><source>The Journal of Molecular Diagnostics : JMD</source><volume>14</volume><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.jmoldx.2011.08.002</pub-id><pub-id pub-id-type="pmid">22166544</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>You</surname> <given-names>X</given-names></name><name><surname>Lotinun</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>N</given-names></name><name><surname>Zou</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>282</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-14146-6</pub-id><pub-id pub-id-type="pmid">31941964</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname> <given-names>SE</given-names></name><name><surname>Sanford</surname> <given-names>DA</given-names></name><name><surname>Becker</surname> <given-names>BA</given-names></name><name><surname>Bain</surname> <given-names>SD</given-names></name><name><surname>Srinivasan</surname> <given-names>S</given-names></name><name><surname>Gross</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Botox induced muscle paralysis rapidly degrades bone</article-title><source>Bone</source><volume>38</volume><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.bone.2005.08.009</pub-id><pub-id pub-id-type="pmid">16185943</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wesström</surname> <given-names>G</given-names></name><name><surname>Bensch</surname> <given-names>J</given-names></name><name><surname>Schollin</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Congenital myotonic dystrophy incidence, clinical aspects and early prognosis</article-title><source>Acta Paediatrica Scandinavica</source><volume>75</volume><fpage>849</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1111/j.1651-2227.1986.tb10301.x</pub-id><pub-id pub-id-type="pmid">3564952</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname> <given-names>DG</given-names></name><name><surname>Nieto</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts</article-title><source>Methods in Enzymology</source><volume>225</volume><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(93)25025-w</pub-id><pub-id pub-id-type="pmid">8231863</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winslow</surname> <given-names>MM</given-names></name><name><surname>Pan</surname> <given-names>M</given-names></name><name><surname>Starbuck</surname> <given-names>M</given-names></name><name><surname>Gallo</surname> <given-names>EM</given-names></name><name><surname>Deng</surname> <given-names>L</given-names></name><name><surname>Karsenty</surname> <given-names>G</given-names></name><name><surname>Crabtree</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Calcineurin/NFAT signaling in osteoblasts regulates bone mass</article-title><source>Developmental Cell</source><volume>10</volume><fpage>771</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.04.006</pub-id><pub-id pub-id-type="pmid">16740479</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittkowske</surname> <given-names>C</given-names></name><name><surname>Reilly</surname> <given-names>GC</given-names></name><name><surname>Lacroix</surname> <given-names>D</given-names></name><name><surname>Perrault</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>In vitro</italic> Bone Cell Models: Impact of Fluid Shear Stress on Bone Formation</article-title><source>Frontiers in Bioengineering and Biotechnology</source><volume>4</volume><elocation-id>87</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2016.00087</pub-id><pub-id pub-id-type="pmid">27896266</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname> <given-names>SH</given-names></name><name><surname>Ranade</surname> <given-names>S</given-names></name><name><surname>Weyer</surname> <given-names>AD</given-names></name><name><surname>Dubin</surname> <given-names>AE</given-names></name><name><surname>Baba</surname> <given-names>Y</given-names></name><name><surname>Qiu</surname> <given-names>Z</given-names></name><name><surname>Petrus</surname> <given-names>M</given-names></name><name><surname>Miyamoto</surname> <given-names>T</given-names></name><name><surname>Reddy</surname> <given-names>K</given-names></name><name><surname>Lumpkin</surname> <given-names>EA</given-names></name><name><surname>Stucky</surname> <given-names>CL</given-names></name><name><surname>Patapoutian</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Piezo2 is required for Merkel-cell mechanotransduction</article-title><source>Nature</source><volume>509</volume><fpage>622</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1038/nature13251</pub-id><pub-id pub-id-type="pmid">24717433</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wozniak</surname> <given-names>MA</given-names></name><name><surname>Chen</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mechanotransduction in development: a growing role for contractility</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>10</volume><fpage>34</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1038/nrm2592</pub-id><pub-id pub-id-type="pmid">19197330</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Dong</surname> <given-names>J</given-names></name><name><surname>Pan</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts</article-title><source>Cell</source><volume>114</volume><fpage>445</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00549-X</pub-id><pub-id pub-id-type="pmid">12941273</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Goyal</surname> <given-names>R</given-names></name><name><surname>Grandl</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Localized force application reveals mechanically sensitive domains of Piezo1</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12939</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12939</pub-id><pub-id pub-id-type="pmid">27694883</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Topol</surname> <given-names>L</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation</article-title><source>Development</source><volume>130</volume><fpage>1003</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1242/dev.00324</pub-id><pub-id pub-id-type="pmid">12538525</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanconato</surname> <given-names>F</given-names></name><name><surname>Forcato</surname> <given-names>M</given-names></name><name><surname>Battilana</surname> <given-names>G</given-names></name><name><surname>Azzolin</surname> <given-names>L</given-names></name><name><surname>Quaranta</surname> <given-names>E</given-names></name><name><surname>Bodega</surname> <given-names>B</given-names></name><name><surname>Rosato</surname> <given-names>A</given-names></name><name><surname>Bicciato</surname> <given-names>S</given-names></name><name><surname>Cordenonsi</surname> <given-names>M</given-names></name><name><surname>Piccolo</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth</article-title><source>Nature Cell Biology</source><volume>17</volume><fpage>1218</fpage><lpage>1227</lpage><pub-id pub-id-type="doi">10.1038/ncb3216</pub-id><pub-id pub-id-type="pmid">26258633</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zayzafoon</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Calcium/calmodulin signaling controls osteoblast growth and differentiation</article-title><source>Journal of Cellular Biochemistry</source><volume>97</volume><fpage>56</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1002/jcb.20675</pub-id><pub-id pub-id-type="pmid">16229015</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>D</given-names></name><name><surname>You</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Quantifying fluid shear stress in a rocking culture dish</article-title><source>Journal of Biomechanics</source><volume>43</volume><fpage>1598</fpage><lpage>1602</lpage><pub-id pub-id-type="doi">10.1016/j.jbiomech.2009.12.028</pub-id><pub-id pub-id-type="pmid">20185133</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.52779.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Reviewing Editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper describes a new pathway for mechanotransduction in bone and its relevance during skeletal development. This involves the activation of Piezo 1/2 channels in osteoblast progenitors, which leads to calcium signals that activate calcineurin with further downstream effects on YAP1, NFATc1 and β-catenin to regulate bone formation and resorption.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Piezo1/2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP-β-catenin&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Mone Zaidi as the Reviewing Editor and Clifford Rosen as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The study explores a role for the Piezo proteins in bone formation using <italic>Prrx1</italic> and <italic>Osx</italic> as the Cre tools. Piezo1 and Piezo2 were found to be expressed in long bones during embryonic development and to regulate osteoblastogenesis in response to mechanical forces. The experiments are methodologically sound, carefully conducted and well controlled. They provide major new insights, and are explained in a well crafted and logically presented manuscript. With that said, the Reviewers and Editors have expressed concerns that are summarized below. These concerns would need to be resolved in a revised version.</p><p>Essential revisions:</p><p>1) There is a concern about the overlap of the present manuscript and two prior publications in <italic>eLife</italic> from other groups, notably Sun et al., 2019 and Li et al., 2019), which document a role for mechanosensitive-responsive Piezo1/2 channels in bone formation. While it was recognized that those past reports were not as technically sophisticated as the present submission, there is a concern regarding novelty. That said, the reviewers recognized that the present study, apart from being cutting-edge, provided new insights into areas of skeletal development. It is therefore critical that the authors highlight how specifically this study adds new dimensions to previous work and moves the field forward.</p><p>2) There is the missed opportunity of making the manuscript more distinctive. For example, there is a clear difference in the sites of bone fracture, notably limb versus rib, in in Piezo1 CKOs driven by <italic>Prrx1</italic> and <italic>Osx Cre</italic>, respectively. Studies examining the expression pattern of the Piezo1/2 proteins in sorted <italic>Prrx1</italic>-positive and <italic>Osx</italic>-positive osteoblast progenitors during differentiation under induced mechanotransduction conditions could shed light on this difference.</p><p>3) It was felt that the connection between Yap and Piezo activity was very interesting and was likely to be important for the growing Hippo-Yap field. However, insufficient evidence was presented to establish that activated Yap pathways contribute to osteoblast differentiation through Piezo. It was also unclear how precisely non-canonical Yap signaling plays a role – specifically, molecular mechanisms remained scanty. The authors would need to answer several key questions: (a) what are the respective functions of Yap1 and β-catenin in osteogenesis mediated by Piezo1/2; (b) what is the physiological function the NFAT/YAP/β-catenin complex; (c) what is the contribution of YAP1 to the rescue in Piezo1 and Piezo1/2 mutants by enhanced β-catenin activity; and (d) whether there is crosstalk between Wnt/β-catenin and Hippo/Yap signaling? The authors should comment in more depth on potential Hippo signaling in their system. This possibility is suggested by their data but does not come out well in the Discussion.</p><p>4) The authors show Piezo1/2 expression in long bone, but not in the axial skeleton or the skull. Specifically, are there abnormalities in craniofacial bones or teeth?</p><p>5) BTX treatment is not the best means to examine the mechanosensor function of Piezo proteins in bone formation, as injured muscle and nerves are known to alter bone formation indirectly. While the hind-limb suspension model or tibia axial loading would provide a better assessment, it would suffice to provide full histomorphometric analysis to confirm the function of the Piezo proteins in bone formation.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.52779.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) There is a concern about the overlap of the present manuscript and two prior publications in eLife from other groups, notably Sun et al., 2019 and Li et al., 2019), which document a role for mechanosensitive-responsive Piezo1/2 channels in bone formation. While it was recognized that those past reports were not as technically sophisticated as the present submission, there is a concern regarding novelty. That said, the reviewers recognized that the present study, apart from being cutting-edge, provided new insights into areas of skeletal development. It is therefore critical that the authors highlight how specifically this study adds new dimensions to previous work and moves the field forward.</p></disp-quote><p>Thanks for the compliments that <italic>“</italic>the present study, apart from being cutting-edge, provided new insights into areas of skeletal development”. We have read previous reports carefully: Sun et al., 2019, Li et al., 2019 and Wang et al., 2020. We also appreciate the suggestion from the reviewers and editors. We have now highlighted how specifically in our study adds new dimensions to previous work and moves the field forward in the Introduction, and Discussion, which are also summarized as follows:</p><p>1) While all of the recently published studies focus on postnatal bone and regulation of mature osteoblast/osteocyte functions by the mechanical force channel Piezo1, our studies also tackle the roles of both Piezo1 and 2 in early skeletal (cartilage and bone) development. We have stated in the Introduction that “mechanical forces are part of environmental cues that are sensed and responded to during embryonic development and adult life for proper morphogenesis and tissue/organ functions” and “despite the long-recognized key regulatory roles of mechanotransduction for embryonic development and sensory perception, little concrete information on the molecular mechanisms that integrate biophysical stimuli with gene regulation to guide fundamental events such as cell fate determination, proliferation and apoptosis is known”. Our study therefore emphasized on osteoblast differentiation from embryonic gmesenchymal progenitor cells and adult bone marrow stromal cells (BMSCs) where stem cells are found. Our work uncovered the temporal and spatial expression of Piezo1 and 2 in embryonic long bones in situ and their roles in osteoblast differentiation from embryonic mesenchymal progenitor cells or BMSCs. In addition, despite the lower expression levels of <italic>Piezo2</italic> in the bone forming cells, it is important to know its functions. Our findings indicate that the role of Piezo2 in the skeleton should not be ignored. Despite the lack of apparent phenotypes in skeletal development in the <italic>Piezo2</italic> mutants, <italic>Piezo2</italic> loss did enhance the long bone phenotypes of <italic>Piezo1</italic> mutants. Our studies of Piezo1/2 in early embryonic development and BMSCs together advance the current mechanistic understanding of mechanic force sensation and response in cell fate decision from progenitor or stem cells. Importantly, our studies provide new opportunities to understand how mechanical information from environment in the form of biophysical stimuli such as stress, strain and fluid flow generated by gravity, cell movement and cell-cell or cell-extracellular matrix (ECM) interactions, join well-known complex networks of biochemical signaling that direct the development of higher vertebrate embryos as well stem cell regulation during tissue regeneration.</p><p>2) It is satisfying to see that reduction of Yap1 activities by loss of Piezo1 function was shown in two of the three recently published work. Our study specifically advanced current understanding of Yap1 activation in mechanotransduction by connecting Piezo1/2 mediated Ca<sup>2+</sup> signaling with a signaling cascade leading to downstream actomyosin cytoskeleton rearrangement and a concerted activation of key transcription factors including Yap1, β-catenin (Ctnnb1) and NFAT, all of which have been demonstrated to play key roles in promoting osteoblast differentiation. Our finding that the Piezo channels regulate noncanonical Yap1 activation independently of the Mst (Stk3 and 4)/Lats kinase cascade open new doors to further understanding regulation of not only Yap1, but also β-catenin and NFAT in many other physiological and pathological contexts, given the importance of mechanotransduction and these transcription factors in the normal functions and diseases of many tissues and organs. More details are provided in our response to Point 4.</p><p>3) All 4 studies include ours provided a good opportunity to compare notes and clarify some issues in the future. For example, three studies (Sun et al., 2019, Li et al., 2019, and ours showed that loss of Piezo1 in osteoblast lineage cells reduced bone formation and osteoblast differentiation, while Wang et al., 2020 indicated that loss of Piezo1 in osteoblast cells increased bone resorption without reducing bone formation.</p><disp-quote content-type="editor-comment"><p>2) There is the missed opportunity of making the manuscript more distinctive. For example, there is a clear difference in the sites of bone fracture, notably limb versus rib, in in Piezo1 CKOs driven by Prrx1 and Osx Cre, respectively. Studies examining the expression pattern of the Piezo1/2 proteins in sorted Prrx1-positive and Osx-positive osteoblast progenitors during differentiation under induced mechanotransduction conditions could shed light on this difference.</p></disp-quote><p>Thanks for the comments. As we pointed out in the manuscript, the <italic>Prrx1Cre</italic> and <italic>OsxCre</italic> (<italic>Sp7-Cre</italic>) are expressed in overlapping but different tissues and cells. In the limb, <italic>Prrx1Cre</italic> is expressed in all mesenchymal progenitor cells that give rise to cartilage, bone and tendon/ligament. Its activity is also found in the limb muscle, while <italic>Sp7-Cre</italic> expression is limited to osteoblast lineage cells and hypertrophic chondrocytes. However, <italic>Sp7</italic> is expressed in all developing bones, many of them do not express <italic>Prrx1</italic>, for instance, the rib, which explains lack of rib phenotypes in the <italic>Prrx1Cre</italic> driven mutants. In the developing limb, tendon, ligament and muscle play critical roles transmitting the forces between skeletal and muscular tissues, and this function might require extra-skeletal Piezo1 function. This may explain why the <italic>Prrx1Cre</italic> driven <italic>Piezo1</italic> mutants resulted in more severe bone defects. To further understand the difference between the <italic>Prrx1</italic>-positive and <italic>Sp7</italic>-positive osteoblast progenitors, we have also sorted the Prrx1-positive BMSCs and Sp7-positive osteoblast progenitors, cultured them and determined Piezo1/2 expression during osteoblast differentiation under induced mechanotransduction conditions. The protein levels were not high enough to be reliably detected in the cultured cells by Western blotting, but we found that mRNA expression of <italic>Piezo1</italic> was slightly upregulated by fluid stress in the Prrx1 positive, but not Sp7 positive cells. There was no significant difference in <italic>Piezo2</italic> expression, and its expression levels were much lower than those of <italic>Piezo1</italic>. The data have been added as the revised Figure 4D and p11 in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3) It was felt that the connection between Yap and Piezo activity was very interesting and was likely to be important for the growing Hippo-Yap field. However, insufficient evidence was presented to establish that activated Yap pathways contribute to osteoblast differentiation through Piezo. It was also unclear how precisely non-canonical Yap signaling plays a role – specifically, molecular mechanisms remained scanty. The authors would need to answer several key questions: (a) what are the respective functions of Yap1 and β-catenin in osteogenesis mediated by Piezo1/2; (b) what is the physiological function the NFAT/YAP/β-catenin complex; (c) what is the contribution of YAP1 to the rescue in Piezo1 and Piezo1/2 mutants by enhanced β-catenin activity; and (d) whether there is crosstalk between Wnt/β-catenin and Hippo/Yap signaling? The authors should comment in more depth on potential Hippo signaling in their system. This possibility is suggested by their data but does not come out well in the Discussion.</p></disp-quote><p>Thanks for agreeing that the connection between Yap and Piezo activity was very interesting and was likely to be important for the growing Hippo-Yap field. We have performed additional experiments and added discussion in our data interpretation to make our points more clear. Here are our answers to the raised questions:</p><disp-quote content-type="editor-comment"><p>a) What are the respective functions of Yap1 and β-catenin in osteogenesis mediated by Piezo1/2?</p></disp-quote><p>The phenotypes of neonatal bone fractures, reduced bone formation and increased bone resorption found in the <italic>Prrx1-Cre; Piezo1</italic>, <italic>Prrx1-Cre; Piezo1/</italic>2 or <italic>Sp7-Cre; Piezo1</italic>, <italic>Sp7-Cre; Piezo1/2</italic> mutants were similar to those found in the <italic>Yap1/Taz</italic> and <italic>β</italic>-<italic>catenin</italic> mutants. Our rescuing experiments with BIO treatment (revised Figure 10 and Figure 10—figure supplement 1) indicate that at least part of the functions of Piezo1/2 induced Yap1 activation is to promote β-catenin activation. However, the incomplete phenotypic and Yap1 expression rescue by BIO treatment suggest that Yap1 has non-overlapping functions with β-catenin. A possible scenario is that Yap1 and β-catenin each have their unique targets to promote bone formation aside from enhancing each other’s activities. In addition, each also has its own parallel upstream regulatory pathways such as Piezo1/2 as explained in detail in (c). We have also performed new experiments (revised Figure 10—figure supplement 1C) as explained in the following (c) and (d) to make these points more clear in subsection “Enhanced Ctnnb1 activities partially rescued the bone defects of <italic>Piezo1/2</italic> bone mutants” and Discussion paragraph three.</p><disp-quote content-type="editor-comment"><p>b) What is the physiological function the NFAT/YAP/β-catenin complex?</p></disp-quote><p>Our data indicate that the physiological function of the complex is to allow calcineurin-activated NFAT to coordinately activate YAP and β-catenin. In addition, such complex formation indicate that Yap was activated together with β-catenin, suggesting that β-catenin can also be activated by mechanotransduction via Yap1 and may mediate some of Yap1 activity in promoting bone formation. This point has been made more clear in Discussion paragraph three.</p><disp-quote content-type="editor-comment"><p>c) What is the contribution of YAP1 to the rescue in Piezo1 and Piezo1/2 mutants by enhanced b-catenin activity?</p></disp-quote><p>It is very likely that Yap1 and β-catenin each have their unique targets to promote bone formation aside from enhancing each other’s activities. In addition, each also has its own upstream regulatory pathways. While BIO treatment strongly upregulated β-catenin protein levels, the increase of Yap1 was less appreciable (Figure 10C), suggesting that while β-catenin activation is essential for osteoblast differentiation and can promote Yap1 activation (revised Figure 9—figure supplement 1A and revised Figure 10—figure supplement 1C), Yap1 is also regulated by Piezo1/2 via β-catenin-independent pathway(s). In addition, blocking Yap1 transcription activity by Verteporfin (VP)(Liu-Chittenden et al., 2012) reduced the effects of BIO in promoting both β-catenin and Yap levels, suggesting that β-catenin requires Yap1 activity to be fully upregulated, consistent with previous published results (Pan et al., 2018). It is possible that the incomplete Yap1 protein rescue by BIO treatment contributed to the incomplete phenotypic rescue of the <italic>Piezo1</italic> and <italic>Piezo1/2</italic> mutant by BIO treatment (revised Figure 10). It is the concerted activation of NFATc1, Yap and β-catenin that constitutes fully functional mechanotransduction pathways downstream of Piezo channels in promoting bone formation. More results and discussion have been added in subsection “Enhanced Ctnnb1 activities partially rescued the bone defects of <italic>Piezo1/2</italic> bone mutants”.</p><disp-quote content-type="editor-comment"><p>d) whether there is crosstalk between Wnt/β-catenin and Hippo/Yap signaling?</p></disp-quote><p>Yes, definitely! The cross talk between Wnt/β-catenin and Hippo/Yap1 signaling have been shown by a number of previous publications. The exact nature of such crosstalk is likely to be context dependent and several crosstalk mechanisms may exist in parallel. In our study, the crosstalk was shown in revised Figure 9—figure supplement 1A. While β-catenin promoted Yap transcription activity, Yap also promoted β-catenin transcription activity. In addition, we also further investigated the crosstalk between endogenous Wnt/β-catenin and Hippo/Yap1 signaling in primary BMSCs during the revision (revised Figure 10—figure supplement 1C and subsection “Enhanced Ctnnb1 activities partially rescued the bone defects of <italic>Piezo1/2</italic> bone mutants”). We showed that while Wnt/β-catenin signaling activation by BIO increased β-catenin protein levels and reduced β-catenin phosphorylation as expected, BIO treatment also increased Yap1 protein levels and reduced Yap1 phosphorylation. In addition, reduction of Yap1 phosphorylation by treating the cells with XMU-MP-1, an inhibitor of Hippo kinase Stk3/4 (or Mst<sub>1/2</sub>) (Fan et al., 2016), was also accompanied by increase in total and non-phosphorylated β-catenin protein levels, supporting a positive interaction between the Wnt/β-catenin and Hippo/Yap1 signaling pathways in the BMSCs. In addition, blocking Yap1 transcription activity by Verteporfin (VP)(Liu-Chittenden et al., 2012) reduced the effects of BIO in promoting both β-catenin and Yap1 levels, suggesting that β-catenin requires Yap1 activity to be fully upregulated (revised Figure 10—figure supplement 1C).</p><disp-quote content-type="editor-comment"><p>4) The authors show Piezo1/2 expression in long bone, but not in the axial skeleton or the skull. Specifically, are there abnormalities in craniofacial bones or teeth?</p></disp-quote><p>Like in the long bone, our preliminary results showed Piezo1 is also expressed in the osteoblast progenitor and differentiated osteoblast cells in the skull. <italic>Piezo2</italic> is not expressed in osteoblast lineage cells in the developing cranial bone. However, we did not see consistent bone formation difference between the <italic>Piezo1</italic> or <italic>Piezo2</italic> mutants and the wild type controls at developmental or early postnatal stages. These data are consistent with similar findings in Wang et al., 2020. We have not yet examined Piezo1/2 expression in the developing teeth or spine, nor the phenotypes in the absence of Piezo1/2. These will be interesting topics for future thorough investigations.</p><disp-quote content-type="editor-comment"><p>5) BTX treatment is not the best means to examine the mechanosensor function of Piezo proteins in bone formation, as injured muscle and nerves are known to alter bone formation indirectly. While the hind-limb suspension model or tibia axial loading would provide a better assessment, it would suffice to provide full histomorphometric analysis to confirm the function of the Piezo proteins in bone formation.</p></disp-quote><p>It is known that muscle contractions and external gravitational loading are two primary sources of mechanical forces exerted on bone. It is necessary to test whether Piezo1/2 in osteoblast cells are required to sense mechanical forces exerted by muscle contractions using the established BTX injection model, while we agree that the BTX model has its limitations. The role of <italic>Piezo1</italic> in an external gravitational loading (the hindlimb suspension (HS) model) and tibia axial loading have been shown by three recent papers published in <italic>eLife</italic> (Sun et al., 2019, Li et al., 2019, Wang et al., 2020). We are aware that there are indirect detrimental effects of BTX treatment on muscles, but at least some of these effects are not specific to the injected limbs and also found in the contralateral control limbs (Ellman et al., Calcif Tissue Int. 2014). By using the contralateral leg as the control, much of the indirect effects in the BTX model could be normalized. We would like to mention that none of the current loading and unloading models are perfect. Muscle atrophy is also found in the HS models and tibia axial loading is performed under artificial conditions. Studies in all these models collectively provide complementary insights into the roles of Piezo1/2.</p><p>While the BTX model is relevant in testing the role of Piezo1/2 in osteoblast mechanosensing (revised Figure 5C), we feel it is not feasible and necessary to confirm with full histomorphometric analysis the function of the Piezo proteins in bone formation within two months for the following reasons: 1, We have shown in multiple assays including histomorphometric analysis that bone formation was severely reduced in the <italic>Prrx1-Cre-driven Piezo1/2</italic> mutant mice in the manuscript (Figure 2E, F). As defects in bone formation in the HS and tibia axial loading models have been demonstrated by histomorphometric analysis in the less severe <italic>Piezo1</italic> osteoblast-specific mutants (Sun et al., 2019, Li et al., 2019), it is less likely that reduced bone formation did not contribute to blunted bone loss in the BTX-injected, more severe <italic>Sp7-Cre</italic> driven <italic>Piezo1/2</italic> mutants. 2, We already found that loss of <italic>Piezo1/2</italic> in early osteoblast cells led to very severe reduction of bone formation (Figure 2E, F), such that dynamic bone formation parameters was not quantifiable in our <italic>Piezo</italic> mutants. Lastly, I have talked to our colleague Dr. Roland Barron, an expert in histomorphometric analysis and the core at MGH and both told us that it is not possible for them to finish sample preparation and analyses within 2 months even if the mice were ready for BTX injection two months ago. We were told that the reasonable estimate is 4-6 months given the need for mouse breeding and their current work load.</p></body></sub-article></article>